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To Ronja and Sorje
What is essential is invisible to the eye.
—The Little Prince, Antoine De Saint-Exupéry, 1943

ABSTRACT
The usage of computerised methods in radiological image interpretation is 
becoming more common. Texture analysis has shown promising results as an 
image analysis method for detecting non-visible and visible lesions, with a number 
of applications in magnetic resonance imaging (MRI). Although several recent 
studies have investigated this topic, there remains a need for further analyses 
incorporating different clinical materials and taking protocol planning for clinical 
analyses into account. The purpose of this thesis was to determine the clinical 
applicability of MRI texture analysis from different viewpoints. 
This study is based on three patient materials and one collection of healthy 
athletes and their referents. A total of 220 participants in wider on-going 
study projects at Tampere University Hospital were included in this thesis. The 
materials include a study on non-Hodgkin lymphoma, representing soft tissue 
imaging with malignant disease treatment monitoring; and two studies on central 
nervous system diseases, mild traumatic brain injury and multiple sclerosis. A 
musculoskeletal imaging study investigated load-associated physiological changes 
in healthy participants’ bones. Furthermore, manual Region of Interest (ROI) 
definition methods and the selection of MRI sequences for analyses of visible and 
non-visible lesions were evaluated. 
In summary, this study showed that non-visible lesions and physiological 
changes as well as visible focal lesions of different aetiologies could be detected 
and characterised by texture analysis of routine clinical 1.5 T scans. The details of 
MRI sequence selection and ROI definition in this study may serve as guidelines 
for the development of clinical protocols. However, these studies are partly 
experimental and need to be validated with larger sample sizes.

TIIVISTELMÄ
Tietokoneavusteisten menetelmien käyttö lisääntyy radiologisessa diagnostiikassa. 
Tekstuurianalyysi on antanut lupaavia tuloksia magneettikuvien tarkastelussa. Sen 
avulla on voitu määrittää sekä pieniä hajanaisia että suurempia paikallisia muu-
toksia. Menetelmää tulisi tutkia edelleen, koska kliinisen menetelmän kehittämis-
tä varten tarvitaan lisätietoa sen soveltuvuudesta erilaisille aineistoille sekä analyy-
simenetelmän eri vaiheiden optimoimisesta. Tämän väitöstutkimuksen tavoite oli 
selvittää magneettikuvauksen (MRI) tekstuurianalyysin kliinistä käytettävyyttä eri 
kannoilta.
Tutkimusaineisto koostui kolmesta potilasmateriaalista ja yhdestä terveiden 
urheilijoiden joukosta sekä heidän verrokeistaan. Aineisto kerättiin osina Tam-
pereen yliopistollisessa sairaalassa toteutettuja laajempia tutkimusprojekteja, ja 
mukaan otettiin yhteensä 220 osallistujaa. Ensimmäisessä osatyössä tarkasteltiin 
pehmytkudoskuvantamista, non-Hodgkin-lymfooman hoitovasteen arviointia 
tekstuurianalyysilla. Kaksi seuraavaa osatyötä käsitteli keskushermoston kuvan-
tamista: lieviä aivovammoja sekä MS-tautia. Viimeisessä osatyössä arvioitiin lii-
kunnan vaikutusta urheilijoiden ja verrokkien reisiluun kaulan luurakenteeseen. 
Kudosten ja muutosten vertailuissa oli edustettuna sekä ympäröivästä kudoksesta 
visuaalisella tarkastelulla erottumattomia että selkeästi erottuvia rakenteita. Lisäk-
si tutkimuksessa selvitettiin mielenkiintoalueen käsityönä tehtävän rajaamisen ja 
MRI- kuvaussekvenssin valinnan vaikutusta analyysiin.
Yhteenvetona todetaan, että tekstuurimenetelmällä on mahdollista havaita ja 
karakterisoida tutkimukseen valikoidun aineiston edustamia etiologialtaan erilai-
sia muutoksia kliinisistä 1.5 Teslan magneettikuvista. Tutkimuksessa käsitellyt yk-
sityiskohdat MRI-kuvasarjojen valinnasta sekä mielenkiintoalueiden piirtämisestä 
antavat pohjaa kliinisen protokollan kehittämiseen. Osa tutkimusaineistoista oli 
kokeellisia, ja niiden tulokset tulisi vahvistaa laajemmilla kliinisillä tutkimuksilla.
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ACC  Average correlation coefficients
ADC  Apparent diffusion coefficient
ANN   Artificial neural network
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BMD  Bone mineral density
BV/TV  Bone volume fraction (bone volume/total volume)
CAD  Computer-aided diagnosis
CIS  Clinically isolated syndrome
CNS  Central nervous system
COST  European Cooperation in Science and Technology
CSF  Cerebrospinal fluid
CT  Computed tomography
DCE  Dynamic contrast enhanced
DICOM Digital imaging and communications in medicine
DTI  Diffusion tensor imaging
DXA  Dual energy x-ray absorptiometry
FAT SAT Fat saturation
FDG-PET 18F-fluorodeoxyglucose positron emission tomography
FISP  Fast imaging with steady state precession
FLAIR  Fluid attenuation inversion recovery
FLASH  Fast low angle shot
FLT-PET 18F-fluoro-thymidine positron emission tomography
FSE  Fast spin echo/Turbo spin echo (TSE)
FSPGR  Fast spoiled gradient recalled echo
GCS  Glasgow Coma Scale
GDM   Gradient density matrix 
GE  General Electric
GLCM  Grey level co-occurrence matrix
GRE  Gradient echo
k-NN  k-Nearest neighbour classification
LDA  Linear discriminant analysis
MDF   Most discriminative features
MEDIC T2* weighted spoiled gradient echo with multiple echoes
MEF   Most expressive features 
MPGR  Multiplanar gradient-recalled acquisition in steady state
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13
LIST OF SYMBOLS AND ABBREVIATIONS
TI  Inversion time
TIRM  Inversion recovery turbo spin echo
TR  Time to repetition
TSE  Turbo spin echo/Fast spin echo
TUVA   Tumor response evaluation
T1  Longitudinal relaxation time
T2  Transverse relaxation time
T2*  Effective transverse relaxation time
WHO  World Health Organization
WM  White matter
1-NN   Nearest-neighbour classification
2D  Two-dimensional
3D  Three-dimensional

15
LIST OF ORIGINAL PUBLICATIONS 
This thesis is based on the following original articles, referred to in the text by 
their Roman numerals (I–IV):
I  Harrison LC, Luukkaala T, Pertovaara H, Saarinen TO, Heinonen TT, 
Järvenpää R, Soimakallio S, Kellokumpu-Lehtinen PL, Eskola HJ, Dastidar 
P. Non-Hodgkin Lymphoma response evaluation with MRI Texture Classification. 
Journal of Experimental and Clinical Cancer Research. 2009 Jun 22;28:87.
 II  Holli KK, Harrison L, Dastidar P, Wäljas M, Liimatainen S, Luukkaala T, 
Öhman J, Soimakallio S, Eskola H. Texture analysis of MR images of patients 
with mild traumatic brain injury. BMC Medical Imaging. 2010 May 12;10:8.
III  Harrison LC, Raunio M, Holli KK, Luukkaala T, Savio S, Elovaara I, 
Soimakallio S, Eskola HJ, Dastidar P. MRI texture analysis in multiple sclerosis: 
toward a clinical analysis protocol. Academic Radiology 2010; 17:696-707.
IV Harrison LCV, Nikander R, Sikiö M, Luukkaala T,  Helminen M, Ryymin 
P, Soimakallio S, Eskola HJ, Dastidar P, Sievänen H. MRI Texture Analysis of 
Femoral Neck: Detection of Exercise Load-Associated Differences in Trabecular 
Bone. Accepted for publication in Journal of Magnetic Resonance Imaging on 
8. Feb.2011.

17
1. INTRODUCTION
A number of computer aided visualisation methods, in addition to qualitative 
and quantitative analysis techniques, are available in clinical radiology. These 
methods provide clinicians with a comprehensive view of the imaged object from 
the macroscopic to the microscopic or even to the molecular level of the imaged 
object. This thesis focuses on non-ionising imaging method magnetic resonance 
imaging (MRI) as a promising imaging modality for quantitative texture analysis.
 Research groups led by F. Bloch and E.M. Purcell in the 1940s discovered 
methods for measuring nuclear magnetic resonance in organic materials, leading 
to their receipt of the Nobel Prize in Physics in 1952 (Purcell, 1952; Bloch, 
1952). Five decades later, the 2003 Nobel Prize in Physiology or Medicine 
was awarded to P. Lauterbur and P. Mansfield for their discoveries concerning 
“magnetic resonance imaging” (Mansfield, 2003; Lauterbur, 2003). Apart from 
these eminent scientists’ discoveries, other fundamental inventions in the fields of 
medicine, physics, electronics, signal processing and image analysis find their uses 
in MRI devices and applications.
MRI analysis methods constitutes a wide field of interest from visualisation in 
two (2D) and three dimensions (3D); volumetric, shape and texture analyses of 
specific tissues and abnormalities; and functional measures of cell activity, blood 
perfusion and oxygen concentration. Different segmentation methods and 3D 
visualisation of magnetic resonance images have provided not only advanced 
diagnostic tools for radiologists but offer clinicians new insights and powerful 
tools for treatment planning in operative specialities and in oncology. Specific 
imaging sequences highlighting the diffusion properties of water have opened 
unforeseen levels of detail, especially in brain imaging. Now, when viewing the 
imaged object at the level of individual pixels, the smallest elements in a digital 
image; the grey level values of the pixels may be investigated with histogram 
analyses and more advanced methods, and the relationships between the grey 
levels of pixels are used to describe the texture of the tissues. Texture analysis (TA) 
based on MRI is an emerging field of research, with applications in a wide variety 
of radiological topics, including the detection of lesions and characterisation of 
and differentiation between pathological and healthy tissues in different organs 
(Castellano et al., 2004; Kassner and Thornhill, 2010). 
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The most significant objective in quantitative image analysis is to find 
tissue-specific features that have biological significance and are correlated 
with pathophysiologies that may be detected by other methods, i.e., clinical 
examination, other imaging modalities or histopathological diagnosis, and 
secondly to provide this new tissue property information to be used alone or in 
combination with other clinical information to allow more reliable detection and 
characterisation of disease. 
The present thesis aims to increase our knowledge of magnetic resonance 
imaging-based texture analysis for clinical use. Texture analysis based mostly 
on statistical parameters was applied to a selection of clinical materials as a step 
towards the development of a tissue classification method as a clinical diagnostic 
and follow-up tool.
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2. BACKGROUND AND    
 LITERATURE REVIEW
2.1 Introduction to texture analysis
Texture is an important pattern property of the two-dimensional pictorial and 
three-dimensional volumetric descriptions of an object. Texture is present 
everywhere, both in nature and in man-made objects. Textures may be detected 
qualitatively by the different senses; one may feel the texture of different surfaces 
(for example, textiles or tree bark). Visually, one may detect the same texture with 
new features. There is no precise definition of texture in the literature. It may 
be described by many adjectives: fine, coarse, smooth, irregular, or lineated, to 
mention only a few (Haralick et al., 1973). The ability of human vision to detect 
and discriminate between complex textures is limited (Julesz et al., 1973). Image1 
presents several examples of textures. Quantitatively, texture may be defined 
and analysed according to numerous parameters through different methods of 
calculation (Tuceryan and Jain, 1998). These methods are able to detect textural 
differences below the limits of human visual perception. 
FIGURE 1. Examples of textures.
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Texture has long been used as a parameter for the qualitative and quantitative 
classification and analysis of materials in industry and medicine. Kaizer used 
autocorrelation function-based TA for aerial photographs in the 1950s (Kaizer, 
1955). Haralick tested texture features based on grey tone spatial dependencies 
on three different scale images: photomicrographs, aerial photographs and 
multispectral scanner satellite image, with good classification results (Haralick et al., 
1973). These two approaches to texture were among the first examples of statistical 
TA. Statistical TA is also important for machine vision, which is used in different 
industries for automated inspection to classify objects, detect defects and control 
quality. An overview of texture analysis methods is presented in the next Chapter, 
and the methods used in this study are reviewed in more detail in Chapter 2.3.
Medical applications of texture analysis provide a quantitative means of 
identifying anatomical and pathological structures. In 1974, Chien and Fu 
published their application of co-occurrence matrix for automated chest X-ray 
analysis (Chien and Fu, 1974). In radiology, applications based on radiograph, 
ultrasound, computed tomography and magnetic resonance image data have 
proven able to provide advanced non-visible information about tissues of interest. 
A detailed review of recent publications on MRI TA with study settings possible 
to repeat in clinical imaging, is presented in Chapter 2.4.
2.2 Texture analysis methods 
The wide variety of texture methods proposed in the literature can be divided into 
four major categories, referred to by Tuceryan and Jain as statistical, geometrical, 
model-based and signal-processing methods (Tuceryan and Jain, 1998). In reviews 
of medical TA, Materka and Castellano term the geometrical methods group 
structural, and the signal-processing methods transform methods (Castellano 
et al., 2004; Materka and Strzelecki, 1998). Both of these nomenclatures are 
commonly used, and the contents of the groups are analogous. 
Statistical methods comprise the oldest approach in texture analysis. They 
describe texture by computing the local features of spatial grey level distribution 
and relationships between pixels. These features can be classified into first-order 
and second-order statistics. First-order statistics describe image properties that 
depend solely on individual pixel values, whereas second-order statistics describe 
the properties of pixel pairs (Tuceryan and Jain, 1998). Statistical methods include 
features derived from the histogram, gradient, autocorrelation function, run-
length matrix and co-occurrence matrix. The run-length matrix approach and the 
co-occurrence matrix approach were introduced in the 1970s by Galloway and 
Haralick, respectively (Galloway, 1975; Haralick et al., 1973; Haralick, 1979). 
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Model-based TA involves fractal features (Mandelbrot, 1977; Pentland, 1984), 
Markov random fields (MRF) (Jain, 1989) and autoregressive (AR) models 
(Haralick, 1979; Jain, 1989). A fractal is a geometric shape or object that is 
made up of smaller copies of itself. Mandelbrot’s fractal geometry provides a 
mathematical model for many complex forms found in nature. Fractals are 
generally self-similar and independent of scale. In MRF models the pixel intensity 
value depends on the neighbouring pixel intensities. Autoregressive models 
assume that pixel intensity is the weighted sum of neighbouring pixel intensities.
Geometrical or structural TA techniques define texture with local primitive 
elements, such as lines or shapes, which are replicated at other locations in the 
image (Goutsias et al., 2000; Allen and Mills, 2004). These techniques are not 
used as widely as other texture analysis methods, but they provide a good symbolic 
description of the image and are more useful for texture synthesis. 
 Signal-processing methods describe the textural properties of the object as 
parameters derived from transformations used in signal processing, e.g., Fourier, 
Gabor, Wavelet and Stockwell transforms (Tuceryan and Jain, 1998; Allen and 
Mills, 2004; Qian and Chen, 1993; Russ, 2002; Stockwell et al., 1996).
The textural properties of objects vary greatly, and the best discriminating 
textural features vary even within the same material. Among the wide range of 
texture parameters that may be calculated, researchers must define and select the 
features that provide the best discrimination properties for their data of interest. 
Limiting the feature set is an important step towards reducing the processing 
time and optimising classification. Several texture analysis methods may be used 
in combination to obtain better classification results. Different classification 
methods have been used to attain accurate classification.
2.3 Texture analysis software (MaZda package)
The texture analysis application used in this thesis is introduced here, along with 
a more detailed discussion about the nature of the parameters calculated. The 
parameters introduced in this section are also commonly used in many of the 
studies referred to in the literature review; however, the parameter calculation is 
performed by different applications in some of those studies.
Recently, two European cooperation projects on coordinating and developing 
quantitative MRI were established. These projects were coordinated by the 
European Cooperation in Science and Technology (COST), which is one of 
the longest-running instruments supporting cooperation among scientists 
and researchers across Europe. COST action B11, namely the Quantitation 
of Magnetic Resonance Image Texture project (1998-2002), focused on recent 
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developments in quantitative MRI, in particular texture analysis, to maximise 
the amount of clinical diagnostic information that could be extracted from this 
technique (Materka and Strzelecki, 1998; COST B11, 2001). The MaZda MRI 
texture analysis software package was developed at The Institute of Electronics in 
the Technical University of Lodz, Poland, in cooperation with the B11 project. 
MaZda and an integrated B11 software package became the official tool for 
MR-image analysis within the framework of the project (Materka et al., 2006; 
Szczypiński et al., 2009). Similar work continued in 2003-2008 with COST 
action B21, Physiological Modelling of MR Image Formation (COST B21, 
2008), and a book on the topic of TA was published in 2006 (Hájek et al., 2006). 
 MaZda and integrated B11 software is run under Microsoft Windows 9x/
NT/2k/XP operating systems. MaZda (3.20) calculates almost 300 texture 
parameters, divided into histogram, gradient, run-length matrix, co-occurrence 
matrix, autoregressive model and wavelet-derived parameter feature sets. Regions 
of interest (ROI) are set manually or semi-automatically by drawing on a layer on 
the image. (Materka et al. 2006; MaZda)
The texture features calculated by MaZda (3.20) (Table 1) and some other 
functions of the software package are presented in the following sections of this 
chapter. Mathematical notations for the TA parameters are presented in Appendix.
TABLE 1. Texture features calculated by MaZda (3.20)
Histogram
Mean, variance, skewness, kurtosis, percentiles 1-%, 10-%, 50-%, 90-% and 99-%
Absolute gradient
Mean, variance, skewness, kurtosis, percentage of pixels with a nonzero gradient
Run-length matrix
Run-length nonuniformity, grey level nonuniformity, long run emphasis, short run 
emphasis, fraction of image in runs
Co-occurrence matrix
Angular second moment, contrast, correlation, sum of squares, inverse difference moment, 
sum average, sum variance, sum entropy, entropy, difference variance, difference entropy
Autoregressive (AR) model
Theta (θ): model parameter vector, 4 parameters;
Sigma (σ): standard deviation of the driving noise
Wavelet
Energy of wavelet coefficients in sub-bands at successive scales;
Maximum 4 scales each with 4 parameters
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2.3.1 Histogram-based parameters
The number of distinct grey tones that can be represented by a digital image 
depends on the number of bits per pixel. For example, if information in a single 
pixel is represented by 8 bits, then 256 grey tones are available, while 16 bits per 
pixel can encode 65,536 tones. 
Grey level intensity histogram is a function that counts the number of observed 
pixels with specific grey level tones. It counts the frequencies of discrete intervals; 
in this application, the number of intervals equals the number of possible grey 
level tones in the image. Histograms can be easily calculated from images, and 
the results are plotted on a graph. Several statistical properties of the image can 
be calculated from the histogram; in MaZda (3.20), the following histogram 
parameters can be calculated. Mean is the average intensity level of the image. 
Variance describes how far values lie from the mean, i.e., the roughness of the 
image. Skewness describes the histogram symmetry about the mean, i.e., whether 
there is a wider range of darker or lighter pixels than average; positive skewness 
indicates that there are more pixels below the mean than above, and a negative 
skewness indicates the opposite. Kurtosis describes the relative flatness of the 
histogram, i.e., how uniform the grey level distribution is compared to a normal 
distribution; negative kurtosis describes a flat distribution, and positive kurtosis 
describes a peaked distribution. Percentiles give the highest grey level value under 
which a given percentage of the pixels are contained. These parameters are first-
order statistical parameters because their calculation is based on single pixel values, 
not relationships between pixel pairs. (Materka et al., 2006; Lahtinen, 2009)
2.3.2 Gradient-based parameters
A gradient is a directional change in grey level intensity in an image. High gradient 
values represent dramatic changes in grey level between light and dark tones; low 
gradient values are produced when the change in tone is smooth. The measure 
of mean grey level variation across the image is represented by the mean absolute 
gradient. Gradient variance describes the how far the values are from the mean. 
Gradient skewness and kurtosis are functions of gradient asymmetry. (Materka et 
al., 2006; Lahtinen, 2009)
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2.3.3 Run-length matrix-based parameters
The run-length matrix contains information about the number of runs with pixels 
of defined grey levels and run lengths in an image. These matrices can be calculated 
for different run angles. In this application, the orientations of horizontal, vertical 
and two diagonals are calculated. Long and short run emphasis parameters give 
measures of proportions of runs with long and short lengths. Short run emphasis 
is expected to be larger in coarser images, and long run emphasis is larger in 
smoother images. Grey level nonuniformity calculates how uniformly runs are 
distributed among the grey levels; it takes small values when the distribution of 
runs is uniform. Similarly, run length nonuniformity measures the distribution 
of grey levels among the run lengths. The fraction of image in runs describes the 
fraction of image pixels that are part of any run available in the defined matrix. 
(Materka et al., 2006; Lahtinen, 2009)
2.3.4 Co-occurrence matrix-based parameters
The grey level co-occurrence matrix (GLCM), also called the grey tone spatial 
dependency matrix, describes how often different combinations of pixel grey level 
values occur in an ROI or image. The relationships of pixel pairs, i.e., with different 
angles and separation between the reference and neighbour pixels, are calculated 
in separate matrices. Several parameters are calculated from these matrices. The 
angular second moment, also known as energy, is a measure of the homogeneity of 
the image, and homogenous images give high values. Contrast is a measure of the 
local variation present in the image. Correlation measures the linear dependencies 
of the grey level in the image. The sum of squares defines the variance in the co-
occurrence matrix. The inverse difference moment measures image homogeneity 
such that a smooth image gives a high value. The sum average gives the average 
of sums of two pixel values in the original image of interest. The sum variance is 
calculated based on the sum average. Entropy measures the disorder of the image. 
The highest value for entropy is reached when all probabilities are equal. The sum 
entropy is calculated in a similar way as the other sum parameters. Difference 
variance and difference entropy are based on differences calculated between two 
pixel values. (Materka et al., 2006; Lahtinen, 2009)
2.3.5 Autoregressive model-based parameters
Autoregressive models assume a local interaction between image pixels and describe 
each pixel grey level value as a weighted sum of the values of the neighbouring 
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pixels. For coarse textures, the coefficients of neighbouring pixels will be similar 
each other, while for fine textures, the coefficients vary more widely. In MaZda, 
five parameters are given for each ROI: the coefficients for the four neighbouring 
pixels (Theta, θ), and the standard error of noise (Sigma, σ). (Materka et al. 2006; 
Lahtinen, 2009)
2.3.6 Wavelet-based parameters
Wavelet analysis presents the image as a set of independent spatially-oriented 
frequency channels. In wavelet transformations the image signal is put through 
a low-pass and high-pass filter cascade, where the signal is down-sampled and 
decomposed simultaneously to increase the frequency resolution. The outputs 
give detail and approximation coefficients for the original signal. In MaZda, the 
energy of Haar wavelet sub-bands are calculated. (Materka et al., 2006) 
2.3.7 Grey level intensity normalisation
MaZda (3.20) provides three methods for image grey level intensity normalisation: 
analysis of the original image without normalisation; analysis for an image grey 
scale range between 1% and 99% of the cumulated image histogram; and analysis 
for image intensities in the range [m-3σ, m+3σ], where m is the mean grey level 
value and σ is the standard deviation. (Materka et al., 2006)
2.3.8 Feature selection methods
MaZda (3.20) provides two automated methods for the selection of up to ten 
texture features that show the best discrimination between texture categories or 
ROIs. The Fisher coefficient (Fisher) method uses a ratio of between-class variance 
to within-class variance. The other method uses classification error probability 
(POE) combined with average correlation coefficients (ACC). Alternatively, the 
user may manually select up to 30 features for further analysis and classification 
in the B11 application. (Materka et al., 2006)
2.3.9 Analysis and classification
The B11 application integrated in MaZda is used for data analysis and classification. 
B11 investigates how well input-data texture features can distinguish texture 
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categories by principal component analysis (PCA), linear discriminant analysis 
(LDA) and nonlinear discriminant analysis (NDA). Classification tests on input 
data may also be performed with nearest neighbour (k-NN) and artificial neural 
network n-class (ANN n-class) classifiers. Details of these analyses are given in 
Szczypiński et al. (2009) and Materka et al. (2006).
2.4 Literature review on MRI texture analysis
In radiology, there are several types of diagnostic and other clinical questions 
to be answered about the images. For example: are focal or diffuse lesions and 
abnormalities detected? What are the probable differential diagnostic aetiologies 
of the findings? Have previously detected lesions recovered or worsened over time 
and/or due to treatment procedures performed? Recent studies on MRI texture 
analysis on the fields of soft tissue imaging, neuroradiology and skeletal imaging 
as well as some technical considerations and phantom studies are discussed below.
2.4.1 Soft tissue tumour and abdominal imaging 
MRI is commonly used as a diagnostic imaging modality in soft tissue tumours. 
In addition to conventional expertise-driven visual analysis of images in the 
clinical environment, several studies on efficiency in TA have been applied for 
the diagnosis of abdominal organ diseases and soft tissue lesions with promising 
results. 
Signal intensity and homogeneity characteristics have been evaluated to find 
differences in benign and malignant soft tissue masses (Mayerhoefer et al., 2008). 
The image data consisted of 1.0 T T1-weighted, T2-weighted and short T1 
inversion recovery (STIR) series with variations in the acquisition parameters. 
Texture analysis was run with MaZda (3.20), Fisher and POE+ACC methods 
were used for feature selection and k-NN and ANN were used for classification. 
There was no clear difference in the performance of parameters selected by Fisher 
compared to POE+ACC. The ANN classifier performed better to separate benign 
and malignant lesions. Differences detected between groups were small, and in 
general, the data based on STIR images led to the most successful classification. 
Several machine learning systems have been tested in a study of diverse group 
of histologically confirmed soft-tissue tumours in an attempt to automatically 
discriminate between malignant and benign tumours (Juntu et al., 2010). T1-
images were included in the analysis and fixed size ROIs were used to define tumour 
area for texture parameter calculation in MaZda (3.20). Eight feature selection 
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methods were tested to select optimal features for classification. These methods 
belong to three feature selection families: 1) subset feature selection methods 
(forward search, backward search, bidirectional search, and greedy stepwise 
method), 2) feature ranking methods (chi-squares statistics and information gain 
methods) and 3) embedded methods in which feature selection is combined with 
a classifier [C4.5 decision trees and Vapnik’s support vector machine (SVM)]. 
The forward search method was found to identify the best discriminating feature 
subset. Vapnik’s nonlinear SVM classifier performed the classification task better 
than a neural network or Quinlan’s C4.5 decision tree classifier. The SVM had 
better classification accuracy [93%; (91% specificity; 94% sensitivity)] than the 
radiologists [classification accuracy of 90% (92% specificity; 81% sensitivity)]. 
The overall results of this study were highly promising, particularly taking into 
account the diverse aetiologies of the tumours and some variations in MR 
acquisition. 
Healthy and cirrhotic livers were investigated in a study of 1.5 T T2-weighted 
images (Jirák et al., 2002). MaZda was used to calculate textural features. The 
Fisher method, POE, and multidimensional discrimination measure in addition 
to manual parameter selection were used to describe the feature sets for the 
classification procedure. K-NN and ANN were successfully used to classify 
healthy and diseased livers, but these methods were unable to distinguish between 
three sub-groups of liver cirrhosis, which are clinically characterised by different 
Child-Pugh scores. 
In a similar study, a computer-aided diagnosis (CAD) system including ANN 
based on texture analysis was implemented to diagnose hepatic fibrosis based on 
MRI images (Kato et al., 2007). A series of respiratory-triggered T2-weighted 
fast spin echo (FSE) and T1-weighted spoiled gradient echo (GRE) with contrast 
enhancement were obtained with a 1.5 T scanner. Histogram features (mean grey 
scale value and SD) and co-occurrence matrix features (contrast, angular second 
moment, entropy, mean, and inverse difference moment) were used as input for 
ANN. The analysis method reflected the degree of hepatic fibrosis, and contrast 
enhanced images at the equilibrium phase gave the best performance.
Focal liver lesion classification was performed in a recent study by Mayerhoefer 
and colleagues (2010) on 3.0 T standard clinical acquisition protocols of T1- 
and T2-weighted images without contrast enhancement. The apparent spatial 
resolution of the images was increased by zero-fill interpolation. MaZda (4.60) was 
used for texture parameter calculation. Fisher, POE+ACC and mutual information 
methods were used to select texture feature subsets for further classification by 
LDA in combination of k-NN and k-means clustering. Classification was feasible 
for two types of focal liver lesions, cysts and haemangioma. Co-occurrence matrix 
features were selected more frequently by automated feature selection methods 
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than parameters originating from other categories. The T2-weighted image data 
produced slightly better overall classification results than the T1-weighted data. 
The LDA/k-NN classifier approach was superior to the k-means classifier. 
In breast imaging, dynamic contrast-enhanced (DCE) MRI has emerged as 
an alternative method for diagnosing breast cancer. In clinical radiology, tumour 
diagnostics is based on morphology and enhancement kinetics, but researchers 
have shown interest in texture-based quantitative methods as well. These methods 
have been able to discriminate breast tissue and lesion types with promising results 
(Gibbs and Turnbull, 2003; Holli et al., 2010; Nie et al., 2008). 
2.4.2 Neuroradiology
Texture analysis has been viewed as a potential method for the quantitative 
evaluation of diseases in neuroimaging, and Kassner and Thornhill recently 
published an excellent review article on its applications (Kassner and Thornhill, 
2010).
TA as a qualitative means of representing fine changes in tissues was reportedly 
successful in epilepsy related studies. Hippocampal abnormalities were detected by 
texture features calculated by MaZda from temporal lobe epilepsy or hippocampal 
sclerosis patients compared to healthy referents (Yu et al., 2001; Bonilha et al., 
2003).
Focal cortical dysplasia has also been identified in patients with the disease 
compared to normal controls by evaluating grey matter thickening by relative 
signal intensity, run-length coding and the transition between grey and white 
matter by absolute gradient in a study of 1.5 T T1-weighted GRE images 
(Bernasconi et al., 2001). The previous study setting was extended with co-
occurrence matrix-derived parameters (Antel et al., 2003), which showed 
that angular second moment, contrast and difference entropy values exhibited 
statistically significant differences between patients and healthy controls.
 Sankar et al. evaluated structural changes in the temporopolar cortex and its 
white matter in patients with temporal lobe epilepsy. These analyses were based 
on volumetric and texture (entropy and gradient) means in 1.5 T T1-weighted 
GRE images (Sankar et al., 2008). Cortical and white matter atrophy, as well as 
decreased texture values, were detected in temporopolar locations ipsilateral to the 
seizure focus.
Hippocampus volume, signal intensity and wavelet texture appearance 
were investigated in a recent study (Jafari-Khouzani et al., 2010) of 1.5 T fluid 
attenuation inversion recovery (FLAIR) images from patients with lateralising 
mesial temporal lobe epilepsy. Mean and standard deviation signal intensities 
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successfully lateralised the site of epileptogenicity with an accuracy of 98%. 
Wavelet texture features were successful in 94% of cases, and hippocampal 
volumetry was successful in 83% of cases.
The manifestation of multiple sclerosis (MS) in MRI images has been 
investigated in several studies. Spinal cord images of four clinical subgroups 
of MS and healthy referents were obtained with a 1.5 T volumetric inversion-
prepared fast spoiled gradient echo (FSPGR) sequence (Mathias et al., 1999). 
Texture analysis was applied with first order statistical and co-occurrence matrix-
based features. There were statistically significant differences in texture between 
controls and patients, whereas disease subgroups were not distinguishable at a 
statistically significant level.
Another recent study investigated the discrimination of MS from cerebral 
microangiopathy lesions based on 1.5 T FLAIR images with pattern recognition 
methods based on four classifiers (minimum distance, LDA, logistic regression 
and probabilistic neural network (PNN)) using histogram, co-occurrence matrix 
and run-length matrix-based features (Theocharakis et al., 2009). All texture 
features other than skewness and grey-level nonuniformity exhibited statistically 
significant differences between groups. The PNN classifier outperformed other 
classifiers with an overall accuracy of 88.46%. 
 A comparison of different texture feature sets’ abilities to classify MS lesions 
vs. normal-appearing white matter (NAWM), MS lesions vs. white matter (WM) 
and NAWM vs. WM from 1.5 T T2-weighted turbo spin echo (TSE) images was 
performed with MaZda 3.20 (Zhang et al., 2008). Two feature sets were used; 
one that consisted of co-occurrence matrix-based features only, and another made 
up of features that emerged from different parameter categories calculated by 
MaZda. Classification by 1-NN and ANN was successful for MS vs. NAWM 
and MS vs. WM with both feature sets. However, the combined set of features 
showed higher discrimination power as evaluated by the Fisher coefficient. The 
classification was unsuccessful for tissue pair WM-NAWM.
 In a recent longitudinal study (Zhang et al., 2009), texture analysis based on 
the polar Stockwell Transform (PST) was performed on new acute MS lesions. 
The lesions included in the study showed new gadolinium-enhancement on 1.5 
T T1-weighted spin-echo (SE) post-contrast sequences of patients imaged every 
two months. The TA was based on T2-weighted FSE images acquired 2 months 
before new lesion detection, images at the time of detection and 2, 4, 6 and 8 
months after detection. PST texture changes appeared to be independent from the 
changes in signal intensity and volume. PST was able to identify abnormalities in 
pre-lesional NAWM and to measure tissue injury in acute lesions as well during 
lesion recovery. 
30
2. BACKGROUND AND LITERATURE REVIEW
Herlidou-Même et al. (2003) investigated the robustness of texture analysis 
based on histogram, co-occurrence, gradient and run-length matrix parameters 
in a multicentre study. These authors used scans of test objects, patients with 
intracranial tumours and healthy referents. Images were acquired in three sites 
with 1.5 T scanners using centre-specific routine acquisition parameters for 
T2-weighted FSE and T1-weighted spoiled grass sequences. Correspondence 
factorial analysis was used to select the best discriminating texture features, and a 
hierarchical ascending classification and Mann-Whitney test were used to evaluate 
the discrimination between tested tissues. No significant differences were observed 
between data originating from different centres, and texture features suitable for 
tissue discrimination were found in these data.
The performance of 2D and 3D co-occurrence matrix parameters in the 
discrimination of solid tumour, necrosis, edema and white matter was evaluated 
in glioma data (Mahmoud-Ghoneim et al., 2003). The analysis was based on 1.5 
T T1-weighted GRE images. The classification based on the 3D data by LDA 
produced better discrimination between necrosis vs. solid tumour and edema vs. 
solid tumour than the 2D data classification results. 
Another recent study (Georgiadis et al., 2009) also compared the discrimination 
power of 2D versus 3D analyses. In this study, textural features of co-occurrence 
and run-length matrices on 1.5 T T1-weighted contrast enhanced series of 
intracranial tumours were classified by a linear least squares mapping technique 
SVM. Classification by 3D features outperformed that by 2D features when 
discriminating primary tumours from metastatic tumours, whereas discrimination 
of benign from malignant tumours resulted in exact classification with both 2D 
and 3D feature types. 
Zacharaki et al. reported the classification of brain tumour types and grades 
based on 3.0 T data acquired from four fixed sequences and relative cerebral 
blood volume (rCBV) maps (Zacharaki et al., 2009). Tumour shape features, 
image intensity characteristics and texture features based on a Gabor filter were 
calculated. Optimal feature subsets selected by t test and constrained LDA were 
classified with three methods: LDA with Fisher discriminant rule, k-NN and 
nonlinear SVM. The accuracy of classification by SVM was higher than that 
achieved by the other classifiers. The most accurate discrimination was achieved 
when distinguishing grade II glioma from metastases (97.8% accurate) and the 
least accurate when distinguishing grade II from grade III glioma (75%). 
De Nunzio et al. (2011) investigated whether 3D texture analysis could be used 
to characterise glioma-related pathological vs. healthy tissue in 3 T diffusion tensor 
imaging (DTI), an MRI technique that highlights tissue diffusion properties. 
These preliminary studies aimed for the automatic detection of cerebral glioma 
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by means of statistical TA features calculated by MaZda, and the use of an ANN 
showed promising results in discriminating tissues. 
Textural differences between Alzheimer’s disease and controls were found in 
a study by Freeborough and Fox (1998), in which 1.5 T T1-weighted images 
were examined with co-occurrence matrix textural parameters. Additionally, 
Torabi (2006) investigated co-occurrence matrix features in Alzheimer’s 
disease and in normal brains and were able to achieve accurate classifications 
using PCA for feature reduction and an ANN classifier. 
Brown et al. discovered a non-invasive method for detecting genetic signatures 
in oligodentroglioma using texture analysis based on S-transformation (Brown et 
al., 2008). The analysis was performed on 1.5 T T1-weighted contrast enhanced, 
T2-weighted and FLAIR sequences with variable acquisition parameters. The 
textural appearance of tumours originating from patients with clinically relevant 
coincident allelic loss of specific chromosomal arms was different from those in 
patients with the alleles in question intact. Especially the analysis based on T2-
weighed images performed with high sensitivity and specificity.
Kassner et al. (2009) evaluated acute ischemic stroke patients’ T1-weighted SE 
post-contrast images obtained with a 1.5 T scanner and detected co-occurrence 
matrix-based texture changes. These changes may be superior to visual evidence of 
enhancement for the prediction of haemorrhagic transformation.
2.4.3 Skeletal imaging
Texture is recognised as an important pattern property of bones and has been 
quantitatively analysed with different imaging modalities. Radiography and 
computed tomography (CT) are the most commonly used techniques, but 
magnetic resonance imaging has also been used. Here, a pair of recent studies is 
presented; microimaging studies are not discussed.
Osteoporotic patients and their healthy referents were imaged with a 1.5 T 
scanner. MaZda was used to calculate trabecular bone texture parameters from 
spoiled gradient recalled (SPGR) and fast spoiled gradient echo (FSPGR) 
gradient sequences of the calcaneus (Herlidou et al., 2004). Correspondence 
factorial analysis was used to select the most significant texture parameters for 
hierarchical ascending classification. In this study, Herlidou et al. showed that 
statistical 2D texture information from trabecular tissue characterize osteoporosis 
and age effects on the bone.
Wrists were imaged with a 3.0 T scanner using a true fast imaging with a steady 
precession (FISP) sequence to investigate whether bone structural parameters were 
correlated with texture parameters (Tameem et al., 2007). Structural parameters 
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were extracted from high-resolution MR images. 3D co-occurrence matrix-based 
texture values were calculated from MR images, and lower resolution images 
were sub-sampled from the original images. The results indicate that images with 
clinically applicable resolution provide textural information about trabecular 
bone architecture. This study highlights the potential of using clinical MRI to 
quantify bone architecture. 
2.4.4 Phantom studies and technical evaluations
Mayerhoefer et al. (2009b) recently published a systematic study on MRI 
acquisition parameter variations and protocol heterogeneity effects on texture 
analysis. In this study, phantoms originally designed as models for liver cirrhosis 
and with relaxation times in the range of biological tissues were imaged on a 
3.0 T scanner with a T2-weighted multislice multiecho sequence. Acquisition 
parameters TR, TE, number of averages (NA) and sampling bandwidth were 
used as independent variables, and three spatial resolutions were used. Texture 
parameters were calculated by MaZda 3.30. LDA and k-NN classifier were 
used for pattern discrimination. All categories of calculated texture features 
(co-occurrence matrix, run-length matrix, gradient, autoregressive model and 
wavelet) were sensitive to variations in acquisition parameters, but as long as the 
spatial resolution was sufficiently high, clinically feasible variations in acquisition 
parameters had little effect on the classification results. The discriminatory power 
of co-occurrence matrix-based features was superior to the other features at lower 
resolutions with data sets containing spatial resolution heterogeneity. 
Image interpolation effects on texture-based classification were investigated 
on another study on polystyrene spheres and agar gel phantoms with a 3.0 T 
T2-weighted multislice multiecho sequence (Mayerhoefer et al., 2009a). Matrix 
size was increased by three image processing methods: linear and cubic B-spline 
interpolation operated at the pixel level of images and zero-fill interpolation 
operated in k-space. Texture features were calculated with MaZda 4.60 from 
fixed-size ROIs. Texture patterns were classified by k-means clustering. Insufficient 
original image resolution could not be compensated with interpolation methods. 
Otherwise, image interpolation was found to improve classification based on, for 
example, co-occurrence matrix-derived parameters. Zero-filling was superior to 
the other methods used. 
Collewet et al. (2004) evaluated the influence of MRI acquisition protocols 
and grey level normalisation methods on texture classification. They used soft 
cheese samples imaged on a 0.2 T MRI scanner with proton density-weighted 
and T2-weighted SE sequences. They used gradient-, co-occurrence- and run-
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length matrix, autoregressive model and wavelet-based texture parameters. 
Original images and their copies processed with three grey level normalisation 
methods were tested. Classification was performed with a 1-NN classifier. 
When no normalisation or normalisation by multiplicative methods preserving 
the relative variation between two grey levels was performed before the texture 
calculation, the classification errors depended on the acquisition protocol. The 
best classification results were obtained when using a method that converts image 
intensities in the range [m-3σ, m+3σ], where m is the mean grey level value and 
σ is the standard deviation. The [m-3σ, m+3σ] method enhances the variations 
in grey levels between neighbours, thereby improving classification performance.  
2.5 Clinical materials
Four clinical materials covering different topics in radiological imaging were 
selected for this thesis to demonstrate the performance of texture analysis in a 
variety of clinical applications, including soft tissue tumours, traumatic injuries, 
chronic progressive disease and a physiological condition. The clinical questions 
for MR imaging in these materials focus on the detection of non-visible and 
visible changes in imaged tissues. In each topic, quantitative image analysis 
methods, such as texture analysis, can potentially provide new clinically important 
information, particularly in combination with current clinical imaging practices.
2.5.1 Soft tissue tumours: Non-Hodgkin lymphoma
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of cancers 
comprising very slow-growing low-grade to aggressive, highly malignant 
lymphomas. Lymphoma mass lesions are commonly localised to the neck, chest, 
abdomen and pelvis. A variety of diagnostic tools are used to stage the disease 
as well as in response assessment; these include biopsies, computed tomography 
(CT), integrated positron emission tomography-computed tomography (PET-
CT), magnetic resonance imaging (MRI), and 18F-fluorodeoxyglucose (FDG) or 
18F-fluoro-thymidine (18FLT) PET (Ansell and Armitage, 2005; Hampson and 
Shaw, 2008). Chemotherapy is the mainstay of therapy.
The Response Evaluation Criteria in Solid Tumors (RECIST) guidelines 
(Therasse et al., 2000; Eisenhauer et al., 2009) recommend measuring tumour 
response through one-dimensional measures of radiological images, while the 
World Health Organization criteria (WHO, 1979) recommends two dimensional 
analysis, and several research groups uses volumetric three-dimensional analysis 
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(Therasse et al., 2006). Response evaluation based on PET examinations evaluates 
malignant lesion activity by measuring its uptake of specific tracers (Ansell and 
Armitage, 2005; Hampson and Shaw, 2008). 
In routine clinical practice, treatment planning is driven by repetitive response 
evaluations. Response evaluation based on mass lesion dimensions does not take 
into account the possible appearance of residual non-active-masses, whereas 
methods measuring mass-lesion activity with tracers have limited capacity to 
differentiate inflammatory processes from active disease. Integrated PET-CT 
may outperform both PET and CT alone in diagnostic and response evaluation 
performance; however, some sub-types of NHL may possibly be FDG negative 
(Kwee et al., 2008). Diffusion-weighted MRI (DWI) with apparent diffusion 
coefficient (ADC) mapping (Perrone at al., 2011) and dynamic contrast-
enhanced (DCE) MRI (Lee et al., 2011) could be considered as supportive tools 
for analysing lymph node enlargements. Among these methods, new quantitative 
methods, such as MRI texture analysis, are important topics to investigate as they 
may provide additional information about structural changes in mass lesions that 
may be useful for treatment response monitoring.
2.5.2 Central nervous system: Mild traumatic brain injury
Traumatic brain injury varies from mild to severe. The criteria for mild 
traumatic brain injury (MTBI), according to the WHO Collaborating Centre 
for Neurotrauma Task Force on Mild Traumatic Brain Injury (Carroll et al., 
2004), include several variables that define the severity of injury: the Glasgow 
Coma Scale (GCS) score, the occurrence of transient neurological abnormalities, 
the duration of loss of consciousness and post-traumatic amnesia, and the 
presence of intracranial lesions not requiring surgery. A working group set up 
by the Finnish Medical Society Duodecim has published a national Current 
Care guideline for adult brain injuries including definitions of injury severities 
(Aikuisiän aivovammat, Current Care Summary, 2008). In mild traumatic brain 
injury (MTBI), the current clinical routine CT and MRI scans may be normal 
both in the acute phase and when repeated in the follow-up phase; however, these 
patients may develop chronic symptoms that interfere with their everyday life. 
Diffusion tensor imaging has been shown to provide advanced information about 
conventionally non-visible mild injuries (Rutgers et al., 2008). However, currently 
there is no clinical method for the detection of subtle changes in cerebral tissues 
based on conventional MR images. Thus, the performance of texture analysis in 
detecting non-visible traumatic changes in MTBI should be tested.
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2.5.3 Central nervous system: Multiple sclerosis
Multiple sclerosis is a chronic autoimmune disease of the central nervous system. 
The sub-types of disease are named according to the disease course and progression: 
relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive 
(SPMS), progressive-relapsing (PRMS), and clinically isolated syndrome (CIS) 
suggestive of MS.
The complex pathophysiology of MS, including inflammation, demyelination, 
axonal degeneration and neuronal loss, generate visible focal lesions as well as 
non-visible diffuse changes in the brain and spinal cord MR images. MRI plays 
an essential role in the diagnosis and follow-up of MS. The current practise in 
diagnosing MS is based on the McDonald clinical diagnostic criteria (McDonald 
et al., 2001; Polman et al., 2005; Polman et al., 2011; Galea et al., 2011; Kilsdonk 
et al., 2011). The McDonald criteria include an evaluation of MS disease attacks, 
cerebrospinal fluid analysis and MRI findings. With reference to these criteria, 
the dissemination of lesions in space and in time can be demonstrated by T2 
and gadolinium-enhancement of lesions in typical areas of the central nervous 
system (CNS): periventricular, juxtacortical, infratentorial and spinal cord. In the 
literature on MS, MRI texture analysis has been applied as a quantitative means 
to characterise disease-related changes in the central nervous system (Kassner and 
Thornhill, 2010). In the future, TA may provide additional information for the 
clinical radiologist. However, before clinical use of TA in MS, the robustness of 
the analysis protocol needs to be investigated. 
2.5.4 Musculoskeletal: Trabecular bone strength and changes  
 caused by physical loading
Osteoporosis is a serious public health problem, and the prevention of this bone 
fragility as well as related fractures are of interest to bone researchers. Bone 
strength is commonly estimated by bone mineral density (BMD), as measured 
by dual energy X-ray absorptiometry (DXA) (Blake and Fogelman, 2010) and 
quantitative-CT (QCT) (Adams 2009). Bone cortical geometry and trabecular 
architecture are both essential to bone strength. Bone structural features, such as 
bone volume fraction (bone volume/total volume; BV/TV), trabecular number 
(Tb.N), trabecular thickness (Tb.Th) and trabecular separation (Tb.Sp), can be 
calculated from high-resolution QCT and MRI data (Manske et al., 2010).
It has been demonstrated that different exercises affect bone structure in 
different ways and that some types of loading exercises have bone-strengthening 
properties (Nikander et al., 2009). In particular, Nikander et al. evaluated the 
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cortical bone of athletes using MRI. MRI provides a non-ionising method to 
assess bone structure from the proximal parts of body, which is important because 
neither these studies nor population screening could ethically use ionising imaging 
modalities in healthy study participants of reproductive age. The impact of 
exercise on trabecular bone is also an interesting topic, and the current repertoire 
of MRI sequences available for clinical imaging provides suitable alternatives for 
bone imaging (Bydder and Chung, 2009). Texture, as a measure of structure at 
different magnitudes, might have the potential to discriminate trabecular bone 
structures exposed to different loading. 
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3. AIMS OF THE STUDY
This thesis employed MRI-based texture analyses with histogram, run-length-
matrix, co-occurrence-matrix, autoregressive model and wavelet-derived 
parameters in a clinical environment. Quantitative MRI texture analysis was 
applied to three clinical medical imaging situations that are conventionally 
evaluated using qualitative means by experienced radiologists (Study I-III) and 
one study of a physiological situation (Study IV). The specific aims were the 
following: 
1) To evaluate the effectiveness of texture analysis for the characterisation of 
visible lesions on normal-appearing tissue (Study III).
2) To evaluate the effectiveness of texture analysis for the detection of non-
visible changes in tissues (Study I, II, III, and IV).
3) To compare ROI settings and different imaging sequences for texture analysis 
protocols (Study I, II, III, and IV). 
4) To investigate the applicability of MRI-based texture analysis in clinical 
imaging settings (Study I, II, III, and IV).
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4.1 Study design
In Study I, texture analysis was applied at the diagnostic stage and at two treatment 
response staging timepoints in patients with non-Hodgkin lymphoma. In this 
study, the role of MRI TA in providing additional information on subtle under-
treatment changes in homogenous mass lesions was investigated. The change in 
tumour volume is used as a control for therapy response.
Mild traumatic brain injury may not be visually detectable in routine MRI 
scans during either the diagnostic or follow up phases. In Study II, TA is applied 
to acute phase images of patients and their referents to determine whether any 
microstructural traumatic changes can be detected in cerebral tissues that have a 
homogenous appearance.
 Study III concentrates on MRI TA of MS, specifically in the separation of 
focal and diffuse changes. The robustness of analysis protocol phases is tested 
in the perspective to development of a clinical protocol. 
In Study IV, non-visible physical loading-related changes in the trabecular bone 
of the femoral neck are investigated by texture analysis. 
The main features of the investigated data are given in Table 2.
TABLE 2. The main features of data from Studies I–IV.
Data Features
Study I
NHL
Study II
MTBI
Study III
MS
Study IV
Bone
Focal lesions ◼
Diffuse changes ◼ ◼ ◼ ◼
Malignancy ◼
Treatment response monitoring ◼
Traumatic lesions ◼
Long-term disease ◼
Physiological changes ◼
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4.2 Study populations
Study patient materials (I–III) were selected from several prospective clinical 
research projects ongoing at Tampere University Hospital. Patients included 
participants in a tumour response evaluation project, neuroinflammatory diseases 
project, mild traumatic brain injury project and healthy referents of the MTBI 
project. The participants in the bone study were healthy athletes and nonathlete 
referents participating in a study project on bone strength evaluation. The Ethics 
Committee of the Tampere University Hospital approved these studies, and 
participants provided written informed consent.
4.2.1 Non-Hodgkin lymphoma 
Nineteen Non-Hodgkin lymphoma (NHL) patients participating in the Tumor 
Response Evaluation project were included this study (14 males, 5 females; mean 
age ± SD, 61.7 ± 10.9 years). These patients had histologically diagnosed high/
intermediate- (N=8, 42%) or low-grade (N=11, 58%) NHL with at least one 
lymphoma mass lesion of three or more centimetres in diameter either in the 
abdominal area (N=16) or in the clavicular and axillary lymph node area (N=3). 
Exclusion criteria were a history of other neoplasms, central nervous disease; 
congestive heart failure NYHA stages III–IV, serious psychiatric disease, human 
immunodeficiency virus infection and pregnancy. 
Patients were treated with chemotherapy alone or in combination with a 
humanised antibody, rituximab. Chemotherapy regimens were selected according 
to patients’ clinical status. No exceptions were made to standard treatment 
procedures; chemotherapy was administered in three-week cycles, and 4 to 9 
courses were given according to clinical response. The treatment regimens and the 
number of courses are explained in detail in (Study I).
4.2.2 Mild traumatic brain injury 
Patients with mild traumatic brain injury (MTBI) having a GCS score of 13-
15 on arrival to the hospital emergency room were recruited for the project. 
For this study, forty-two patients (17 males, 25 females; mean age ± SD, 38.8 
± 13.6 years) were included. All patients met the criteria of MTBI according to 
the WHO Collaborating Centre for Neurotrauma Task Force on Mild Traumatic 
Brain Injury (Carroll et al., 2004). Their CT and MRI scan findings were normal 
based on qualitative visual evaluation. Exclusion criteria were age under 18 or over 
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65, presence of severe traumatic brain injury, previous brain trauma, other major 
cognitive disorder, and history of major alcohol or drug abuse. The reference 
group consisted of ten healthy age- and gender-matched controls (4 males, 6 
females; mean age ± SD, 39.8 ± 12.9 years; range 28 to 61 years). 
4.2.3 Multiple sclerosis 
In this study, thirty-eight consecutive multiple sclerosis patients with a definite 
diagnosis based on revised McDonald criteria (McDonald et al., 2001; Polman et 
al., 2005) were included (15 males, 23 females; mean age ± SD, 42 ± 12 years). 
They were participating in a study project of neuroinflammatory disease patients 
in which biomarkers and new imaging techniques were evaluated. The only 
exclusion criterion was cortisone treatment within the eight weeks prior to the 
MRI examination.
4.2.4 Trabecular bone
Ninety-one adult female athletes competing actively at the national or 
international level and twenty non-athletic referents participated in this cross-
sectional study. The exercise-loading types represented by the athletes were 
grouped into five categories according to a recent protocol (Nikander et al., 2009): 
1) the high-impact (H-I) exercise-loading group comprised of triple-jumpers 
(N=9) and high-jumpers (N=10) (mean age ± SD, 22.3 ± 4.1 years); 2) the odd-
impact (O-I) exercise-loading group comprised of soccer (N=10) and squash 
(N=10) players (25.3 ± 6.7 years); 3) the high-magnitude (H-M) exercise-loading 
group comprised of power-lifters (N=17) (27.5 ± 6.3 years); 4) the repetitive, 
low-impact (L-I) exercise-loading group comprised of endurance runners (N=18) 
(28.9 ± 5.6 years); and 5) the repetitive, non-impact (N-I) exercise-loading group 
comprised of swimmers (N=18) (19.7 ± 2.4 years). The non-athletic reference 
group (N=20) mean age was 23.7 years and SD 3.8 years. 
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4.3 Magnetic resonance image acquisition
The MR imaging for all four studies was performed with 1.5 T scanners. The 
imaging in the non-Hodgkin lymphoma study was performed with a GE Signa 
HD scanner (GE Healthcare, Milwaukee, Wisconsin, USA), and the three 
other studies were imaged with a Magnetom Avanto scanner (Siemens Medical 
Solutions, Erlangen, Germany). These MRI scanners are maintained under the 
Tampere University Hospital quality control program. The quality of image sets 
used in analyses were evaluated by an experienced radiologist and certified as 
uniform and of good quality.
4.3.1 Non-Hodgkin lymphoma 
Three timepoints were included in the TA: The first MR imaging was carried out 
at the diagnostic stage, before any treatment was administered (examination 1). 
The following MR examinations were performed after the first chemotherapy 
cycle (examination 2) and after the fourth chemotherapy cycle (examination 3). 
The analysis of lymphoma mass volumes was performed for the first and second 
examinations. The analysed sequence was an axial T2-weighted fast spin echo 
(FSE) fat saturation (FAT SAT) sequence (TR 620 ms, TE 10 ms, slice thickness 5 
mm-12 mm, matrix 256 x 256, pixel size 1.33 mm x 1.33 mm to 1.80 mm x 1.80 
mm) acquired with intravenous contrast agent gadolinium chelate (gadobenate 
dimeglumine).
Texture analysis was performed on both T1-weighted and T2-weighted axial 
image sequences from the three imaging timepoints of every patient. The T1-
weighted series contained T1-weighted spin echo (SE) and T1-weighted SE 
FAT SAT sequences (TR 320-700 ms, TE 10 ms, slice thickness 5 mm-12 mm, 
pixel size 1.33 mm x 1.33 mm to 1.80 mm x 1.80 mm), and the T2-weighted 
sequences were FSE FAT SAT (TR 3 320–10 909 ms, TE 96 ms, slice thickness 
5 mm-12 mm, pixel size 1.33 mm x 1.33 mm to 1.80 mm x 1.80 mm). Imaging 
sequence parameters, such as TR and slice thickness, varied between and within 
patients according to their clinical status.
4.3.2 Mild traumatic brain injury
MRI was performed within three weeks from the day of patient admission to the 
hospital. The fixed imaging sequences included in the texture analysis were 1) an 
axial T2-weighted FLAIR (TR 9000 ms, TE 109 ms, TI 2500 ms, slice thickness 
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5.0 mm, pixel size 0.90 mm x 0.90 mm) and 2) a sagittal T1-weighted 3D 
magnetization prepared gradient echo (T1w MPR) (TR 1910 ms, TE 3.1 ms, TI 
1100 ms, slice thickness 1.0 mm, pixel size 0.98 mm x 0.98 mm, flip angle 15o).
4.3.3 Multiple sclerosis 
The fixed MRI protocol for texture analysis included 1) an axial T1-weighted 3D 
magnetization prepared gradient echo sequence (T1w MPR) (TR 1160 ms, TE 
4.24 ms, TI 600 ms, slice thickness 0.9 mm, pixel size 0.45 mm x 0.45 mm, echo 
train length 1, flip angle 15o); 2) the same T1-weighted gradient echo sequence 
acquired with the intra-venous contrast agent gadoterate meglumine; and 3) an 
axial T2-weighted FLAIR (named as TIRM in Study III) sequence (TR 8500 
ms, TE 100 ms, TI 2500 ms, slice thickness 5 mm, pixel size 0.45 mm x 0.45 
mm, echo train length 17, flip angle 150°).
4.3.4 Trabecular bone 
MRI of the proximal femurs of participants’ dominant legs was performed 
with careful imaging plane orientation setting; the plane was set perpendicular 
to the femoral neck axis according to information from the localisation series. 
The sequences for analyses were 1) an axial 3D T1-weighted FLASH (Fast Low 
Angle SHot) sequence with interpolation in slice selection direction (TR 15.3 ms, 
TE 3.32 ms, slice thickness 1.00 mm, pixel size 0.91 mm x 0.91 mm, flip angle 
10º) and 2) an axial 3D heavily T2*-weighted spoiled gradient echo sequence 
called MEDIC (TR 40 ms, TE 17 ms, slice thickness 1.00 mm, pixel size 0.91 
mm x 0.91 mm, flip angle 10º). Image slice samples from both sequences with 
magnified images of the region of interest are shown in Figure 2.
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FIGURE 2. MRI images of a femoral neck. The imaging plane has been set perpendicular to the 
axis of the femoral neck. A FLASH image is shown in the first row on the left, with a magnified 
image of the region of interest shown at right. A MEDIC image is shown in a similar way below.
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4.4 Texture analysis
Analysis of the DICOM format images was conducted in a Microsoft Windows 
XP environment. The stand-alone DICOM viewer Osiris (Windows version 
4.19, The Digital Imaging Unit of the Service for Medical Computing of the 
University Hospitals of Geneva, Switzerland) was used to select slices from each 
image series for analysis.
The MaZda software package (MaZda version 3.20 for studies I, III, IV; and 
version 4.5 for Study II) was used for the texture analysis. MaZda calculates 
almost 300 texture parameters divided into the following feature sets: histogram, 
gradient, run-length matrix, co-occurrence matrix, autoregressive model and 
wavelet-derived parameters. The texture parameters are discussed in Chapter 
2.3, and mathematical equations are presented in Appendix. Run-length matrix 
parameters were calculated in four directions: horizontal (0o), vertical (90o), 45o 
and 135o, and co-occurrence matrix parameters were calculated at five distances 
(1, 2, 3, 4 and 5 pixels), four times for each distance (at θ = 0⁰, 45⁰, 90⁰ and 
135⁰). Regions of interest (ROI) were set manually by freehand drawing or by 
placing pre-defined fixed-size ROI-boxes on the image. Grey level intensities were 
normalised in the range [m-3σ, m+3σ], where m is the mean grey level value and σ 
is the standard deviation. 
4.4.1 Non-Hodgkin lymphoma 
This portion of the study focused on the detection of subtle non-visible textural 
changes in lymphoma masses during treatment. The homogeneous parts of the 
lymphoma lesions were set as ROIs by freehand drawing method on selected 
image slices originating from the three evaluation stages. Membranous marginals 
and non-homogenous parts of the masses were excluded. Texture parameters based 
on histogram, gradient, run-length matrix, co-occurrence matrix, autoregressive 
model and wavelet methods were calculated. Automated Fisher and POE+ACC 
methods provided by MaZda were used to establish the best discriminating texture 
features to highlight changes in lymphoma tissue texture during treatment. The 
identified parameters were then used as feature sets in further analyses. T1- and 
T2-weighted images were analysed separately. Figures 3 and 4 show images from 
a single patient with ROIs.
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FIGURE 3. Axial T1-weighted SE fat saturation image slices of a typical subject (left), and ROIs 
drawn on a lymphoma mass (right). Images in the first row are from the diagnostic phase 
(examination 1), images in the second row are from examination 2, and images in the last row 
are from examination 3. 
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FIGURE 4. Axial T2-weighted FSE fat saturation image slices of a typical subject (left), and ROIs 
drawn on the lymphoma mass (right). Images in the first row are from the diagnostic phase 
(examination 1), images in the second row are from examination 2, and images in the last row 
are from examination 3. 
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4.4.2 Mild traumatic brain injury
Texture analysis was focused on identifying non-visible traumatic changes in brain 
tissue on certain anatomical locations of interest. Another aim of this study was to 
evaluate the effect of ROI placement on tissue texture appearance. The locations 
were named as levels in image sets. One image slice from image set was selected to 
represent each level. Levels 1–3 were derived from the axial FLAIR sequence, with 
level 1 containing the mesencephalon, level 2 containing the corona radiata and 
level 3 containing the centrum semiovale. Level 4 was a corpus callosum image 
obtained from a sagittal T1w MPR sequence.
For each image ROIs were manually placed symmetrically on the left and 
right hemispheres on each level of interest. A detailed description of ROIs is 
presented in Table 3. Two freehand-drawn ROIs covered the mesencephalon cross 
section, and the size of these ROIs varied depending on the size of the individual 
mesencephalon. The white matter and corpus callosum ROIs (rostrum, body and 
splenium) were predefined circles. Their size was defined based on the common 
size of the corpus callosum and when considering white matter, such that other 
structures and possibly observed microhaemorrhages, macroscopic hemosiderin 
deposits or hyperintensities could be carefully avoided to overlap. However, 
all patient scans were normal without evidence of contusion. The anatomical 
locations investigated with ROIs marked are presented in Figures 5 and 6.
TABLE 3. Description of ROIs used in the MTBI study. “Levels” refers to anatomical levels in the 
axial view: 1) mesencephalon; 2) corona radiata; 3) centrum semiovale; or in the sagittal view 4) 
midline. The ROI sizes are given in pixels.
Level ROI ROI type ROI size
1 Mesencephalon (left, right) Freehand ~1200
1, 2 White matter, temporal lobe, (left, right) Circular     177
3 White matter, anterior (left, right) Circular     177
3 White matter, medial (left, right) Circular     177
3 White matter, posterior (left, right) Circular     177
4 Corpus Callosum, splenium Circular       68
4 Corpus Callosum, body Circular       68
4 Corpus Callosum, rostrum Circular       68
 
Image histogram, co-occurrence matrix, run-length matrix, absolute gradient, 
autoregressive model and wavelet-based textural features were calculated from 
each ROI. Texture feature subsets were selected automatically by the Fisher 
coefficient method. 
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FIGURE 6. Sagittal T1w MPR showing the corpus callosum included in the analysis on the left 
side. ROIs are drawn in the image at right. The anterior ROI was placed at the rostrum, the middle 
ROI was placed at the body and the posterior ROI was placed at the splenium of the corpus 
callosum.
4.4.3 Multiple sclerosis
This analysis concentrated on detecting textural differences in normal and 
disease-burden tissue samples and on the robustness of the analysis protocol. 
Variation in intra-tissue textural appearance between three sequential image slices 
and image slices originating from two anatomical levels was investigated. The 
texture classification power of three MRI sequences was evaluated. Two types of 
ROIs were used, fixed size ROI-boxes and freehand drawn ROIs on focal MS 
lesions. Figure 7 shows examples of ROI setting with both methods. The two 
anatomical levels taken into analysis based on anatomical landmarks were the 
1) corona radiata/centrum semiovale and 2) basal ganglia. The ROIs of different 
structures defined from images are presented in Table 4. The criteria for the 
selection of an ROI representing an MS focal lesion was a T2-weighted plaque 
in the cerebral hemisphere, while the NAWM ROIs were defined as the white 
matter surrounding the focal MS lesion. Figures 8 and 9 present the anatomical 
levels analysed with image slices and ROIs drawn on them. 
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FIGURE 7. Detail from a brain image at the level of the basal ganglia showing an MS-plaque 
near the posterior horn of the lateral ventricle. The centre and right images show examples of 
freehand and fixed-size ROI setting, respectively.
TABLE 4. Description of ROIs used in the MS study. The level numbers indicate the anatomical 
levels: 1) corona radiata/centrum semiovale, 2) basal ganglia. The ROI sizes are given in pixels.
Level ROI ROI type ROI size
1, 2 White matter (WM) square 100
1, 2 Normal-appearing white matter (NAWM) square 100
1, 2 Cerebrospinal fluid square 100
1, 2 Normal-appearing grey matter apart lesion square   36
1, 2 Normal-appearing grey matter near lesion square   36
2 Nucleus caudatus square 100
2 Nucleus lentiformis square 100
1, 2 MS plaque, freehand ROI freehand varying
1, 2 MS plaque, fixed-size ROI square 100
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Texture features based on image histogram, co-occurrence matrix, run-length 
matrix, absolute gradient, autoregressive model and wavelets were calculated for 
each ROI. Two automated methods, Fisher and POE+ACC, were used to identify 
the 10 texture features that gave the best discrimination between tissue pairs. In 
addition, 25 texture features that were reported to be efficient in a recent multiple 
sclerosis study (Zhang et al., 2008) were used (Table 5). These three textural 
feature sets were then used for further analyses.
TABLE 5. A list of the texture parameters used in manual feature selection. For co-occurrence 
matrix parameters, the distance between analysed pixels is 1, and parameters are calculated in 
four directions. Run-length parameters are calculated in four angles. 
Parameters used in manual feature selection
Parameter group Parameter
Co-occurrence matrix Contrast
Co-occurrence matrix Difference variance
Co-occurrence matrix Sum of squares
Co-occurrence matrix Sum variance
Run-length matrix Grey level nonuniformity
Gradient Mean absolute gradient
Gradient Variance of absolute gradient
AR model Standard deviation
Wavelet Energy, subband 1, HL
Wavelet Energy, subband 2, HL
4.4.4 Trabecular bone
This analysis was focused on the cross-section of the femoral neck at the insertion 
of the articulation capsule to find co-occurrence matrix-based texture differences 
due to exercise loading. Image slices representing the anatomical region of interest 
were selected manually from both sequences and were included in the analysis. 
Inferior (I), anterior (A), superior (S) and posterior (P) quadrants of the trabecular 
bone were set as ROIs (Figure 10). Three co-occurrence matrix texture parameters 
that had previously shown significant correlation with trabecular structural indices 
(Tameem et al., 2007) were calculated for further analyses. These parameters were 
1) angular second moment, 2) entropy and 3) sum entropy. Each parameter 
was calculated for four distances between pixels and in four directions for each 
distance for each ROI, producing a total of 48 textural features for each ROI. 
Variation in intra-tissue textural appearance between two adjacent image slices 
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was analysed to test the reproducibility of these measurements. In addition, the 
usability of two sequences was evaluated.
Image plane was set perpendicular to femoral neck 
axis with help of localization series.
Two sequences including 120 image slices with 
thickness of 1.00mm were obtained for TA 
purposes.
The image stacks were scrolled trough to find 
image slices with anatomical landmarks: 
articulation capsule insertion to femoral neck. 
These images were stored in DICOM format.
Selected image slices were opened in MaZda 
texture analysis software. Trabecular bone was 
divided manually into four ROIs representing the 
anatomical quadrants (anterior, inferior, posterior 
and superior).
FIGURE 10. Trabecular bone texture analysis: Phases of the analysis process before texture 
parameter calculation.
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4.5 Statistics and classification
4.5.1 Non-Hodgkin lymphoma 
Analyses were run between all combinations of three imaging stages separately 
for T1- and T2-weighted images. Default neural network parameters in the B11 
application (version 3.4, MaZda software package) were used for texture data 
analyses: the first hidden layer = 1; the second hidden layer = 2; backprop eta = 
0.15; backprop iter. limit = 150 000 and optimisation iter. limit = 50. Nearest-
neighbour (1-NN) classification was performed for the raw data, the most 
expressive features resulting from PCA and the most discriminating features 
resulting from LDA. Nonlinear discriminant analysis carried out the classification 
of features with ANN.
 Two statistical analyses, the Gage R&R test (Statistica/W, version 5.1, 98 
edition. Statsoft Inc, Tulsa, OK, USA) and Wilcoxon Signed Ranks test (SPSS 
for Windows, version 14.0.2. SPSS Inc., Illinois, USA), were run for the selected 
feature groups. A p-value < 0.05 was considered statistically significant. A 
summary of the Gage R&R terminology in this application is given in Table 6. 
TABLE 6. Summary of Standard Gage R&R terminology and its application in Study I.
Standard Gage R&R 
terminology
Study I application of R&R terminology
Operators Timepoints of MRI examinations (diagnostic stage, two response 
evaluation stages).
Parts Patients
Trials Repeated measurements (ROIs from adjacent image slices) at 
fixed timepoints.
Repeatability Difference across measurements (texture parameter value 
variation between two adjacent image slices originating from a 
single patient and from the same sequence at a fixed timepoint). 
Repeatability was expected to be zero.
Reproducibility Difference across timepoints (texture parameter value variation 
between image slices originating from the same sequence type 
at different timepoints). Reproducibility was expected to be 
quite large and significant according to research topic.
Variability Difference across patients (there is no exact expected value for 
patient-to-patient variation).
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4.5.2 Mild traumatic brain injury
The texture features selected by the Fisher criterion were subjected to statistical 
analyses. Textural differences between tissue samples in different hemispheres were 
analysed by Wilcoxon signed ranks test. The Friedman test was used to compare 
tissue samples originating from different anatomical levels of the same hemisphere 
and samples from the corpus callosum (rostrum, body and splenium). These tests 
were run separately for patients and healthy referents. Statistically significant 
difference was defined as a p-value under 0.05. Analyses were run in SPSS (SPSS 
for Windows, version 14.0.2, SPSS Inc., Illinois, USA).
4.5.3 Multiple sclerosis
Intra-tissue textural variation between anatomical levels was analysed by 
calculating Wilcoxon signed ranks test values for all 280 texture parameters for 
all ROIs and evaluating the number of statistically significant differences (p < 
0.05). These tests were run separately for each MR sequence. Intra-tissue textural 
variation between sequential image slices were run for T1-weighted images of 
randomly sampled sub-population (N=23) by the Friedman test with the same 
method used for the test between anatomical levels.
Texture classification for tissue pairs was run using the 10 best texture 
features selected with both automated methods as well as for the 25 manually 
selected features in B11. Principal component analysis was followed by 1-NN 
classification with the leave-one-out-method for the most expressive features 
identified by PCA. NDA was run with ANN classification included. In addition, 
the 10 features that best performed the classification of white matter and MS 
in different sequences were examined with Wilcoxon signed ranks test to detect 
statistical differences between tissue pairs (WM vs. MS freehand ROI, WM vs. 
MS fixed-size ROI, NAWM vs. MS freehand ROI, and NAWM vs. MS fixed-
size ROI) for both imaging levels and all three sequences. A level of p < 0.05 was 
considered statistically significant.
Wilcoxon signed ranks tests and Friedman tests were performed using SPSS for 
Windows (Version 16.0.2. SPSS Inc., Illinois, USA).
4.5.4 Trabecular bone
A Kruskal-Wallis test was conducted to evaluate overall differences among the five 
groups of athletes and their referent group. A p-value < 0.0033 was considered 
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significant. Post hoc analysis based on the Mann-Whitney test was performed 
between each exercise-loading group and the referent group, and a significance 
criterion of p < 0.01 was used. These tests were performed for the three selected 
texture parameters angular second moment, entropy and sum entropy, with each 
parameter determined for four distances between pixels and four directions for 
each distance. Reproducibility testing between two sequential image slices was 
conducted for both sequences for the three texture parameters, with inter-pixel 
distance showing the most consistent discrimination between the groups. The 
measure of reproducibility, or R-value, was calculated by dividing the variance 
of differences between the texture parameter values of two adjacent slices by the 
variance of a given parameter in the population. 
Tests were run in SPSS for Windows, version 16.0.2. SPSS Inc. Illinois, USA.
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5.1 Characterisation of visible lesions    
 on normal-appearing tissue 
In Study III, the classification of multiple sclerosis plaques from white matter 
and normal-appearing white matter close to the focal lesions was evaluated. Four 
tissue pairs 1) WM fixed size ROI vs. MS freehand ROI; 2) WM fixed size ROI vs. 
MS fixed size ROI; 3) NAWM fixed size ROI vs. MS freehand ROI; and 4) WM 
fixed size ROI vs. MS fixed size ROI were defined from two anatomical levels on 
fixed axial imaging sequences, FLAIR, and T1-weighted magnetization prepared 
gradient echo with and without contrast agent. Classification procedures, run 
separately for each image series, showed highly accurate classification. There were 
slight differences in classification results between the methods used for feature 
selection, ROI type (fixed-size and freehand drawn) and imaging sequence. The 
best classification was achieved by the POE+ACC automated feature selection 
method, but the other methods achieved almost the same level of accuracy. 
The Wilcoxon signed ranks test showed highly significant statistical differences 
between all tested tissue pairs, anatomical level and sequence combinations. 
T1-weighted magnetization-prepared gradient echo sequence acquired with 
intravenous contrast agent performed slightly better than the other two series. A 
summary of classification results obtained with NDA and ANN is presented in 
Table 7.
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TABLE 7. Correct classification of focal MS lesions from white matter (WM) and normal-appearing 
white matter (NAWM) based on three imaging sequences: T1-weighted magnetization prepared 
gradient echo (T1w MPR), previous with contrast agent (T1w MPR+C) and FLAIR. The percentage 
of correct classifications is presented for four tissue pairs of interest and for three feature 
selection methods: Fisher (F), POE+ACC (P) and manual (M). Imaging level 1 refers to corona 
radiata/centrum semiovale, and level 2 refers to basal ganglia.
Imaging 
sequence
Imaging 
level
Feature 
selection
WM vs.
MS 
freehand 
ROI
WM vs.
MS
fixed
ROI
NAWM vs. 
MS  
freehand 
ROI
NAWM vs. 
MS
fixed 
ROI
  T1w MPR 1 F 100 % 100 % 100 % 98 %
P 100 % 100 % 100 % 98 %
M 100 % 98 % 100 % 98 %
2 F 98 % 97 % 100 % 100 %
P 100 % 100 % 100 % 100 %
M 98 % 98 % 100 % 97 %
  T1w MPR+C 1 F 100 % 100 % 96 % 100 %
P 100 % 100 % 100 % 100 %
M 100 % 96 % 100 % 96 %
2 F 100 % 100 % 98 % 100 %
P 100 % 100 % 97 % 100 %
M 98 % 98 % 98 % 98 %
  FLAIR 1 F 100 % 97 % 100 % 96 %
P 100 % 98 % 100 % 96 %
M 100 % 96 % 100 % 98 %
2 F 100 % 97 % 100 % 97 %
P 100 % 100 % 100 % 98 %
M 100 % 98 % 100 % 98 %
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5.2 Detection of non-visible changes in tissues 
Non-Hodgkin lymphoma treatment evaluation by MRI in Study I showed that as 
lymphoma masses decreased in size between diagnosis and treatment, the texture 
of the masses also changed. The classification of lymphoma tissue changes between 
different timepoints in the treatment process was challenging; the overall accuracy 
of classification performed with 1-NN on the basis of RDA, PCA, and LDA, and 
ANN on the basis of features of NDA, achieved only moderate success. ANN 
run on the most expressive features of NDA reached a classification accuracy of 
up to 96% in T2-weighted series within diagnostic stage and second treatment 
evaluation and 95% within T1-weighted images. In analyses based on RDA, PCA 
and LDA in this timepoint combination, classification accuracy reached 82–87% in 
T1-weighted images and 79–86% in T2-weighted images. Discrimination between 
other combinations of timepoints produced marked misclassification. NDA-based 
analyses of combinations of diagnostic stage vs. first response evaluation and first 
vs. second evaluations maintained a classification accuracy of 75–88%, while other 
analyses were less effective. The combination of all three imaging timepoints was the 
worst, with classification accuracies of 53–70%. Classification accuracy by ANN 
run with NDA in MaZda is summarised in Table 8. 
TABLE 8. Correct classification of imaging stages in non-Hodgkin lymphoma treatment response 
evaluation. ANN classification included non-linear discriminant analysis (NDA) in the MaZda 
software package. T1w refers to T1-weighted images, and T2w refers to T2-weighted images. 
The classification results for imaging timepoints are given in rows. E1, examination 1; E2, 
examination 2; E3, examination 3.
Examinations T1w T2w
E1, E2, E3 69% 70%
E1, E2 84% 65%
E1, E3 95% 96%
E2, E3 87% 88%
Statistical tests were calculated from images of 18 patients. One patient who had 
been included in the primary MaZda texture parameter calculation was excluded 
due to a smaller amount of image data than other patients, leading to reduced 
textural data. Wilcoxon test results were in line with the classification results, 
i.e., the most statistically significant differences were found between diagnostic 
stage and second response evaluation, particularly in T2-weighted images. In 
other comparisons, the statistically significant differences for separability of 
timepoints are quite heterogeneous among texture parameters ranked as good 
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for discrimination by MaZda. The variation in texture parameter values between 
image slices originating from a single patient and the same sequence at a fixed 
timepoint were measured by Gage R&R test repeatability. This test showed some 
differences, indicating that visually homogenous parts of a lymphoma mass have 
some textural differences between image slices. The reproducibility parameter 
showed clear changes between timepoints, exceeding the changes detected 
between image slices and therefore representing significant difference in texture 
between evaluation timepoints.
Mild traumatic brain injury patients with visually normal MRI scans and their 
healthy referents were investigated in Study II using texture analysis to detect non-
visible changes due to trauma. Wilcoxon and Friedman tests were used to evaluate 
the number of texture parameter value differences between tissue samples as a 
sign of traumatic changes. Patients clearly demonstrated more differences between 
the left and right mesencephalon than did controls (39% and 13%, respectively). 
Analyses of differences in white matter between hemispheres showed quantitatively 
fewer statistically significant changes; however, MTBI patients distinctly had 
more statistically significant hemisphere differences, especially in the level of 
corona radiata (23% vs. 5%). In addition, differences in white matter texture at 
different anatomical locations within the same hemisphere were detected. The 
white matter textural appearance at the level of the mesencephalon was somewhat 
different from that at locations in the superior brain. Furthermore, in the antero-
posterior view at the level of the centrum semiovale, posterior white matter 
samples were different from frontal and central samples in both hemispheres. The 
body of the corpus callosum had a different texture in patients compared to the 
controls, and in addition, the rostrum and splenium were distinct from the body. 
A brief summary of interhemispheric and midline structure differences is given in 
Table 9. The results are presented in full detail in Study II.
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TABLE 9. Interhemispheric and midline structure differences in MTBI patients and healthy 
referents. Percentages represent texture parameters with statistically significant differences (p 
< 0.05) in interhemispheric and midline comparisons. The Wilcoxon test was used for WM and 
mesencephalon, and the three ROIs representing the corpus callosum were analysed with the 
Friedman test. A total of 277 parameters were analysed. Level 1, mesencephalon; level 2, corona 
radiata; level 3, centrum semiovale.
Interhemispheric and midline structure 
differences
patients referents
Mesencephalon, patients 39 % 13 %
WM, level 1 10 % 4 %
WM, level 2 23 % 5 %
WM, level 3 7 % 4 %
Corpus callosum, rostrum 2 % 2 %
Corpus callosum, body 18 % 1 %
Corpus callosum, splenium 2 % 1 %
In addition to Study II, cerebral tissue was examined also in Study III. Normal-
appearing white matter near the focal lesion was compared to white matter 
sample further from the lesion. These tissue samples could not be distinguished 
visually, but texture-based classification was 85% accurate, indicating that 
there are textural differences between these tissue samples. In the studied MRI 
images, the texture of the nucleus caudatus and nucleus lentiformis were visually 
indistinguishable. The quantitative methods used also failed to classify these 
structures. 
In Study IV, textural differences in trabecular bone due to exercise loading were 
evaluated in a large cohort of top-level athletes and healthy referents. Kruskal-
Wallis test for the superior part of the femoral neck showed a clear overall 
separability of all groups on FLASH sequence data. In contrast, the MEDIC data 
did not show any statistically significant difference between groups when evaluated 
with strict criteria for significance (p < 0.0033). Post-hoc analysis based on Mann-
Whitney tests of paired comparisons between athlete groups and referents showed 
statistically significant differences in odd-impact and high-magnitude exercise 
loading groups compared to controls. The post-hoc tests showed differences 
primarily at the superior region of the femoral neck. 
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5.3 Comparison of the ROI setting and imaging   
 sequences for texture analysis protocol
5.3.1 Regions of Interest (ROI)
In Study III, ROI setting with fixed-size vs. freehand ROIs were compared in one 
type of tissue sample, the MS plaque. The freehand-drawn ROIs lead to slightly 
better differentiation between MS focal lesions and WM than the manually placed 
fixed-size ROIs. These results are presented in Table 6. When anatomical levels 
and slice-to-slice variation was investigated, the textural appearance of freehand-
drawn ROIs differed in more parameters than did fixed-size ROIs (Figure 11).
FIGURE 11. Reproducibility of texture parameter values calculated from fixed-size and freehand-
drawn ROIs of MS plaques. The results for T1w MPR, T1w MPR+contrast agent and FLAIR MRI 
sequences are presented. “Inter-levels” refers to comparisons of ROIs drawn on two image slices 
originating from different anatomical locations of single image sequences. Intra-level analysis 
of three sequential slices is given for both anatomical levels considered, and information about 
the level in question is given in the figure. The evaluation of intra-tissue differences is given as 
the percentage of texture parameters with no statistically significant difference among a total 
of 280 parameters. 
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5.3.2 Selection of images for analyses
In Studies II and III, several anatomical locations for ROIs were considered. In 
Study II, textural differences in brain tissues between hemispheres and different 
anatomical locations were investigated in mild traumatic brain injury patients 
and their healthy referents. More statistically significantly different parameters 
between analysed locations were observed in MTBI patients than in controls, 
indicating that the presence of differences is possibly related to tissue damage. 
Therefore, only the results of controls (N=10) were used to evaluate the influence 
of ROI placement at different anatomical locations. A total of 277 texture 
parameters were calculated from each ROI. In the area of mesencephalon, the 
left and right sides of the cross section of the structure were investigated, and 
statistically significant differences were found in 13% of all parameters. Distinct 
anatomical parts of the corpus callosum differed from each other in 1–2% of 
parameters. In comparisons of white matter between hemispheres, 4–5% of 
parameters exhibited significant differences (Figure 12).
In Study III, the textural appearance of a large set of brain tissues was evaluated 
in two anatomical locations and in three sequential image slices with the same 
method as the images in Study II. A total of 280 parameters were evaluated. 
Estimation of anatomical level effect on tissue sample texture showed changes 
in white matter in 3% of parameters in T1w MPR, 6% in T1w MPR+C and 
12% in FLAIR sequence. Fixed-size ROIs encompassing normal-appearing white 
matter, cerebrospinal fluid, normal-appearing grey matter, nucleus caudatus, 
nucleus lentiformis and MS plaques showed statistically significant differences in 
1–9% of 280 parameters. A marked difference in textural appearance was detected 
between freehand-drawn ROIs of MS in different levels (16-30%). T1-weighted 
images with and without contrast enhancement were used in an analysis of intra-
tissue textural changes between sequential image slices. Test was applied for the 
anatomical levels and tissues used in the inter-level testing. In the T1-weighted 
native series white matter samples had 5% of parameters statistically significantly 
different at the anatomical level of the corona radiata and centrum semiovale; 
and 7% at the level of the basal ganglia. In contrast series, these percentages were 
4% and 5%, respectively. Other samples of fixed-size ROIs lead to differences in 
1–13% of all parameters. Freehand-drawn ROIs on MS showed differences in 
5–13% of parameters. The full details of those results are presented in Study III 
(Figure 12).
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FIGURE 12. Reproducibility of texture parameter values calculated from ROIs representing 
single tissues in different anatomical locations of a single image slice, sequential slices and slices 
originating from a single MRI sequence but at different locations. Intra-tissue differences are 
given as the percentage of texture parameters with no statistically significant differences (280 
total parameters in MS, 277 total parameters in MTBI). Here, white matter (WM) differences 
among MS study (III) participants are presented for comparison of different anatomical levels 
and for sequential image slices of two levels. Healthy MTBI study referents (II) were used to 
investigate interhemispheric changes in white matter and mesencephalon and sagittal changes 
in the corpus callosum (3 ROIs). Three MRI sequences (T1w MPR, T1w MPR+contrast agent and 
FLAIR) are presented.
5.3.3 Selection of sequences for analyses
In Study I, the data were comprised of T1- and T2-weighed sequences with 
variable acquisition parameters. The classification of pre-treatment and under-
treatment lymphoma masses was challenging. Differences between timepoints 
were quite small when evaluated by classification results provided by B11 analyses. 
However, when concentrating on Wilcoxon test results, textural data originating 
from T2-weighted images showed several statistically significant differences, 
particularly in comparisons of the first and third imaging stages. 
In Study III, texture information calculated from three different sequences 
produced similar classification results, while the T1-weighted contrast-enhanced 
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series showed slightly better performance than FLAIR or the T1-weighted 
magnetization prepared gradient echo sequence without contrast enhancement.
Study IV compared axial FLASH and axial MEDIC sequences. The textural 
data calculated from the FLASH sequence enabled clear discrimination between 
referents and two groups of athletes, but the MEDIC sequence could not capture 
between-group differences with strict criteria for significance. Data not presented 
in Study IV showed that texture data from MEDIC images have the same trend 
as the FLASH data but with weaker p-values for significance.
Table 10 shows a ranking of the sequences used in different materials. 
TABLE 10. Ranking of MRI sequences used in analyses and recommendations for their usage in 
clinical protocols based on their performance in the present studies. In Study II, the sequences 
used are marked with ◼ but could not be compared because the different sequences were used 
to visualise different anatomical locations. 
MRI sequences used in analyses Study INHL
Study II
MTBI
Study III
MS
Study IV
Bone
T1w SE, FAT SAT 2nd choice
T2w FSE, FAT SAT 1st choice
T1w MPR ◼ 2nd choice
T2w FLAIR ◼ 2nd choice
T1w MPR+contrast agent 1st choice
FLASH 1st choice
MEDIC -
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5.4 The applicability of MRI-based texture analysis in  
 clinical imaging settings
The four studies presented here analyse images of different areas and structures 
within the body. They are related to different types of medical (studies I–III) and 
physiological (Study IV) conditions. Table 1 summarises the features of the data. 
Table 11 addresses the specific study questions and the overall performance from 
a clinical perspective.
TABLE 11. Specific study questions and overall performance of the texture analysis applications 
in studies I–IV.
Study questions and 
overall performance
Study I
NHL
Study II
MTBI
Study III
MS
Study IV
Bone
Detection of visible lesions ◼
Detection of non-visible changes ◼ ◼ ◼ ◼
Analysis of freehand and fixed-size ROIs ◼
Analysis of ROI placement ◼ ◼
Analysis of image sequences for TA ◼ ◼ ◼
Overall performance of TA in addressing 
the clinical question poor moderate good good
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6.1 Effectiveness of texture analysis     
 for the characterisation of visible lesions  
 on normal-appearing tissue 
In the literature, texture analyses for the differentiation of normal tissue from 
pathological focal lesions have achieved very good classification results. In Study 
III, imaging was performed according to the hospital’s clinical protocol for 
neuroinflammatory disease imaging, thus providing a strong clinical basis for 
the texture analysis. The results demonstrated the accurate classification of MS 
plaques from white matter and lesion-adjacent normal-appearing white matter by 
TA on data from three sequences. This strengthens the results recently obtained 
in the field of MRI TA on MS (Zhang et al., 2008). The results show that TA 
based on statistical, auto-regressive-model and wavelet-derived parameters achieve 
excellent discrimination between different tissues of interest. Because these lesions 
have different micro-texture appearances relative to normal tissues, quantitative 
discrimination using TA is effective. 
6.2 Effectiveness of texture analysis for the detection  
 of non-visible changes in tissues
Lymphoma response to chemotherapy treatment was evaluated in Study I. The 
lymphoma mass response to the treatment was controlled by early lesion volume 
calculations from images at the diagnostic stage compared to their volumes after 
the first treatment. The volume evaluation showed lymphoma mass reductions in 
all patients, indicating good early treatment response. The texture analysis did not 
show similarly clear changes in tissue microstructure within the same time interval, 
but in a comparison between the diagnostic stage and the second treatment 
evaluation stage, the power of texture parameters to classify changes was increased. 
The classification accuracy might have been better if fixed acquisition protocols 
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had been used for imaging. However, for clinical use, treatment-related textural 
changes in lymphoma masses should be detected as early as possible, ideally at 
the first response evaluation, to give clinicians the most timely information about 
treatment effectiveness. Other limitations of this study include its small sample 
size and the lack of healthy control tissue. The usage of healthy referents’ lymph 
nodes as reference tissue for lymphoma masses was withdrawn in the initial phase 
of setting up the TA study protocol because the estimated size of healthy lymph 
nodes would not have been sufficient for accurate manual segmentation (i.e., ROI 
drawing) or for texture calculation. However, these MR images on treatment 
response evaluation represent the true clinical imaging practice at the time of 
data collection (2002-2005) in Tampere University Hospital, and the extracted 
textural properties of the lymphoma masses demonstrated relevant changes. This 
can be seen as an encouraging start for further studies on larger cohort sizes using 
present-day imaging processes to assess the impact of TA as an adjuvant tool in 
therapy response evaluation and therapeutic decision making.
Imaging symptomatic mild traumatic brain injury patients may reveal only 
normal findings in CT and MRI, despite the presence of small injuries in the brain 
that result in neuropsychological findings. Study II focused on texture analysis 
of the visually normal MRI scans of MTBI patients and their healthy referents. 
Inter-hemisphere differences in texture appearance in the mesencephalon and 
intra- and inter-hemisphere differences in white matter were detected in MTBI 
patients. Also anatomical parts of the corpus callosum differed from each other. 
This likely reflects that the anatomical parts of the corpus callosum have different 
physiological functions. In addition, the density of the white matter tracts differs 
in the different parts of the corpus callosum. As a first approach to detect mild 
traumatic changes in cerebral tissue by means of texture analysis, there were 
certain challenges. In this study, no clinical information about patient symptoms 
was provided to correlate with image analysis or to suggest specific brain locations 
that should be searched for traumatic changes. However, texture analysis based 
on normal clinical imaging procedures was able to detect changes associated with 
traumatic injury in cerebral tissue. Future research projects should be dedicated 
to understanding injury-related changes in TA of different parts of the corpus 
callosum and white matter locations, as well as investigating their correlation with 
neuropsychological findings. In the initial stages of MTBI, TA could be used as 
an additional tool to analyse cases with normal-appearing conventional MRI. 
In Study III, the differentiation between NAWM and WM was evaluated. 
Depending on the threshold value, correct classification of 85% in FLAIR images 
can be categorized as moderate performance, indicating that WM near MS focal 
lesions has a somewhat different textural appearance from WM apart from the 
lesions. This result is congruent with the recent results published by Zhang et 
71
6. DISCUSSION
al. (2008). It should be considered whether the classification accuracy could 
be enhanced by the use of new imaging sequences, specific texture analysis or 
classification methods. The lack of a control group is a limitation of this study, 
particularly when focusing on non-visible changes. A healthy control group 
would have been useful in strengthening the results in classification of normal and 
normal-appearing white matter and also could have increased the sample size for 
intra-tissue comparisons, which will be discussed in 6.3.2.
Very little is known about the exercise load-related textural changes that occur 
in trabecular bone. Study IV was performed using a clinical scanner with two 
commonly used sequences, and co-occurrence matrix-based texture features were 
calculated from a large study population of different types of athletes and their 
referents. Texture analysis successfully identified differences between two groups 
of top-level female athletes (odd-impact and high-magnitude) and the normally 
exercising referents. These findings represent subtle changes emerging from 
the size of single trabeculae in the bone. Limited spatial resolution is a known 
disadvantage of this clinical imaging method, but in the light of these results and 
those of a recent study (Tameem et al., 2007), even normal clinical resolution 
images may capture textural features that reflect trabecular architecture and thus 
provide a non-ionising method for assessing bone structure. However, additional 
studies should be carried out to validate this method.
6.3 Comparison of ROI setting and imaging sequences  
 for texture analysis protocols 
6.3.1 Regions of Interest (ROI)
Quantitative analyses may be performed with manual, semi-automated or 
automated applications. The manual or semi-automated phase of data collection 
mainly concerns ROI drawing. Depending on the study questions and materials 
as well as the algorithm, automated methods can sometimes perform this task 
accurately and successfully. Despite the substantial advances in automated 
methods, there is still a need for the radiologist’s learned professional skill 
in visually evaluating normal and abnormal findings, and manual or semi-
automated applications may outperform automated processes. It should be taken 
into consideration that applications based on the manual definition of areas are 
dependent on the expertise of the performer, as well as the clinical complexity 
of the materials may vary. The current literature contains many examples of 
fixed-size ROIs as well as freehand-drawn ROIs; however comparisons of 
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the manual methods of ROI placement in MRI TA have not been examined. 
The topic of ROI drawing is relevant from both a scientific and clinical point 
of view. Study III showed that freehand-drawn ROIs of MS lesions produce 
somewhat better differentiation from WM than do fixed-size ROIs. However, 
when between anatomical levels and slice-to-slice variation was investigated, the 
textural appearance of freehand-drawn ROIs differed in more parameters than 
did fixed-size ROIs. Thus, standard size ROI boxes are more reproducible than 
manually defined freehand ROIs. On the other hand, the benefit of manually 
defined freehand ROI is that it avoids pixels representing surrounding tissues. 
Standard size ROI box may overlap with neighbouring tissue, thus incorporating 
partial volume pixels or even whole pixels from adjacent tissues in the calculated 
parameter values. Focal lesions can often be visually detected based on grey level 
contrast and appearance of the lesion and normal tissues. Therefore, the placement 
of ROIs for analyses with visual inspection-based manual methods is quite 
straightforward for users with clinical experience, and the usage of automated 
segmentation methods can be considered as well. However, for certain clinical 
applications, it may be faster and easier to place pre-defined fixed size ROI boxes 
on appropriate structures than to trace tumour or lesion borders, particularly in 
cases of diffuse changes caused by disease or lesions with indistinct transitions to 
normal-appearing tissues. 
6.3.2 Selection of images for analyses
In Studies II and III, several anatomical locations for ROIs were considered. Study 
III tested a protocol that included two anatomical levels based on anatomical 
landmarks and clinical knowledge of common sites for MS plaque appearance. 
Texture information calculated from two anatomical levels from each sequence 
lead to similar classification results for white matter/MS plaque tissue pairs. When 
anatomical levels and three sequential image slices from each level were compared 
with intra-tissue calculations, fixed-size ROIs of different tissues lead to uniform 
results, and a few parameters exhibited differences between anatomical levels. The 
mean percentages of a total of 280 parameters with no statistically significant 
variation between image slices were at least 90%.
The image selection analysis in Study II focused on healthy controls, and 277 
texture parameters were investigated. When interhemispheric differences in white 
matter were investigated, 95% of parameters were not significantly different 
between hemispheres. Three anatomical parts of the corpus callosum (sagittal 
view) were precisely equal, with only 1-2% parameters differing, but parameters 
calculated from the mesencephalon showed a moderate difference between the left 
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and right sides. These results indicate that the intracranial tissues and structures 
investigated with fixed size ROIs are consistent with respect to anatomical level 
changes. This provides the clinical operator some freedom for slice and ROI 
selection. However, careful attention should be paid to location selection, and 
the microstructure underlying homogenous-appearing tissue in image should be 
considered. However, if the study protocol leaves some freedom for selecting ROI 
locations, it is preferable for ROIs to be drawn with a uniform method to avoid 
unnecessary variation. 
6.3.3 Selection of sequences for analyses
In Study I, textural changes in lymphoma masses were detected better with T2-
weighted image data in the most prominent comparison: pre-treatment stage vs. 
second treatment evaluation. It should be noted that there were certain differences 
in acquisition parameters between patients that may have masked some subtle 
similarity in images within groups, although TA studies on variable acquisition 
properties have reported successful (Juntu et al., 2010; Herlidou-Meme et al., 
2003). No contrast enhancement media was included in the sequences used for 
TA, so it remains to be investigated if contrast enhancement may provide any 
additional information on lymphoma texture.
In Study III, texture information calculated from three different sequences lead 
to similar classification results. However, between the two T1-weighted series 
collected, the contrast-enhanced series performed slightly better than the series 
without and also performed better than the T2-weighted FLAIR. 
Study IV compared the performance of axial FLASH and MEDIC series. The 
textural data calculated from FLASH images discriminated between referents and 
two groups of athletes with high accuracy, while textural data based on MEDIC 
failed to do so with strict criteria for significance.
In general, in the light of the recent studies described in the literature review 
(2.4) and those included in this thesis, a wide variety of imaging sequences have 
been used for texture analysis with promising results. The selection of imaging 
sequence is always driven by the clinical imaging question; however, as seen in 
these studies, some sequences are more suitable than others for detecting textural 
changes. 
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6.4 Applicability of MRI-based texture analysis  
 in clinical imaging settings
Texture analysis is based on pixels or voxels, the smallest elements in an image. 
Visual inspection is not well capable of detecting and differentiating between 
all of the complex textural features that can be formed by these small elements. 
The current literature, including the results of this study, has proven that MRI 
data of different tissues, organs and pathologies contain texture features that can 
be detected with several mathematical methods. These features provide clinical 
radiologists with a potential quantitative means increasing the specificity and 
sensitivity of primary diagnostics and in disease follow-up. The investigations 
presented in this study are based on routine clinical imaging protocols with 
commonly available 1.5 T scanners. The trend in clinically routine imaging 
can also be seen in recent publications, where studies performed at 3.0 T are 
increasingly performed in addition to the most common field strength of 1.5 T. 
In Study I, there were variations in acquisition parameters due to the clinical 
status of the patients. Despite this, moderately successful overall classification 
could still be achieved. Furthermore, two recent studies on soft tissue masses were 
performed with some variations in acquisition parameters with promising results 
(Mayerhoefer et al., 2008; Juntu et al., 2010). A multicentre study on intracranial 
tumours by Herlidou et al. (Herlidou-Meme et al., 2003) also showed that image 
sets with acquisition variation could be suitable for texture analysis. Mayerhoefer 
et al. discovered variations in acquisition parameters and stated that as long as 
spatial resolution is sufficiently high, clinically feasible variations in acquisition 
parameters have little effect on classification results (Mayerhoefer et al., 2009b). 
These results indicate that images acquired with different parameters or in 
different centres are not inappropriate for texture analysis.
In imaging certain diseases and organs, many imaging centres have fixed MRI 
protocols that may also be used for quantitative image analyses, as was the case for 
the studies II–III presented here. 
Study II demonstrated the potential of combining several texture parameters to 
detect subtle, diffuse changes possibly related to mild traumatic brain injury. The 
detection and assignment of the traumatic changes is clinically important, and 
this initial approach should be further verified to determine the clinical relevance 
of different magnitudes of textural changes. MRI texture analysis for detecting 
non-visible traumatic changes could be used in combination with clinical tests 
or other advanced imaging methods, such as DTI, to estimate the injury load 
in MTBI, especially in the patient group for which conventional scans remain 
negative. However, more specific studies and application development must be 
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conducted before this kind of computer-aided diagnosis application can be used 
in a clinical environment. The other neuroradiological study, III, concentrated 
on multiple sclerosis, with clear success. In the future, it would be interesting to 
apply texture calculation over ROIs covering all normal-appearing white matter 
in a 2D image slice or all white matter volume in a 3D analysis and to investigate 
how sensitive this method is in detecting subtle changes in a larger ROI. In this 
study, analyses were run in a 2D environment because the software used in the 
three studies was implemented in 2D analyses. Furthermore, radiologists generally 
conduct visual inspection of MRI image data by scrolling through a series of 2D 
images, so this approach is familiar to clinicians. The present version of MaZda 
software is implemented in both 2D and 3D analyses. There are also several 3D 
applications that have been reported to perform texture-based classification and 
tissue characterisation with equal or superior results to 2D methods (Mahmoud-
Ghoneim et al., 2003; Georgiadis et al., 2009).
Study IV used skeletal MRI and focused on small anatomical details in the 
structure of trabecular bone. With a large cohort size, it was possible to show 
physiological load-related changes in the femoral necks of two athlete groups. This 
particular study was part of a wider project (Nikander et al., 2009) on detecting 
sports-related positive changes in bone strength and offers new insight on MRI as 
a non-ionising imaging method for population screening. The ability to conduct 
quantitative image analysis further increases the applicability of this method. 
Evaluating the performance of the present studies is somewhat challenging 
because to best of my knowledge, this is the first data on lymphoma treatment 
evaluation based on MRI texture analysis; the MTBI and trabecular bone study 
settings are also experimental and do not have precedents in the literature. Only 
the MS data may be compared to reference studies on the same study question.
In summary, in this study, texture analysis has been performed in order to 
obtain clinically important information on diffuse changes that are difficult to 
detect by qualitative visual inspection and to determine the tissue characterisation 
power of texture parameters in visually separable focal structures. A large collection 
of texture parameters based on histogram, autoregressive model, wavelet, and 
gradient-, run-length- and co-occurrence matrices were calculated from 1.5 T 
image data. The combined results of these studies provide promising evidence of 
the applicability of texture analysis for clinical imaging as well as a guide to the 
next steps of developing a clinical analysis protocol. The capability of TA to detect 
and characterise pathological and physiological changes in tissues has been shown 
in this study, as well as in other recent studies. However, it is also important to 
focus on other imaging and clinical findings, including histopathological findings 
of the patients and normal control populations whenever possible, to define 
normal threshold values for texture parameters. 
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1) The effectiveness of texture analysis for the characterisation of focal, visible 
lesions on normal-appearing tissue was investigated in multiple sclerosis 
patients in Study III. Texture analysis based on statistical, autoregressive 
model and wavelet texture parameters derived from MRI data were able 
to discriminate focal MS lesions from white matter and normal-appearing 
white matter with excellent accuracy and high statistical significance. As 
performed, this texture analysis method is suitable for similar tasks. 
2)  The effectiveness of texture analysis for the detection of non-visible changes 
in tissues was investigated in Studies I, II, III and IV. The performance varied 
somewhat between the studies. However, non-visible diffuse changes were 
detected in all studies, and as Studies I, II and IV represent experimental 
studies in their fields, the texture analysis method shows clear potential 
for detecting subtle non-visible changes. The challenge for future research 
remains to validate these results in larger and prospective clinical trials.
3) A comparison of freehand-drawn and fixed-size ROIs in Study III (MS 
lesions) revealed that freehand-drawn ROIs were better able to differentiate 
between tissues. Meanwhile, fixed-size ROIs provided better reproducibility. 
In Studies II and III, analyses of ROI placement in different image slices 
originating from different anatomical locations of the brain showed no 
significant differences in the cerebral structures and tissues investigated.
   According to the present study, the performance of data originating from 
different imaging sequences on texture analysis varied to some extent. T2-
weighted series performed best in the NHL treatment response evaluation 
(I); T1-weighted MPR with contrast enhancement produced the best 
classification in the MS Study (III); and FLASH images highlighted the 
load-specific changes of femoral neck trabecular bone (IV).
4)  The overall applicability of MRI-based texture analysis in common clinical 
imaging settings and the selected study materials was acceptable. In light of this 
study, routine clinical images are suitable for this kind of quantitative analysis. 
However, as Studies I, II, and IV are experimental and there are no earlier studies 
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on the same questions performed by other groups, information on the level of 
expected differences between tissues and lesions investigated is lacking, and there 
may be under- or over-detection of the changes. Further validation is needed to 
verify the utility and normal threshold values of these approaches.
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Discrete wavelet transformation is computed with a filter a cascade.
Only subband energy is calculated on different scales.
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The given image ( , ) with  discrete intensity levels.
The second order histogram is defined as the co-occurrence matrix P ( , ),
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Abstract
Background: To show magnetic resonance imaging (MRI) texture appearance change in non-
Hodgkin lymphoma (NHL) during treatment with response controlled by quantitative volume
analysis.
Methods: A total of 19 patients having NHL with an evaluable lymphoma lesion were scanned at
three imaging timepoints with 1.5T device during clinical treatment evaluation. Texture
characteristics of images were analyzed and classified with MaZda application and statistical tests.
Results: NHL tissue MRI texture imaged before treatment and under chemotherapy was classified
within several subgroups, showing best discrimination with 96% correct classification in non-linear
discriminant analysis of T2-weighted images.
Texture parameters of MRI data were successfully tested with statistical tests to assess the impact
of the separability of the parameters in evaluating chemotherapy response in lymphoma tissue.
Conclusion: Texture characteristics of MRI data were classified successfully; this proved texture
analysis to be potential quantitative means of representing lymphoma tissue changes during
chemotherapy response monitoring.
Background
Quantitative image analysis may provide new clinically
relevant information on the target of interest, constituting
a major advantage in clinical work as well as in research.
The most significant objectives in quantitative image anal-
ysis are to find tissue-characterizing features with biologi-
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cal significance and which correlate with pathophysiology
detected by other methods, i.e. clinical examination, other
imaging modalities and pathological-anatomical diagno-
sis, and secondly to provide this new information on the
properties of tissues to be used alone or in combination
with other clinical information allowing more reliable
detection of disease and sophisticated tissue classification
as a clinical diagnostic and follow-up tool.
Precise and earlier diagnostics and monitoring treatment
response are significant both for the individual patient's
prognosis and on a larger scale in developing treatment
procedures, especially in malignant diseases. Within the
research on solid tumors extensive and widely used
Response Evaluation Criteria in Solid Tumors (RECIST)
Guidelines may be followed to obtain intra- and inter
center comparable results. RECIST defines measurability
of tumor lesions and specifies methods of measurements
with different techniques [1]. According to the RECIST cri-
teria measure of tumor response from radiological images
is done by measuring lesions one-dimensionally, further-
more the World Health Organization (WHO) criteria use
two dimensional analysis and several research groups vol-
umetric three-dimensional analysis [2].
Staging of non-Hodgkin's lymphomas (NHL) is the key
element of treatment planning for this heterogeneous
group of malignancies. A variety of diagnostic tools,
including biopsies, computed tomography (CT), mag-
netic resonance imaging (MRI), 18F-fluorodeoxyglucose
positron emission tomography (FDG-PET) or molecular
markers are used in pre-treatment staging [3]. Enhance-
ment with contrast media could also help the evaluation
in using different imaging modalities. The same tools are
applied to evaluate the response to different types of treat-
ment. Novel techniques such as hybrid positron emission
tomography – computed tomography (PET-CT) imaging
and new PET tracers like 18F-fluoro-thymidine (18F-FLT)
may increase the sensitivity of response assessment [4].
Reports aiming international standardization of clinical
response criteria for NHL have been published [5,6], and
these criteria are in wide clinical use. A combination of
cyclophosphamide, doxorubicin, vincristine and pred-
nisone (CHOP) remains the mainstay of therapy. The
addition of a chimeric-anti-CD20 immunoglobulin G1
monoclonal antibody, rituximab (Mabthera®), has
resulted in a dramatic improvement in the outcome of the
most common NHL, diffuse large B-cell lymphoma, but
has also been shown to effective in other type of B-cell
lymphomas [7-9].
Several quantitative MRI studies have indicated that tex-
ture analysis (TA) has the ability to detect differences
between tissues and subtle changes between disease bur-
den and normal tissue. Successful applications of TA have
been reported from studying neurological diseases [10-
15], brain tumors [16,17], amygdale activation [18], mus-
cles [19,20], trabecular bone [21-23], liver [24-26], breast
cancer [27-31] and lymphomas [32].
In this paper we report the ability of TA to detect changes
in NHL solid tissue masses during chemotherapy. The
change in texture appearance is controlled by quantitative
volumetric analysis. We classify statistical, autoregressive
(AR-) model and wavelet texture parameters representing
pre-treatment and two under chemotherapy stages of
tumors with four analyses: raw data analysis (RDA), prin-
cipal component analysis (PCA), linear (LDA) and non-
linear discriminant analysis (NDA). The final objective is
to show that these texture parameters of MRI data can be
successfully tested with Wilcoxon paired test and Repeat-
ability and Reproducibility (R&R) test for assess the
impact of the parameters usability in evaluating chemo-
therapy response in lymphoma tissue.
Methods
Tumor Response Evaluation (TRE) is a wide prospective
clinical project ongoing at our university hospital on can-
cer patients, where tumor response to treatment is evalu-
ated and followed up using simultaneously CT, MRI and
PET imaging methods. Clinical responses for these lym-
phoma patients were assessed according to the guidelines
of the international working group response criteria. In
this texture analysis study, as a part of extensive project,
the focus was on quantitative imaging methods and only
the response in predefined solid NHL masses was evalu-
ated. The ethics committee of the hospital approved the
study and participants provided written informed con-
sent. Primary inclusion criteria were NHL patients with at
least one bulky lesion (over 3 centimeters) coming for cur-
ative aimed treatment. Exclusion criteria were central
nervous disease, congestive heart failure New York Heart
Association Classification (NYHA) III-IV, serious psychi-
atric disease, HIV infection and pregnancy.
Patients
MRI images of nineteen NHL patients participating in the
TRE project were selected for the first part of this study.
One of these patients was excluded due to the smaller
amount of image data from the second part analyses.
There were 14 male and 5 female patients aged 34–75.
These patients had untreated or relapsed histologically
diagnosed high/intermediate (N = 8, 42%) or low-grade
(N = 11, 58%) NHL with an evaluable lymphoma lesion
either in the abdominal area (N = 16) or in the clavicular
and axillary lymph node area (N = 3). The treatment given
was chemotherapy alone or combined with humanized
antibody, rituximab (Mabthera®). Therapy regimens were
CHOP (N = 5), R-CHOP (rituximab and CHOP) (N = 8),
and CVP (cyclophosphamide, vincristine and pred-
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nisone) (N = 1), CHOP-like CNOP (cyclophosphamide,
mitoxantrone, vincristine and prednisone) (N = 1), ChlP
(chlorambucil and prednisone) (N = 1), starting with
CHOP and changing to R-CHOP (N = 2), starting with R-
CHOP and changing to R-CVP (N = 1). Chemotherapy
regimens were selected according to patients' clinical sta-
tus. Chemotherapy courses were repeated every three
weeks, and 4 to 9 courses were given according to clinical
response. Two patients received 4 cycles, four patients 6
cycles, one patient 7 cycles, and 11 received 8 cycles, and
one 9 cycles.
MR imaging schedule
MR imaging in clinical practice as well as in this study was
carried out at staging phase before any treatment (exami-
nation 1, E1), after the first chemotherapy cycle (examina-
tion 2, E2), and after the fourth chemotherapy cycle
(examination 3, E3). In addition patients were followed
up by using MRI six months and 6–61 months after the
completion of therapy. The time frame of the study is pre-
sented in Figure 1.
MR image acquisition
Imaging was performed on a 1.5 T MRI device (GE Signa,
Wisconsin, USA).
One contrast enhanced sequence acquired from the first
and second imaging timepoint were included for volume
analysis of lymphoma masses. The sequence used was
axial T2-weighted fast spin echo (FSE) fat saturation (FAT
SAT) sequence (TR 620 ms, TE 10 ms), with intravenous
contrast agent gadolinium chelate (gadobenate dimeglu-
mine, 0.2 mg/ml, 10 ml), slice thickness ranged from 5
mm to 12 mm.
One or two T1- and T2-weighted axial image serquences
from the first three imaging timepoints of every patient
were taken for texture analysis. The T1-weighted series
comprised T1-weighted spin echo (SE) and T1-weighted
SE FAT SAT sequences (TR 320–700 ms, TE 10 ms), the
T2-weighted sequences were FSE FAT SAT (TR 3 320–10
909 ms, TE 96 ms). Repetition time TR varied between
and within patients. Slice thickness varied between
patients according to clinical status from 5 mm to 12 mm;
most patients had two different slice thickness series, the
general combination was 5 mm and 8 mm series. Pixel
size varied from 1.33 mm*1.33 mm to 1.80 mm*1.80
mm, and a 256*256 matrix was used.
Texture analysis with MaZda
Texture parameter calculation was the first stage of the tex-
ture analyses. Stand-alone DICOM viewer application was
used to select three to five slices from every image series
for analysis. Region of interest (ROI) setting and texture
analysis were carried out with MaZda software (MaZda
3.20, The Technical University of Lodz, Institute of Elec-
tronics) [33,34]. The lymphoma masses were manually
selected and set as ROIs (Figure 2). Texture features calcu-
lated were based on histogram, gradient, run-length
matrix, co-occurrence matrix, autoregressive model and
wavelet-derived parameters [34]. Image grey level inten-
sity normalization computation separately for each ROI
was performed with method limiting image intensities in
the range [μ-3σ, μ+3σ], where μ is the mean grey level
value and σ the standard deviation. This method has been
shown to enhance differences between two classes when
comparing image intensity normalization methods in tex-
ture classification [35].
Fisher coefficient (Fisher) and classification error proba-
bility (POE) combined with average correlation coeffi-
cients (ACC) provided by MaZda were used to identify the
Time frame of the studyF gure 1
Time frame of the study. E1-E5 refers to the MRI exami-
nation timepoints 1–5, respectively.
Axial T1-weighted fat saturation image slice of the abdomen of a typical subject (left), and ROI drawn on lymphoma ass (righ )Fi ure 2
Axial T1-weighted fat saturation image slice of the 
abdomen of a typical subject (left), and ROI drawn on 
lymphoma mass (right).
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most significant texture features to discriminate and clas-
sify the three evaluation stages of lymphoma tissue. Ten
texture features were chosen by both methods (Fisher,
POE+ACC). This feature selection was performed sepa-
rately for the T1- and T2-weighted image sets. In these
subgroups feature selection was run for the following
imaging stages: combination of all imaging timepoints
(E1, E2, and E3), and all combinations of the two afore-
mentioned. Slice thickness was not taken into account.
Volumetric analysis
The volumetry of the solid lymphoma masses was evalu-
ated between diagnostic stage (E1) and after the first treat-
ment (E2). The masses were selected for evaluation before
chemotherapy. The same masses were followed after the
first treatment. Volumetric analysis based on MRI images
was performed with semiautomatic segmentation soft-
ware Anatomatic™ [36] with region growing method.
[37].
Clinical parameters analyses
The patients' subjective views on their clinical symptoms
was observed between two stages: at the diagnosis and
after the first treatment. The subjective views were set in
two groups: symptoms unchanged or relieved.
Grade of malignity was classed into two groups: 1) low; 2)
high/intermediate.
Tissue classification
B11 application (version 3.4) of MaZda software package
was used for texture data analysis and classification. Anal-
yses were run between all combinations of imaging stages
separately for T1- and T2-weighted images. Analyses were
performed for combination of parameters selected auto-
matically with Fisher and POE+ACC methods for 1) the
specific imaging timepoint pair in question and 2) for all
imaging stages in particular image type (T1-, T2-
weighted). Feature standardization was used in B11, the
mean value being subtracted from each feature and the
result divided by the standard deviation. Raw data analy-
sis (RDA), principal component analysis (PCA), and lin-
ear (LDA) and nonlinear discriminant analysis (NDA)
were run for each subset of images and chosen texture fea-
ture groups. B11 default neural network parameters were
used. Nearest-neighbor (1-NN) classification was per-
formed for the raw data, the most expressive features
resulting from PCA and the most discriminating features
resulting from LDA. Nonlinear discriminant analysis car-
ried out the classification of the features by artificial neu-
ral network (ANN). These classification procedures were
run by B11 automatically.
Statistical analyses
Statistical analyses were run for the texture features
MaZda's automatic methods (Fisher and POE+ACC) had
shown to give best discrimination between imaging time-
points. The T1- and T2-weighted image texture parameters
were tested separately. Texture parameters for 18 patients
were included in the test, one patient participating in
MaZda texture parameter calculation was excluded
because of smaller amount of image data than other
patients leading to reduced textural data.
In analyzing and seeking the best parameters for classifi-
cation, it is vital to ensure low overall variation in the
treatment process and to ascertain how this variation can
be focused onto different components in the whole proc-
ess. In the present study the repeatability and reproduci-
bility (R&R) method was applied. The design of the study
was experimental, the aim being to estimate different
sources of variation in the lymphoma texture at the three
different timepoints (examinations 1, 2, and 3) and
repeating the same measurements three times. Because
the distributions were skewed, the range method was
used.
According to the standard Gage R&R terminology time-
points stand for operators, patients for parts and repeated
measurements for trials. In statistical terms the following
variance components were estimated: repeatability (dif-
ference across measurements), reproducibility (difference
across timepoints) and variability (difference across
patients). Repeatability describes intrapatient variation,
i.e., how a given measurer repeats the same planning proc-
ess. Reproducibility describes interpatient variation, i.e.,
how different measurements at the timepoints follow the
same planning process and variability describes interpa-
tient variation, i.e. how well the same physician can repeat
the planning process for different kinds of patients. The
total error – also known as the combined R&R effect –
includes repeatability and reproducibility, and only
patient-to-patient variation is excluded. In industrial
applications the combined R&R should not exceed 10%
of the total variation, but in certain situations a total error
up to 30% may be acceptable. The present statistical anal-
yses were performed by Statistica/W (Version 5.1, 98 edi-
tion, Statsoft. Inc, Tulsa, OK, USA).
Textural data from T1- and T2-weighted fat saturation
image series were analysed separately and both groups
divided into two subgroups according to slice thickness:
5–7 mm and 8–12 mm. Differences between imaging
timepoints were analysed by Wilcoxon Signed Ranks.
Mann-Whitney test was used to test rank parameters
grouped by grade of malignity and subjective change of
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symptoms. These analyses were performed by SPSS for
Windows, version 14.0.2.
Results
Volumetric analysis
The median volume of the lymphoma masses before treat-
ment (E1) was 429 cm3, ranging from 72 cm3 to 2144
cm3. The median volume of the masses calculated from
the second imaging timepoint (E2) was 190 cm3, ranging
from 30 cm3 to1622 cm3. After the first treatment cycle,
the lymphoma mass volume had decreased in all patients.
The median decline in volume was 32%, ranging from 3%
to 76%. The results of this volumetric analysis have been
published earlier in more detail [37]. The volumetry
results of the first and second imaging are given in cm3,
and the volume change is calculated in percentages in
Table 1.
Clinical parameters analyses
According to the patient's subjective estimates clinical
symptoms between first and second imaging timepoint
were unchanged in eight patients and relieved in 11
patients. Grades of malignancy and subjective view on
symptoms are presented in Table 1 with volumetry results.
Texture data: MaZda and B11 analyses
We included in the analyses 108 T1-weighted and 113 T2-
weighted images from E1; 103 T1-weighted and 105 T2-
weighted images from E2; and 97 T1-weighted images and
99 T2-weighted images from E3.
Texture features were selected with Fisher and POE+ACC
methods in MaZda from 300 original parameters calcu-
lated for each of the four subgroups in both image data
classes T1- and T2-weighted.
We found that the most significant features varied clearly
between imaging stages. The whole of 74 TA features
ranked first to tenth significant feature in tested sub-
groups. There were three histogram parameters, 55 co-
occurrence parameters, nine run-length parameters, four
absolute gradient parameters and three autoregressive
model parameters. No wavelet parameters were placed in
the top group.
Data analyses RDA, PCA, LDA and NDA show texture
changes between imaging points. The analyses did not
perform well the task of discriminating all three imaging
timepoints (E1, E2, E3) at same time. Slightly better clas-
sification was achieved between the first and second
examinations, and between the second and third exami-
nations. The method was successful in classifying the tex-
tural data achieved from the pre-treatment and third
imaging timepoints, the best discrimination was obtained
within T2-weighted leading to NDA classification error of
4%, and within T1-weighted NDA 5% error. Classification
of different examination stages lead to same level results
Table 1: Grade of malignancy (1 = low, 2 = high/intermediate), subjective view of change in symptoms between pretreatment stage 
(E1) and after first chemotherapy cycle (E2) (0 = unchanged, 1 = relieved).
Patient Grade of malignity Symptoms Volume
1 = low
2 = high/intermediate
0 = unchanged
1 = relieved
E1 (cm3) E2 (cm3) Change%
1 2 1 429 105 -76%
2 2 1 183 64 -65%
3 1 1 173 66 -62%
4 1 1 529 459 -13%
5 1 0 570 419 -26%
6 1 1 800 595 -26%
7 2 1 146 118 -19%
8 2 0 118 80 -32%
9 1 1 367 246 -33%
10 1 0 850 769 -10%
11 2 1 2144 1622 -24%
12 2 1 72 30 -58%
13 2 0 140 52 -63%
14 2 1 274 93 -66%
15 1 1 795 190 -76%
16 1 0 824 797 -3%
17 1 0 750 579 -23%
18 1 0 273 66 -76%
19 1 0 771 522 -32%
Results of the volumetric analysis of first (E1) and second imaging stages (E2). Volumes are given in cm3, and the volume change calculated in 
percentages.
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in T1- and T2-weighted images. The overall classification
results are presented in Table 2 and Table 3.
Texture data: Statistical analyses
The values of 73 features obtained with MaZda feature
selection methods were tested with Wilcoxon paired test
for groups obtained from imaging timepoints a) E1 and
E2, b) E2 and E3, c) E1 and E3. T1- and T2-weighted fat
saturation image series data were set as their own groups
and further into two subgroups according to slice thick-
ness: 5–7 mm and 8–12 mm.
R&R test parameter repeatability was used to describe the
variation in texture features between image slices within
imaging sequence, and parameter reproducibility to
describe the variation between examination stages. This
test was performed separately for T1- and T2-weighted
images in all three combinations of two imaging points.
Differences in slice thickness were not taken into account.
Reproducibility values were expected to be quite large
because the aim was that the treatment given between
imaging stages would take effect and be shown in image
texture. In contrast, repeatability values (i.e. differences
between images taken at the same timepoint) were
expected to be zero. There is no exact expected ratio for
reproducibility and patient-to-patient variation in such
studies and thus no exact value for percentage of repro-
ducibility, so that the difference between different imag-
ing stages was significant.
The texture parameters giving the best discrimination
within T1-weighted image groups in two imaging stage
comparison are given in Table 4, Table 5 and Table 6; and
respectively for T2-weighted image groups in Table 7,
Table 8 and Table 9. Reproducibility percentage and
Repeatability percentage of the total are given for all
parameters. Wilcoxon paired test p-values are given for all
parameters for separate groups regarding slice thickness
(groups 5–7 mm and 8–12 mm).
R&R inverted ratio and the small difference between val-
ues are associated with poor results in Wilcoxon test with
certain exceptions. Comparisons between first and third
imaging points achieved significant Wilcoxon test p-val-
ues most consistently: within T2-weighted images in both
slice thickness groups, and within T1-weighted images in
the group of thinner slices. Features ranked in T1-
weighted image data were tested in T2-weighted image
data and vice versa. These tests with ranked features trans-
posed with T1- and T2-weighted image groups lead to sta-
tistically relevant p-values in thinner T1-weighted images
and all images in T2-weighted group. In the analyses of
first and second imaging timepoints thin slices in general
achieved poorer separation than thick slices. Between the
second and third imaging sessions Wilcoxon test gave an
unsatisfactory result in T1-weighted group. This trend can
be seen in the B11 classification results in the framework
of T1-weighted images, while the T2-weighted image anal-
yses in B11 show better classification between second and
third than first and second imaging points. The best over-
all discrimination between imaging timepoints in T1-
weighted images was given by the run-length matrix
parameters describing grey level non-uniformity, run-
length non-uniformity, short-run emphasis and fraction
of image in runs in one or more directions calculated
(horizontal, vertical, 45 degrees and 135 degrees). In the
framework of T2-weighted image analyses best the per-
formers were absolute gradient mean and grey level non-
uniformity There were some scattering in well acquitted
parameters between sub analyses.
Table 2: MaZda classification results – results obtained within T1-weighted images.
T1-weighted images classification RDA PCA LDA NDA
Examinations mis% mis% mis% mis%
E1, E2, E3 Combination E1, E2, E3 36% 34% 46% 31%
E1, E2 Combination E1, E2, E3 36% 34% 46% 31%
Combination E1, E2 24% 26% 34% 16%
E1, E3 Combination E1, E2, E3 18% 18% 13% 6%
Combination E1, E3 17% 17% 15% 5%
E2, E3 Combination E1, E2, E3 26% 26% 34% 18%
Combination E2, E3 25% 27% 30% 13%
Imaging timepoint (E1, E2, E3) combinations for classification analyses. Feature selection methods given in rows. Misclassification percentage (mis%) 
given for raw data analysis (RDA), principal component analysis (PCA), linear discriminant analysis (LDA) and non-linear discriminant analysis 
(NDA) in columns. "Combination E1, E2, E3" in feature selection methods refers to features, which have proved to give best discrimination in all 
imaging timepoints analyses with Fisher and POE+ACC methods, combination of two imaging timepoints refers respectively to features from the 
analyses in question.
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Table 3: MaZda classification results – results in groups of T2-weighted images.
T2-weighted images classification RDA PCA LDA NDA
Examinations Feature selection method mis% mis% mis% mis%
E1, E2, E3 Combination E1, E2, E3 34% 35% 47% 30%
E1, E2 Combination E1, E2, E3 29% 29% 39% 19%
Combination E1, E2 37% 35% 40% 35%
E1, E3 Combination E1, E2, E3 15% 14% 19% 4%
Combination E1, E3 16% 17% 21% 4%
E2, E3 Combination E1, E2, E3 25% 24% 25% 14%
Combination E2, E3 24% 23% 30% 12%
Imaging timepoint (E1, E2, E3) combinations for classification analyses. Feature selection methods given in rows. Misclassification percentage (mis%) 
given for raw data analysis (RDA), principal component analysis (PCA), linear discriminant analysis (LDA) and non-linear discriminant analysis 
(NDA) in columns. "Combination E1, E2, E3" in feature selection methods refers to features, which have proved to give best discrimination in all 
imaging timepoints analyses with Fisher and POE+ACC methods, combination of two imaging timepoints refers respectively to features from the 
analyses in question.
Table 4: Summary table of texture parameters ranked 1-10 with Fisher and POE+ACC methods according to test subgroup T1-
weighted images and imaging timepoints E1 and E2.
T1-WEIGHTED IMAGES R&R R&R Wilcoxon Wilcoxon
E1-E2 analyses Repeatability % of total Reproducibility % of total Slice thickness <8 mm
p
Slice thickness >= 8 mm
p
HISTOGRAM PARAMETERS
Percentile, 1% 15.349 0.069 0.286 0.672
CO-OCCURENCE MATRIX 
PARAMETERS
Difference entropy S(1,0) 6.874 25.411 0.074 0.018
Difference entropy S(0,1) 7.725 26.783 0.074 0.028
Difference entropy S(1,1) 6.970 24.413 0.139 0.018
Difference entropy S(2,0) 8.409 28.186 0.114 0.018
Sum average S(0,2) 52.143 4.597 0.285 0.499
Difference entropy S(2,2) 11.265 22.824 0.093 0.018
Difference entropy S(3,0) 15.434 11.836 0.241 0.018
Angular second moment S(5,-5) 18.976 7.234 0.093 0.612
Sum of squares S(5,-5) 58.267 1.780 0.721 0.310
Sum average S(5,-5) 15.420 16.235 0.445 1.000
RUN-LENGTH MATRIX 
PARAMETERS
Grey level nonuniformity, 0° 6.015 43.441 0.051 0.128
Grey level nonuniformity, 90° 8.822 35.055 0.028 0.091
Grey level nonuniformity, 45° 4.635 13.324 0.028 0.176
Grey level nonuniformity, 135° 4.734 39.630 0.037 0.249
ABSOLUTE GRADIENT 
PARAMETERS
Variance 28.133 22.699 0.445 0.018
AUTOREGRESSIVE MODEL 
PARAMETERS
Teta 2 65.193 2.741 0.575 0.237
Teta 4 66.319 2.285 0.575 0.398
Texture parameters are given in rows. In the columns R&R repeatability and reproducibility of total, and Wilcoxon test for fat saturation series 
grouped with image slice thickness less than 8 mm, and 8 mm or thicker.
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Mann-Whitney test was performed for all texture features
ranked 1–5 in any classification sub-analysis separately in
T1- and T2-weighted images and further subgroups
according to slice thickness to analyze differences between
stage of malignity (low vs. high/intermediate) and
between subjective change of symptoms (unchanged vs.
relieved). These analyses did not yield any relevant and
consequential additional information on the relation of
texture features to grouping parameters.
Discussion
The goals of this study were show that a) MRI texture anal-
ysis can be used in NHL chemotherapy response evalua-
tion b) statistical tests Wilcoxon paired test and R&R can
be used to evaluate the separability of texture parameters
used to describe textural changes in NHL.
Limitations of our study may be the non-standardized
MRI sequence protocols within intra and inter patient
images and the use of different slice thickness due to
imaging in clinical practice, where patient's clinical stage
and the size of the tumor were taken into account when
Table 5: Summary table of texture parameters ranked 1-10 with Fisher and POE+ACC methods according to test subgroup T1-
weighted images and imaging timepoints E2 and E3.
T1-WEIGHTED IMAGES R&R R&R Wilcoxon Wilcoxon
E2-E3 analyses Repeatability % of total Reproducibility % of total Slice thickness <8 mm
p
Slice thickness >= 8 mm
p
HISTOGRAM PARAMETERS
Variance 11.452 22.145 0.953 0.465
CO-OCCURENCE MATRIX 
PARAMETERS
Contrast S(2,0) 31.815 28.807 0.139 0.465
Contrast S(3,0) 27.957 40.317 0.051 0.144
Difference variance S(3,0) 26.169 35.250 0.139 0.273
Contrast S(4,0) 29.032 37.330 0.051 0.144
Correlat S(4,0) 25.661 36.025 0.086 0.144
Correlat S(0,4) 21.528 38.249 0.139 0.068
Correlat S(5,0) 23.130 39.697 0.038 0.068
Sum average S(5,0) 55.837 4.961 0.214 0.144
Sum average S(0,5) 44.169 6.142 0.859 0.715
Inverse difference moment S(5,5) 53.397 24.684 0.678 0.465
Difference variance S(5,-5) 50.986 14.473 0.515 0.715
RUN-LENGTH MATRIX 
PARAMETERS
Grey level nonuniformity, 0° 6.015 43.441 0.066 0.273
Run length nonuniformity, 45° 7.013 31.416 0.139 0.068
Grey level nonuniformity, 45° 4.635 13.324 0.066 0.465
Short run emphasis, 135° 13.062 21.630 0.021 0.144
ABSOLUTE GRADIENT 
PARAMETERS
Mean 24.582 28.201 0.038 0.144
Kurtosis 60.387 1.194 0.767 1.000
AUTOREGRESSIVE MODEL 
PARAMETERS
Teta 3 58.511 0.000 0.028 0.465
Texture parameters are given in rows. In the columns R&R repeatability and reproducibility of total, and Wilcoxon test for fat saturation series 
grouped with image slice thickness less than 8 mm, and 8 mm or thicker.
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setting imaging parameters. However, multicenter studies
on MRI TA have shown transferability of TA parameters
achieved from MRI images obtained at different MRI cent-
ers with own acquisition parameters [16,38].
To achieve new clinical relevant information by means of
texture analysis, the texture changes should come out at
the same or earlier timepoint as other quantitative meas-
ures of tumor response, for example decrease in tumor
volume. The RECIST and WHO criteria for evaluating
tumor response in one- or two-dimensional (diameter
and product) tumor size is equivalent to a 65% decrease
in tumor volume [1]. In this study we calculated tumor
size decrease in a short time period: before and after the
first cycle of chemotherapy. There are no commonly used
criteria for early response assessment using volumetric
analysis for use as early in the therapy course as our volu-
metric evaluation was performed. Considering this, we
Table 6: Summary table of texture parameters ranked 1-10 with Fisher and POE+ACC methods according to test subgroup T1-
weighted images and imaging timepoints E1 and E3.
T1-WEIGHTED IMAGES R&R R&R Wilcoxon Wilcoxon
E1-E3 analyses Repeatability % of total Reproducibility % of total Slice thickness <8 mm
p
Slice thickness >= 8 mm
p
HISTOGRAM PARAMETERS
MinNorm 24.793 2.445 0.504 0.465
Percentile, 1% 15.349 0.069 0.964 0.715
CO-OCCURENCE MATRIX 
PARAMETERS
Inverse difference moment S(2,0) 20.950 29.298 0.008 0.068
Contrast S(3,0) 27.957 40.317 0.008 0.068
Correlation S(3,0) 24.569 38.395 0.021 0.068
Difference variance S(3,0) 26.169 35.250 0.021 0.068
Contrast S(4,0) 29.032 37.330 0.010 0.068
Correlation S(4,0) 25.661 36.025 0.021 0.068
Inverse difference moment S(4,0) 19.088 34.553 0.004 0.068
Correlation S(4,4) 17.730 40.414 0.021 0.068
Sum of squares S(4,-4) 52.253 2.218 0.859 1.000
Correlation S(5,0) 23.130 39.697 0.016 0.068
Inverse difference moment S(5,0) 23.111 37.188 0.013 0.068
Sum of squares S(0,5) 66.827 1.190 0.041 0.715
Sum of squares S(5,5) 64.191 3.647 0.477 0.715
RUN-LENGTH MATRIX 
PARAMETERS
Grey level nonuniformity, 45° 4.635 13.324 0.003 0.068
Grey level nonuniformity, 135° 4.734 39.630 0.003 0.068
Fraction of image in runs, 135° 13.014 23.544 0.003 0.068
Texture parameters are given in rows. In the columns R&R repeatability and reproducibility of total, and Wilcoxon test for fat saturation series 
grouped with image slice thickness less than 8 mm, and 8 mm or thicker.
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can use the volumetric results as indicative of early imag-
ing based evaluation of response, not to meet response,
and also accept tumor volume decrease percentages
smaller than 65% as consequential decrease in tumor size.
However, in lymphomas, final clinical response evalua-
tion should include other clinical tests according to [5,6].
Wilcoxon test showed encouraging values in the analyses
of E1 and E3, including transferability of feature sets
between T1- and T2-weighted images. This confirms our
recent results with smaller patient data MaZda texture
analysis of combination of T1- and T2-weighted images in
single analysis [32].
Our study show that the statistical and autoregressive
model texture parameters of MRI data can be successfully
tested one by one with Wilcoxon paired test and Gage
Repeatability and Reproducibility test to assess the impact
of parameter separability in evaluating chemotherapy
response in lymphoma tissue. Our results strengthen the
applicability of Fisher and POE+ACC methods used in
MaZda for automatic feature selection, and also confirm
the suitability of the raw parameters in statistical tests.
This indicates that raw parameters may be used in analy-
ses other than LDA, NDA and PCA tests to acquire classi-
fication.
Table 7: Summary table of texture parameters ranked 1-10 with Fisher and POE+ACC methods according to test subgroup T2-
weighted images and imaging timepoints E1 and E2.
T2-WEIGHTED IMAGES R&R R&R Wilcoxon Wilcoxon
E1-E2 analyses Repeatability % of total Reproducibility % of total Slice thickness <8 mm
p
Slice thickness >= 8 mm
p
HISTOGRAM PARAMETERS
MinNorm 14.090 24.380 0.861 0.636
CO-OCCURENCE MATRIX 
PARAMETERS
Difference variance S(1,-1) 24.802 17.121 0.249 0.266
Sum average S(2,2) 38.483 23.527 0.552 0.163
Contrast S(3,0) 22.618 45.195 0.087 0.025
Contrast S(3,3) 23.282 48.345 0.152 0.102
Contrast S(4,0) 26.599 44.458 0.221 0.013
Contrast S(4,4) 31.083 41.015 0.116 0.049
Difference variance S(4,4) 35.305 32.674 0.196 0.019
Contrast S(4,-4) 40.897 22.850 0.013 0.266
Sum average S(4,-4) 10.802 1.906 0.345 0.210
Contrast S(5,0) 30.110 41.229 0.422 0.007
Sum of squares S(5,0) 64.138 7.335 0.807 0.076
Difference variance S(5,0) 34.811 32.369 0.917 0.009
Contrast S(0,5) 41.519 29.671 0.055 0.210
Contrast S(5,5) 39.461 38.040 0.133 0.102
Sum of squares S(5,5) 80.906 0.000 0.972 0.906
RUN-LENGTH MATRIX 
PARAMETERS
Short run emphasis, 90° 10.659 12.516 0.087 0.149
Fraction of image in runs, 90° 11.662 12.685 0.101 0.124
ABSOLUTE GRADIENT 
PARAMETERS
Mean 18.036 44.271 0.046 0.287
Skewness 63.599 15.598 0.382 0.492
Texture parameters are given in rows. In the columns R&R repeatability and reproducibility of total, and Wilcoxon test for fat saturation series 
grouped with image slice thickness less than 8 mm, and 8 mm or thicker.
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We have shown that texture parameters change during
tumor response to chemotherapy. Comparing initial
imaging to the second imaging timepoint, just after the
first chemotherapy cycle, there were not such clear
changes as at the third imaging timepoint, after four cycles
of chemotherapy. The difference in texture appearance
between staging and the third imaging timepoint was dis-
tinct and emerged from the results of other combinations
in both T1-weighted and T2-weighted image types. There
might have been better separation in texture features
between diagnostic and first evaluation stage if standard-
ized imaging sequence had been used. Our non-standard-
ized MRI sequence may lead too heterogeneous TA
features to exactly describe subtle changes in lymphoma
tissue in extremely early stages of therapy response evalu-
ation. We still cannot state the importance of subtle tex-
tural changes in early response assessment in comparison
to volumetric changes in the same time intervals. Further,
as controls for examined NHL masses no normal lymph
nodes neither NHL masses after treatment were analyzed,
since their small size leading to not exact differentiation
from surrounding soft tissue structures in MR images.
The response evaluation of lymphomas under treatment
using radiological imaging methods is connected strongly
with tumor dimensions, instead when using positron
emission tomography, tumor lesion activity of tracer
uptake is measured. Both methods have certain advan-
tages and disadvantages; major disadvantages related to
sensitivity to differentiate residual masses and inflamma-
tory processes from active disease. Functional responses
for nocicepti stimuli and antivascular therapy have been
detected in recent MRI TA studies [18,31]. In this context
changes in textural appearance in MRI during the treat-
Table 8: Summary table of texture parameters ranked 1-10 with Fisher and POE+ACC methods according to test subgroup T2-
weighted images and imaging timepoints E2 and E3.
T2-WEIGHTED IMAGES R&R R&R Wilcoxon Wilcoxon
E2-E3 analyses Repeatability  % of total Reproducibility % of total Slice thickness <8 mm
p
Slice thickness >= 8 mm
p
HISTOGRAM PARAMETERS
MinNorm 14.090 24.380 0.002 0.124
Variance 1.655 16.743 0.028 0.149
CO-OCCURENCE MATRIX 
PARAMETERS
Contrast S(2,0) 19.563 41.264 0.055 0.001
Contrast S(2,2) 23.139 43.325 0.033 <0,001
Contrast S(3,0) 22.618 45.195 0.023 0.002
Correlation S(3,0) 21.555 40.965 0.009 0.001
Contrast S(0,3) 30.424 34.725 0.116 <0,001
Contrast S(3,3) 23.282 48.345 0.023 0.004
Correlation S(3,3) 22.095 44.779 0.016 0.010
Contrast S(4,0) 26.599 44.458 0.006 0.011
Correlation S(4,0) 23.479 41.166 0.003 0.009
Sum of squares S(4,0) 71.978 3.535 0.807 0.868
Correlation S(4,4) 23.823 42.301 0.016 0.055
Difference entropy S(4,-4) 10.347 7.011 0.039 0.210
Sum average S(0,5) 35.828 0.000 0.972 0.011
Angular second moment S(5,-5) 8.994 12.106 0.064 0.015
Inverse difference moment S(5,-5) 46.459 0.000 0.917 0.795
RUN-LENGTH MATRIX 
PARAMETERS
Grey level nonuniformity, 135° 6.265 33.780 0.003 0.004
ABSOLUTE GRADIENT 
PARAMETERS
Mean 18.036 44.271 0.039 <0,001
Skewness 63.599 15.598 0.221 0.044
Texture parameters are given in rows. In the columns R&R repeatability and reproducibility of total, and Wilcoxon test for fat saturation series 
grouped with image slice thickness less than 8 mm, and 8 mm or thicker.
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ment process probably reflect chemotherapy induced
changes in cellular proliferation.
In treatment with a curative orientation it is essential to
get early an estimate of response to determine further
treatment. MRI texture analysis may provide new insight
to be used alone or in combination with other tools in
diagnostics and response monitoring of non-Hodgkin
lymphomas.
Conclusion
In conclusion NHL tissue MRI texture imaged before treat-
ment and during chemotherapy can be correctly classified.
Our results show promise for texture analysis as a possible
new quantitative means for evaluating NHL response. Sta-
tistical and autoregressive model texture parameters of
MRI data can be successfully tested with Wilcoxon paired
test and Gage Repeatability and Reproducibility test to
assess the impact of the parameters separability in evalu-
ating chemotherapy response in lymphoma tissue.
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Table 9: Summary table of texture parameters ranked 1-10 with Fisher and POE+ACC methods according to test subgroup T2-
weighted images and imaging timepoints E1 and E3.
T2-WEIGHTED IMAGES R&R R&R Wilcoxon Wilcoxon
E1-E3 analyses Repeatability % of total Reproducibility % of total Slice thickness <8 mm
p
Slice thickness >= 8 mm
p
HISTOGRAM PARAMETERS
MinNorm 14.090 24.380 0.003 0.130
CO-OCCURENCE MATRIX 
PARAMETERS
Contrast S(2,0) 19.563 41.264 0.011 0.001
Contrast S(2,2) 23.139 43.325 0.006 <0,001
Contrast S(3,0) 22.618 45.195 0.009 0.001
Correlation S(3,0) 21.555 40.965 0.007 0.001
Sum average S(3,0) 28.935 19.345 0.033 0.035
Contrast S(3,3) 23.282 48.345 0.006 <0,001
Correlation S(3,3) 22.095 44.779 0.007 <0,001
Sum average S(3,-3) 20.384 0.353 0.087 0.017
Contrast S(4,0) 26.599 44.458 0.007 0.001
Contrast S(4,4) 31.083 41.015 0.009 <0,001
Correlation S(4,4) 23.823 42.301 0.007 <0,001
Sum of squares S(4,4) 82.108 0.686 0.345 0.687
Correlation S(5,-5) 39.239 25.122 0.023 0.035
RUN-LENGTH MATRIX 
PARAMETERS
Short run emphasis, 90° 10.659 12.516 0.001 <0,001
Grey level nonuniformity, 45° 15.649 11.529 0.001 <0,001
ABSOLUTE GRADIENT 
PARAMETERS
Mean 18.036 44.271 0.002 0.001
Skewness 63.599 15.598 0.046 0.007
Texture parameters are given in rows. In the columns R&R repeatability and reproducibility of total, and Wilcoxon test for fat saturation series 
grouped with image slice thickness less than 8 mm, and 8 mm or thicker.
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Abstract
Background: Our objective was to study the effect of trauma on texture features in cerebral tissue in mild traumatic 
brain injury (MTBI). Our hypothesis was that a mild trauma may cause microstructural changes, which are not 
necessarily perceptible by visual inspection but could be detected with texture analysis (TA).
Methods: We imaged 42 MTBI patients by using 1.5 T MRI within three weeks of onset of trauma. TA was performed on 
the area of mesencephalon, cerebral white matter at the levels of mesencephalon, corona radiata and centrum 
semiovale and in different segments of corpus callosum (CC) which have been found to be sensitive to damage. The 
same procedure was carried out on a control group of ten healthy volunteers. Patients' TA data was compared with the 
TA results of the control group comparing the amount of statistically significantly differing TA parameters between the 
left and right sides of the cerebral tissue and comparing the most discriminative parameters.
Results: There were statistically significant differences especially in several co-occurrence and run-length matrix based 
parameters between left and right side in the area of mesencephalon, in cerebral white matter at the level of corona 
radiata and in the segments of CC in patients. Considerably less difference was observed in the healthy controls.
Conclusions: TA revealed significant changes in texture parameters of cerebral tissue between hemispheres and CC 
segments in TBI patients. TA may serve as a novel additional tool for detecting the conventionally invisible changes in 
cerebral tissue in MTBI and help the clinicians to make an early diagnosis.
Background
Mild traumatic brain injury (MTBI) accounts for 70 - 90%
of all treated brain injuries [1]. MTBI is usually caused by
a relatively mild blow to the brain that causes just enough
physical injury to possibly compromise the normal brain
functions of memory, attention, mental organization, and
logical thinking may be compromised. Damage to the
brain is often found in the corpus callosum, brain stem,
and in subcortical white matter (WM) regions at the site
of impact or on the contralateral side after MTBI [2].
One of the biggest challenges in addressing neuropsy-
chological functioning and recovery from MTBI is the
diagnosing itself. A variety of neuroimaging modalities
can be used to assist in making the diagnosis of MTBI [3],
but currently CT scan and MRI are the modalities of
choice as a diagnostic tool for acute MTBI. The vast
majority of MTBI patients have normal CT scans, and
although MRI has been found to be more sensitive to
traumatic lesions than CT, most symptomatic patients
also have normal MRI scans.
MR images of tissues contain a lot of microscopic infor-
mation that may not be assessed visually and texture
analysis (TA) technique provides the means for obtaining
this information [4]. Texture is the visual cue due to the
repetition of image patterns that can be described for
example, as smooth or rough, regular or irregular, coarse
or fine. Some textures display complex patterns but may
appear visually regular and are therefore relatively easy to
extract even by visual inspection. However, for textures
that exhibit random appearance patterns where textural
primitives are randomly placed it becomes much more
difficult to recognize and interpreter these textures.
These kind of random patterns rather than regular tex-
tures are more often encountered in medical images.
Basically texture is an image feature which corresponds
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to both brightness value and pixel locations from which
TA allows one to calculate mathematical patterns, texture
features that can be used to discriminate and characterize
the properties of tissues.
TA of MR images is a quantitative method that can be
used to quantify and detect structural abnormalities in
different tissues. TA can be divided into categories such
as structural, model-based, statistical and transform,
according to the means employed to evaluate the inter-
relationships of the pixels [5]. Statistical methods are the
most widely used in medical images. The statistical
approaches analyze the spatial distribution of grey values,
computing local features at each point in the image, and
deriving a set of statistics from the distributions of the
local features. Local features are defined by the combina-
tion of intensities at specific position relative to each
point in image. Statistics are classified as a first-, second-
or higher-order statistics according to the number of
points which define the local feature. In first- order statis-
tics image properties depend solely on individual pixel
values, whereas second-order statistics are properties of
pixel pairs [4]. First order statistics include mean grey
scale, standard deviation of the mean, skewness (devia-
tion of the pixel distribution) and the kurtosis (stepness
of the pixel distribution) which can usually be detected
visually. Second order statistically methods utilizes grey-
level run-length measures and grey-level co-occurrence
matrix. Methods based on second-order statistics tend to
obtain higher discrimination indexes and can not be visu-
ally detected. Therefore the interest in medical image TA
mainly lays in the random textures of second- or higher
order. The most popular texture method for MR images
seems to be the grey-level co-occurrence matrix first pro-
posed by Haralick [6].
Many promising studies have been reported with TA in
the classification of pathological tissues from normal tis-
sues for example from the liver, breast, tumours with
variable locations such as lymphomas and muscles [7-13].
With regard to TA of brain, texture parameters based on
the histogram, co-occurrence matrix, gradient and run-
length matrix have been shown to be good for the charac-
terization of healthy and pathological human cerebral tis-
sues [14-18]. Co-occurrence matrix-based TA has also
been found to be sensitive in differentiating Alzheimer's
disease patients from normal controls [19] and histologi-
cally proven hippocampal sclerosis (HS) from normal
hippocampal cerebral tissue [20]. Mahmoud-Ghoneim et
al. [21] have proposed a three-dimensional (3D) approach
using co-occurrence matrix analysis to increase the sensi-
tivity and specificity of brain tumor characterization and
treatment follow-up with promising results. Ganeshan
[22] and associates 3D selective- and relative-scale tex-
ture analysis to quantify the presence of grey-matter and
white-matter textural abnormalities associated with
schizophrenia concluding that 3D TA of brain MR
enables detection of subtle distributed morphological
features associated with schizophrenia. Kovalev and asso-
ciates [23] also tested 3D co-occurrence matrix TA in
analyzing cerebral tissue and glioma in T1-weighted MR-
images. TA has also been used in analyzing age-related
changes [24] and gender-related differences [25] with
promising results.
In this study we concentrated on evaluating the ability
of two-dimensional (2D) MRI-based TA to characterize
the changes caused by MTBI in cerebral tissue by apply-
ing TA methods. To the best of our knowledge, there are
no published studies on the application of quantitative
MRI TA in studying MTBI.
Methods
Patients with MTBI (GCS score 13-15) were recruited
from the emergency room of Tampere University Hospi-
tal during the period 2006-2007. For the TA study 42 con-
secutive patients (17 male, 25 female; mean age ± SD, 38.8
± 13.6 years; range 18 to 60 years) were included. Clinical
examination on admission and CT examination on the
day of the accident and MRI within three weeks from the
day of admission were conducted on all patients. All
patients met the criteria of MTBI according to the World
Health Organization Collaborating Centre for Neu-
rotrauma Task Force on Mild Traumatic Brain Injury
[26]. Exclusion criteria for this study were age under 18 or
over 65, severe traumatic brain injury, previous brain
trauma, other major cognitive disorder, history of major
alcohol or drug abuse. Ten healthy age and gender
matched controls (4 males, 6 females; mean age ± SD,
39.8 ± 12.9 years; range 28 to 61 years) were also
recruited to form a control group. All patients and
healthy controls gave their written consent and the study
was approved by the Ethics Committee of Tampere Uni-
versity Hospital. All 42 patients were evaluated to have a
normal CT and MRI scan by a specialized radiologist.
The patient's degree of consciousness was assessed to
determine the severity of brain injury using the Glasgow
Coma Scale (GCS) [27]. Possible loss of consciousness
(LOC) was recorded (length in minutes or hours) as well
as post-traumatic amnesia (PTA) (length in minutes or
hours). A number of neurocognitive tests were also per-
formed within 6 weeks of the injury.
MRI examinations
All 42 patients were studied on a 1.5 Tesla MRI machine
(Magnetom Avanto, Siemens Medical Solutions, Erlan-
gen, Germany). The MRI machine is under quality con-
trol program, which includes daily, monthly, and
quarterly measurements. Main magnetic field homogene-
ity and RF -amplifier properties are measured and con-
trolled four times a year. A prescan normalisation filter
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was used for the correction of intensity inhomogeneity in
images. The data used for homogenisation were acquired
through a preliminary low-resolution measurement. An
elliptical filter was used within the slice planes to improve
the signal-to-noise ratio. The sequences included in the
MRI protocol are presented in Table 1.
Texture analysis
For texture analysis an axial FLAIR (T2w FLAIR) and sag-
ittal T1w 3D magnetization prepared gradient echo (T1w
MPR) image series were selected from the whole MRI
study. Three image slices from imaging sequences T2w
FLAIR on three selected levels of interest and one slice
from sequence T1w MPR were chosen for further analy-
sis. Level 1 was level of mesencephalon, level 2 corona
radiata and level 3 centrum semiovale. Level 4 was corpus
callosum from sagittal view in caudo-cranial direction
from the T1w MPR sequence. Image selection was per-
formed with a DICOM viewer Osiris (Windows version
4.19, The Digital Imaging Unit (UIN) of the Service for
Medical Computing (SIM) of the Radiology Department
of the University Hospital of Geneva, Switzerland).
TA was performed with the software package MaZda
(MaZda 4.5, Technical University of Lodz, Institute of
Electronics [28]) specially designed for texture analysis by
Materka and co-workers as part of the European COST
B11 and the following COST B 21 programs. For each
MR image regions of interest (ROI) were manually placed
symmetrically on the left and right hemispheres on each
level of interest. For level 1 ROIs were drawn by hand in
the area of mesencephalon (ROI size around 1200 pixels
depending on the size of the mesencephalon), both left
and right side. Circular ROIs (177 pixels) were placed
both sides in WM (Figure 1a). For level 2 circular ROIs
were placed both sides in WM (177 pixels) (Figure 1b).
For level 3 three circular ROIs (177 pixels) were placed in
both sides in WM from anterior to posterior (Figure 1c).
Circular ROIs (68 pixels) were also placed on the sple-
nium, body and rostrum of the corpus callosum (Figure
1d). The ROIs were carefully placed so they did not over-
lap any microhemorraghes, macroscopic hemosiderin
deposits or hyperintensities, which were observed in few
patients. The ROI drawing was done manually by person
with special interest in developing quantitative radiology
methods in clinical use.
The comparison of texture features was made between
the left and right sides and between segments of CC to
ascertain any changes in texture parameters between
hemispheres or segments on patients and on controls.
After determining the ROIs we calculated texture fea-
tures based on image histogram, the co-occurrence
matrix, the run-length matrix, the absolute gradient and
the autoregressive model and wavelets [28]. Run length
matrix parameters were calculated in four directions:
horizontal (0°), vertical (90°), 45° and 135° and co-occur-
rence matrix parameters were calculated in five distances
(1, 2, 3, 4 and 5 pixels), four times for each distance (in
directions θ = 0°, 45°, 90° and 135°). All of these texture
features (See Additional file 1) were calculated for each
ROI.
The grey level normalization of each ROI was per-
formed using a method which normalizes image intensi-
ties in the range [μ-3σ, μ+3σ]. This method has been
shown to give the best results in MRI texture classifica-
tion among different normalization methods [29]. This
was done to minimize the influence of contrast variation
and brightness. To determine 10 texture features with the
highest discriminative power for separation and classifi-
cation we used feature selection method Fisher coeffi-
cient (F) provided by MaZda [28]. The Fisher criterion
usually produces a set of features with a high discrimina-
tory potential which are also highly correlated with each
Table 1: Sequences included in the MRI protocol for MTBI patients.
Sequence TR TE TI Slice/gap matrix FOV Flip angle
sagittal T1w 3D magnetization prepared gradient echo 1910 3.1 1100 1.0/0 256 × 256 250 15
axial T2w Turbo Spin Echo 44860 96 0 5.0/1.5 293 × 448 230
axial FLAIR 9000 109 2500 5.0/1.5 256 × 256 230
axial T2*w HEMO 800 26 0 7.0/2.0 256 × 256 230 20
axial SE EPI 3 scan diff (b = 0, b = 500, b = 1000) 3400 89 0 5.0/1.5 192 × 192 230
sagittal FLAIR 8860 116 2500 2.0/2.0 256 × 256 230
axial SE MDDW 12dir (b = 0, b = 1000) 3600 96 0 5.0/1.5 128 × 128 230
axial SWI 3D 15 49 40 2.0/0 177 × 256 230 15
TR = repetition time
TE = echo time
TI = inversion time
FOV = field of view
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other. The top 10 feature selections were made when
comparing texture features between hemispheres of WM
in different levels and features in the area of mesencepha-
lon and features between segments of CC.
Data analysis
Statistical analyses were run for every texture feature.
Differences in texture features between hemispheres in
different tissues (the right vs. the left side of mesencepha-
lon and WM) were analyzed by Wilcoxon Signed Ranks.
The parameters in WM between three different levels
and WM anterior-posterior (front, middle and back) on
level 3, in the same hemisphere, were tested with the
Friedman test. Texture parameters calculated from the
segments of CC (rostrum, body and splenium) were also
analyzed with the Friedman test. Similar tests were per-
formed on the group of healthy controls. These analyses
were performed using SPSS for Windows, version 14.0.2.
(SPSS Inc., Illinois, USA). A p-value of under 0.05 was
considered statistically significant.
Results
Analyses of mesencephalon
We tested all raw texture parameters to find out how
many and which of the 277 parameters differed statisti-
cally between hemispheres. The number of texture
parameters (n = 277) which were statistically significantly
different (p < 0.05) analyzed with Wilcoxon test in the
area of mesencephalon between hemispheres is pre-
sented in Table 2.
The parameters which differed statistically significantly
were mainly based on the co-occurrence matrix. The
patients had clearly more differences in texture features
between hemispheres than the healthy controls. The
healthy controls had no significantly differing run-length
matrix based parameters unlike the patients.
The ten most discriminative texture features for separa-
tion of hemispheres in the area of mesencephalon as
identified by calculation of Fisher coefficients, were
mainly derived from the co-occurrence matrix in both
patients and controls. The p-values for the most discrimi-
native texture parameters on patients and on controls
selected with the Fisher method are shown in Table 3.
Especially features derived from autoregressive model;
Teta2, Teta3 and Teta4 (p < 0.001) were significantly dif-
ferent between hemispheres in patients and also in con-
trols. Other parameters selected with the Fisher
coefficient consisted mainly of parameters derived from
the co-occurrence matrix. These were statistically differ-
ent in patients but not in controls and vice versa.
Analyses of white matter
Again we tested all raw texture parameters to find out
how many and which of the 277 parameters differed sta-
tistically between hemispheres in WM in different levels
of interest. The number of texture parameters (n = 277)
which were statistically significantly different (p < 0.05)
analysed with Wilcoxon test in WM between hemi-
spheres in patients and healthy controls are set out in
Table 4.
In the level of corona radiata (level 2) there were clearly
more significantly different parameters between hemi-
spheres than in other levels in patients. In level 2 there
were also clearly fewer texture differences in controls
than in patients.
The ten most discriminative texture features for separa-
tion of WM in the left and right hemispheres varied
clearly between the three levels. The features were mainly
histogram-based or derived from the co-occurrence
matrix. The p-values for the most discriminative texture
parameters in patients and in controls selected with the
Fisher method in level 2 are shown in Table 5.
The most discriminative texture parameters in WM on
patients and on controls varied between levels and
between patients and controls. Only a few parameters
Figure 1 Regions of interest drawn on the each level of interest. Figure 1a: an axial FLAIR (T2w FLAIR) image in level 1. Figure 1b: an axial FLAIR 
(T2w FLAIR) image in level 2. Figure 1c: an axial FLAIR (T2w FLAIR) image in level 3. Figure 1d: sagittal T1w 3D magnetization prepared gradient echo 
(T1w MPR) in level 4. Regions of interest (ROIs) are drawn in the images.
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were significantly different between hemispheres in both
patients and controls.
The texture parameters of WM between different levels
were analyzed with the Friedman test in order to find out
whether the texture differed in the same hemisphere
between levels. It was observed that many of the texture
parameters of WM on level 1 were statistically signifi-
cantly different from parameters on levels 2 and 3. Tex-
ture parameters in the same hemisphere of WM anterior-
posterior (front, middle and back) on level 3 were also
analyzed and it was observed that the texture parameters
in the posterior region differed from the anterior and
central regions in both hemispheres.
Analyses of the corpus callosum
We tested all raw texture parameters to find out how
many and which of the 277 parameters differed statisti-
cally between segments of CC. The number of texture
parameters (n = 277) which were statistically significantly
different (p < 0.05) analyzed with Friedman test in the
segments of CC is presented in Table 6.
Table 2: Numbers of parameters having statistically significant differences (p < 0.05) between hemispheres analyzed with 
Wilcoxon test.
Mesencephalon
Texture parameter groups Patients Controls
Histogram (n = 11) 7 3
GrM (n = 5) 1 0
COM (n = 220) 90 30
RLM (n = 20) 4 0
ARM (n = 5) 3 2
Wavelet (n = 16) 2 2
Total (n = 277) 107 37
The total number of evaluated texture parameters is 277. The total number of parameters having statistically significant differences between 
hemispheres in the area of mesencephalon is in bold face.
GrM: gradient matrix; COM: co-occurrence matrix; RLM: run-length matrix; ARM: autoregressive model; n: number parameters in each group.
Table 3: The ten most discriminating parameters according to the Fisher (F-) coefficient and corresponding Wilcoxon test 
p-values.
Mesencephalon
Most Discriminative Texture 
Parameters on Patients
p-values 
(patients)
p-values 
(controls)
Most Discriminative Texture 
Parameters on Controls
p-values 
(controls)
p-values 
(patients)
Teta4 <0.001* 0.105 S(4,-4)DifVarnc 0.002* 0.519
Teta3 <0.001* 0.020* S(5,-5DifVarnc 0.004* 0.465
S(5,5)Entropy <0.001* 0.105 Teta3 0.020* <0.001*
S(5,5)AngScMom <0.001* 0.020* S(5,-5)DifEntrp 0.004* 0.413
S(4,4)AngScMom <0.001* 0.432 Teta2 0.014* <0.001*
S(4,4)Entropy <0.001* 0.322 S(4,-4)DifEnrtp 0.002* 0.372
Teta2 <0.001* 0.014* S(3,-3)DifVarnc 0.002* 0.160
S(1,-1)DifVarnc <0.001* 0.375 WavEnLL_s-2 0.027* 0,472
S(1,1)DifVarnc <0.001* 0.375 S(5,-5)Contrast 0.002* 0.833
S(3,3)AngScMom <0.001* 0.492 S(4,-4)Contrast 0.002* 0.432
The ten most discriminating parameters according to the Fisher (F-) coefficient and their corresponding Wilcoxon test p-values are calculated 
between hemispheres in the area of mesencephalon for both patients and controls.
Teta, vectors of autoregressive model; AngScMom, angular second moment; SumAverg, sum average; DifEntrp, difference entropy; DiffVarnc, 
difference variance; WavEnLL, energy of wavelet coefficients in subband LL.
* p-values of under 0.05 are considered statistically significant
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In the segments of CC the body of CC had statistically
significantly differing from the other segments on
patients. In healthy controls there were clearly fewer sig-
nificantly different parameters.
The ten most discriminative texture features for the
separation of segments of CC as identified by calculation
of Fisher coefficients, were mainly derived from the co-
occurrence matrix and wavelet based features in both
patients and controls. The p-values for the most discrimi-
native texture parameters in patients and in controls
selected with the Fisher method are shown in Table 7.
The only texture features statistically significant in both
patients and controls were two wavelet based features,
otherwise the statistically significantly differing features
differed between these two groups.
Discussion
The use of imaging to examine patients with MTBI has
been investigated by a number of studies, and imaging
abnormalities in CT, MRI and SPECT have all been asso-
ciated with poor outcome on all modalities [30-33].
Although the imaging modalities have been developing
fast in recent years, with many improvements especially
in MRI techniques, such as diffusion-weighted MRI, DTI
and new MRI sequences [34-36] it is still difficult to
detect damaged lesions and make the diagnosis of MTBI
on the basis of imaging findings. Some prior studies have
demonstrated exclusive abnormalities on DWI, ADC, or
DTI without overt structural damage seen in other
sequences such as T1, T2 [34,37] The use of advanced
imaging modalities [31,38,39] and different computer
assisted detection (CAD) systems such as TA, which pro-
vides quantitative means of characterizing the properties
of tissues in cases which tissue changes cannot be
detected by direct inspection of the image may offer pos-
sible approaches on improving the prognostic capabilities
of conventionally used MRI sequences.
We chose the MR images of MTBI patients for our
study with the objective of detecting textural differences
in different regions of cerebral tissue between the hemi-
spheres. The purpose was to test the performance of TA
to differentiate cerebral hemispheres and to characterize
the changes caused by MTBI in cerebral tissue. Our study
showed that there are significant differences in texture
parameters in cerebral tissue between the hemispheres in
MTBI patients and also differences between patients and
healthy controls. We found texture differences between
sides in the area of mesencephalon and between the
hemispheres in WM, especially in the level of corona
radiata and between different segments of CC. To the
best of our knowledge there are so far no other studies of
texture analysis of MTBI patients for comparison.
It has been established that MR images contain tissue-
specific texture features which can be extracted by math-
ematical methods. It has been proven that TA can be
used for classifying healthy and pathologic human cere-
bral tissue [14-16] and also distinguish different cerebral
tissues. TA has also been used for distinguishing MS
lesions from normal appearing - and normal white matter
[40]. In light of our study we concur that TA can discrim-
inate between different cerebral tissues and that different
structures can also be distinguished from brain MR
images. Traumatic brain injury is followed by activation
of numerous proinflammatory mediators and glial cells.
Both experimental and clinical data show activation of
proinflammatory cytokines at the site of injury [41,42].
This together with an assumption of axonopathic changes
in DTI might suggest inflammatory etiology of TA [43].
In our statistical tests on the raw parameters there were
over a hundred parameters that were statistically signifi-
Table 4: Numbers of parameters having statistically significant differences (p < 0.05) between hemispheres analyzed with 
Wilcoxon test.
White matter
WM Level 1 WM Level 2 WM Level 3
Texture parameter groups Patients Controls Patients Controls Patients Controls
Histogram (n = 11) 8 9 9 9 8 6
GrM (n = 5) 0 0 0 0 0 0
COM (n = 220) 19 2 49 3 9 4
RLM (n = 20) 0 0 4 0 1 0
ARM (n = 5) 0 0 0 1 0 0
Wavelet (n = 16) 1 1 1 0 1 0
Total (n = 277) 28 12 63 13 19 10
The total number of evaluated texture parameters is 277. The total number of parameters having statistically significant differences between 
hemispheres in the cerebral white matter is in bold face.
GrM: gradient matrix; COM: co-occurrence matrix; RLM: run-length matrix; ARM: autoregressive model; n: number parameters in each group.
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cantly different between the left and the right sides of the
mesencephalon in patients. All the histogram-based per-
centiles, which give the highest grey-level value under
which a given percentage of the pixels in the image are
contained, were statistically significantly different (p <
0.001). Other texture parameters which were most often
statistically significantly different consisted mainly of
parameters derived from the co-occurrence matrix which
gave the highest grey-level value under which a given per-
centage of the pixels in the image are contained. We
observed that there were statistically differing run-length
matrix-based parameters, giving information about the
spatial variation of gray-level values, between hemi-
spheres in patients but not in healthy controls. This may
indicate that the presence of these texture parameters is
related to the damage. Clearly there are not so many tex-
ture differences between sides in the area of mesencepha-
lon in healthy controls than in MTBI patients.
The ten most discriminative texture features for separa-
tion of hemispheres in the area of mesencephalon as
identified by calculation of Fisher coefficients, were
mainly derived from autoregressive model and the co-
occurrence matrix in both patients and controls. Features
derived from the autoregressive model; Teta2, Teta3 (p <
0.001) were significantly different between hemispheres
in patients and also in controls. Other selected parame-
ters which were statistically different in patients were not
different in controls and vice versa. The difference
between texture parameters between patients and
healthy controls may due to the fact that the injury of the
patients has caused complexity in the structure of mesen-
cephalon due to some axonal tearing.
In our study, the texture parameters of WM between
hemispheres on different levels were analyzed with Wil-
coxon test. Since texture properties are evaluated on a
millimetre scale, they may capture the local coherence,
direction, and density of fiber bundles, their myelinisa-
tion status, the density and direction of vessels supplying
and draining WM. According to our study the parameters
between WM hemispheres differed most on the level of
corona radiata (level 2) in patients. There was not much
difference between levels in healthy volunteers. The sig-
nificantly differing parameters were mainly based on his-
togram and co-occurrence matrix. And again the run-
length matrix-based parameters were statistically differ-
ent in patients only. It is necessary to take into account
that the human brain is asymmetric in structure and
function and some of these significant differences in
parameters between hemispheres are possibly attibutable
to this since less difference was observed on healthy con-
trols it can be assumed that most of the texture changes
are caused by the injury.
The ten most discriminative texture features for the
separation of hemispheres in the WM as identified by cal-
Table 5: The ten most discriminating parameters according to the Fisher (F-) coefficient and corresponding Wilcoxon test 
p-values.
White matter
Most Discriminative Texture 
Parameters on Patients
p-values 
(patients)
p-values 
(controls)
Most Discriminative Texture 
Parameters on Controls
p-values 
(controls)
p-values 
(patients)
LEVEL 2
S(4,4)Correlat <0.001* 0.492 S(5,5)SumVarnc 0.002* 0.008*
S(4,4)Contrast 0.001* 0.557 S(5,5)Correlat 0.004* 0.008*
S(4,4)SumVarnc <0.001* 0.695 S(4,4)InvDfMom 0.064 0.003*
S(4,4)InvDfMom 0.003* 0.064 WavEnLH_s-3 0.922 0.359
S(4,4)DifVarnc 0.002* 0.770 S(5,5)Contrast 0.010* 0.015*
S(5,5)Correlat 0.008* 0.004* S(0,1)SumAverg 0.164 0.114
S(2,-2)AngScMom <0.001* 0.396 S(1,-1)SumAverg 0.105 0.225
S(0,3)DifEntrp 0.002* 0.695 S(5,-5)SumVarnc 0.105 0.253
S(5,5)Contrast 0.015* 0.010* S(5,-5)Correlat 0.105 0.603
S(5,5)SumVarnc 0.008* 0.002* Teta1 0.064 0.274
The ten most discriminating parameters according to the Fisher (F-) coefficient and their corresponding Wilcoxon test p-values are calculated 
between hemispheres in the cerebral white matter in the level of corona radiata (level 2) for both patients and controls.
Correlat, correlation; DiffVarnc, difference variance; AngScMom, angular second moment; Teta, vectors of autoregressive model; SumAverg, 
sum average; InvDfMom, inverse difference moment; SumVarnc, sum variance; DifEntrp, difference entropy; WavEnLH, energy of wavelet 
coefficients in subband LH.
* p-values of under 0.05 are considered statistically significant
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culation of Fisher coefficients, were mainly derived from
the co-occurrence matrix in both patients and controls.
Only a few parameters were significantly different
between hemispheres in both patients and controls on
each level.
Texture parameters of WM between different levels
were also analyzed. It was observed that many texture
parameters of WM on level 1 were statistically signifi-
cantly different from parameters on levels 2 and 3, but
there were not as many different parameters as between
the left and the right hemisphere. Texture parameters
between the areas of WM anterior-posterior (front, mid-
dle and back) on level 3 were analyzed and it was
observed that mostly texture parameters in the posterior
region differed from the anterior and the central regions
in both hemispheres, which is in line with the fact that
many times the trauma is located in the frontal or occipi-
tal lobe.
According to our results there are significant differ-
ences in texture parameters in the segments of CC and
between healthy volunteers and MTBI patients. Our
study showed that the texture of the body of CC was dif-
Table 6: Numbers of parameters having statistically significant differences (p < 0.05) between segments of CC analyzed 
with Friedman test.
Corpus callosum
patients controls
Texture parameter groups Rostrum Body Splenium Rostrum Body Splenium
Histogram (n = 11) 3 6 1 1 1 0
GrM (n = 5) 0 0 0 0 0 0
COM (n = 220) 3 33 4 4 1 3
RLM (n = 20) 0 0 0 0 0 0
ARM (n = 5) 0 1 0 0 0 0
Wavelet (n = 16) 0 9 0 1 2 0
Total (n = 277) 6 49 5 6 4 3
The total number of evaluated texture parameters is 277. The total number of parameters having statistically significant differences between 
the segments of corpus callosum is in bold face.
GrM: gradient matrix; COM: co-occurrence matrix; RLM: run-length matrix; ARM: autoregressive model; n: number parameters in each group.
Table 7: The ten most discriminating parameters according to the Fisher (F-) coefficient and corresponding Wilcoxon test 
p-values.
Corpus callosum
Most Discriminative Texture 
Parameters on Patients
p-values 
(patients)
p-values 
(controls)
Most Discriminative Texture 
Parameters on Controls
p-values 
(controls)
p-values 
(patients)
WavEnLL_s-2 <0.001* 0.001* WavEnLL_s-2 0.001* <0.001*
WavEnLH_s-2 <0.001* 0.006* WavEnLH_s-2 0.006* <0.001*
S(5,0)SumOfSqs 0.001* 0.601 S(4,-4)SumAverg 0.030* 0.220
S(3,0)Contrast <0.001* 0.368 S(5,-5)SumVarnc 0.007* 0.699
S(4,0)SumOfSqs 0.003* 0.316 S(2,-2)SumEntrp 0.710 0.847
S(4,0)Contrast <0.001* 0.368 S(1,-1)SumOfSqs 0.368 0.110
S(1,0)DifVarnc <0.001* 0.368 S(5,-5)SumAverg 0.012* 0.190
S(2,0)Contrast <0.001* 0.316 S(0,1)SumOfSqs 0.135 0.073
S(1,0)Contrast <0.001* 0.436 S(2,-2)SumOfSqs 0.368 0.404
S(0,1)SumVarnc 0.019* 0.436 S(1,0)SumOfSqs 0.046* 0.272
The ten most discriminating parameters, according to the Fisher (F-) coefficient and their corresponding Wilcoxon test p-values are calculated 
between segments of the corpus callosum for both patients and controls.
SumAverg, sum average; Sum Varnc, sum variance, SumEntrp, sum entropy; DiffVarnc, difference variance, SumOfSqs, sum of squares; 
WavEnLH, energy of wavelet coefficients in subband LH; WavEnLL, energy of wavelet coefficients in subband LL.
* p-values of under 0.05 are considered statistically significant
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ferent in texture from the rostrum or splenium in
patients. The CC is the largest fiber bundle in the human
brain connecting two cerebral hemispheres with hun-
dreds of millions of fibers. The fiber composition in the
CC has been studied in [44,45] and it has been observed
that there are least nerve fibers in the body of CC per unit
area and Glial cells occupied more of the body of the CC
than of the other segments. The different orientation or
densities of the fibers may yield different textures so it
could be assumed that the textural changes in the body of
CC are caused by the different densities and number of
the fibers in different regions of CC. However, since it
was observed that in healthy controls the body of CC was
not different in texture from the rostrum or splenium, we
can presume that the texture differences between the
body and other segments of CC in assume may be caused
by the injury. Again the ten most discriminative parame-
ters differed and there were only a few wavelet-based fea-
tures which were significantly different in both groups.
Because our patient group all had normal MRI scans it
proved to be very challenging to evaluate the texture
changes possibly caused by the injury since we could not
categorize the patients according to which part of the
head the damage may have occurred in. Also, there are
variations in brain structure between individuals making
it difficult to detect and classify abnormal structural pat-
terns caused by MTBI and making it difficult to place the
ROIs in optimal places. We studied if we could detect dif-
ferences in textures between the hemispheres in patients
and controls. Based on this study the ten most discrimi-
nating parameters as identified by calculation of Fisher
coefficients on each selected region might only be perti-
nent to the specific subset of patient tested in this current
study. Therefore they are not to be generalized but they
however give direction to which type of parameters may
be applicable also to other subset of patients. Our results
show that there are significant differences in texture
parameters in cerebral tissue in the area of mesencepha-
lon and also in the segments of CC and in WM on
patients and not so much in healthy controls.
Conclusions
In conclusion, the study indicates that TA could be used
to characterize the changes in cerebral tissue in MTBI
patients. This study suggests that texture analysis with a
variable set of texture features could in the future serve as
an adjuvant diagnostic tool along with traditional MRI
and DTI imaging for studying MTBI patients. However,
to prove an established role of TA in MTBI further stud-
ies are needed, likewise comparison of the texture
changes with other possible diagnostic findings.
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MRI Texture Analysis in Multiple
Sclerosis: Toward a Clinical
Analysis Protocol
Lara C. V. Harrison, MSc, MD, Minna Raunio, MD, Kirsi K. Holli, MSc, Tiina Luukkaala, MSc,
Sami Savio, MSc, Irina Elovaara, MD, PhD, Seppo Soimakallio, MD, PhD, Hannu J. Eskola, PhD,
Prasun Dastidar, MD, PhD
Rationale and Objectives: Magnetic resonance imaging (MRI)-based texture analysis has been shown to be effective in classifying
multiple sclerosis lesions. Regarding the clinical use of texture analysis in multiple sclerosis, our intention was to show which parts of
the analysis are sensitive to slight changes in textural data acquisition and which steps tolerate interference.
Materials and Methods: The MRI datasets of 38 multiple sclerosis patients were used in this study. Three imaging sequences were
compared in quantitative analyses, including a comparison of anatomical levels of interest, variance between sequential slices and two
methods of region of interest drawing. We focused on the classification of white matter and multiple sclerosis lesions in determining
the discriminatory power of textural parameters. Analyses were run with MaZda software for texture analysis, and statistical tests were
performed for raw parameters.
Results: MRI texture analysis based on statistical, autoregressive-model and wavelet-derived texture parameters provided an excellent
distinction between the image regions corresponding tomultiple sclerosis plaques andwhitematter or normal-appearingwhitematter with
high accuracy (nonlinear discriminant analysis 96%–100%). There were no significant differences in the classification results between
imaging sequences or between anatomical levels. Standardized regions of interest were tolerant of changes within an anatomical level
when intra-tissue variance was tested.
Conclusion: The MRI texture analysis protocol with fixed imaging sequence and anatomical levels of interest shows promise as a robust
quantitative clinical means for evaluating multiple sclerosis lesions.
Key Words: Magnetic resonance imaging (MRI); texture analysis (TA); multiple sclerosis (MS); tissue characterization.
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M
ultiple sclerosis (MS) is the most common autoim-
mune disease of the central nervous system, with
complex pathophysiology, including inflamma-
tion, demyelination, axonal degeneration, and neuronal loss.
According to recent pathological evidence, these processes
are not similarly represented in different patients, but may
predominate selectively in individual patients, leading to
heterogeneity in the expression of disease phenotypes. This
diverse representation of different pathologies is also reflected
in disease prognosis and response to therapies.
Diagnostic evaluation of MS with conventional magnetic
resonance imaging (MRI) is generally based on the McDo-
nald criteria (1,2). The development of modern imaging
techniques for the early detection of brain inflammation and
the characterization of tissue-specific injury is an important
objective in MS research. The development of new imaging
techniques is targeted especially at the identification of
high-risk individuals in the early phase of MS disease and at
the improved monitoring of disease activity. A better under-
standing of disease pathogenesis is also the basis for the further
development of new and more effective therapies.
Quantitative MRI studies have shown that brain and focal
lesion volume measures, magnetic transfer ratio and diffusion-
weighted imaging–derived parameters can provide new infor-
mation in detecting MS (3,4). Neurological diseases have
been the focus of recent studies on texture analysis (TA) based
on MRI. TA as a quantitative means of representing fine
changes in tissues has been reported to be successful in studies
of epilepsy (5–8), MS (9–13), brain tumors (14–16), amygdale
activation (17), Alzheimer’s disease (18,19), and cervical
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spondylotic myelopathy (20). Studies on MS TA have shown
this method to be useful in detecting conventionally nonvisible
microstructural changes in MS in the early stages of disease.
In a clinical context, constant innovation in imaging
equipment and imaging sequences provides a challenging
atmosphere in developing a robust multipurpose texture anal-
ysis protocol for neuroradiological quantitative analyses.
Recent publications highlight various texture parameter sets
in image analysis, whereas study protocol image acquisition
settings differ. It appears that TA parameter subsets that distin-
guish subtle changes in tissues with the best classification
results change relative to the imaging sequences (21). The
foundation of a quantitative TA protocol consists of image
acquisition and image processing, and it requires results
obtained from fine structural changes between tissues through
several manual, semiautomatic or automatic steps. In partic-
ular, nonstandardized manual phases of the process may cause
immeasurable sources of error.
Regarding the clinical use of TA in MS diagnostics and
follow-up, our intention was to determine which parts of the
analysis are sensitive to small changes in a textural data analysis
protocol and which steps tolerate interference in data acquisi-
tion. In this study, we focused specifically on theMRI protocols
available in the majority of centers for clinical purposes. There-
fore, a 1.5 T device and images acquired in normal clinical
procedures were chosen to be used in this study.
We compared three imaging sequences with respect to TA
classification results. Further, we analyzed two anatomical
levels of interest for each sequence, and for two sequences
we performed analyses of three sequential image slices to esti-
mate the significance of image slice selection. In evaluating the
TA method discrimination power, we used several standard
size regions of interest (ROI) representing different tissues,
pathological focal lesions, and diffuse-disease suspect tissue
in the classification process. Additionally, we compared stan-
dard size and freehand-drawn ROIs of lesions from normal
and normal-appearing brain tissue. The major goal of this
study was to clarify the impact of different steps of analysis
on TA classification and furthermore develop a robust quan-
titative MRI TA protocol for scientific and clinical use in MS
evaluation and other neuroradiological purposes.
MATERIALS AND METHODS
Patients
MRI images of 38 patients participating in a prospective neu-
roinflammatory diseases research project were selected for this
study. Because this study focused on normal clinical practice in
MRI imaging of MS, the patient population represented
average patients in our center being consecutively imaged
for MS diagnosis and follow-up, showing some heterogeneity
in age and subtypes in their disease. Imaging was performed
between May 2006 and January 2007. There were 15 males
and 23 females between ages 18 and 67 years (mean age 42,
median 39), with different subtypes of MS: relapsing-
remitting (n = 19), secondary progressive (n = 10), primary
progressive (n = 4), progressive-relapsing (n = 2), and clini-
cally isolated syndrome (n = 3). The diagnoses were based
on revised McDonald’s criteria (2). The Ethics Committee
of the hospital approved the study and participants provided
written informed consent.
MRI Acquisition
MRIwas performed on a 1.5 TMRI device (Siemens, Avanto
SyngoMRB15, Erlangen, Germany). Thewhole-brainMRI
protocol included standardized axial T2-weighted Inversion
Recovery Turbo Spin Echo (TIRM) sequence (repetition
time 8500 ms, echo time 100 ms, TI 2500 ms, slice thickness
5mm, zero gap between slices, pixel size 0.45mm 0.45mm,
echo train length 17, flip angle 150); T1-weighted three-
dimensional magnetization prepared gradient echo sequence
(MPR) (repetition time 1160 ms, echo time 4.24 ms,
TI 600 ms, slice thickness 0.9 mm, pixel size 0.45 mm 
0.45 mm, echo train length 1, flip angle 15); and previous
T1-weighted gradient echo sequence acquired with intra-
venous contrast agent gadoterate meglumine (DOTAREM
10 mL). The imaging artefacts were minimized with use of
two filters. A prescan normalization filter was used for the
correction of intensity inhomogeneity (heterogeneous bright-
ness) in images. The data used for homogenization were
acquired through a preliminary low-resolution measurement.
An elliptical filter was used within the slice planes to improve
the signal-to-noise ratio in the T2 TIRM sequence.
The quality of image sets was evaluated by an experienced
radiologist. The image sets were uniform and of good quality.
The images were free of motion artefacts.
Texture Analysis
The texture analysis study protocol is illustrated in the flow
chart (Fig 1). The protocol starts with image acquisition; in
this study, we examined three imaging sequences from each
patient. Two clinically important anatomical levels were
defined, and one image slice was selected from each level and
sequence. Further, for analysis of textural variation between
sequential slices, sequential images were chosen from both
anatomical levels of a subgroup of patients and image series.
ROIs representing tissues and anatomical structures were set
with two manual methods: standard-size ROI boxes and
nonstandard size, freehand drawn ROIs. Texture features
were calculated from the ROIs. All features calculated as well
feature sets selected with different methods were fed as input
for analyses of intra-tissue variability and classification of tissues.
Image series used in quantitative analyses were
T2-weighted TIRM (T2 TIRM), native T1-weighted
gradient echo (T1 MPR), and gadoterate meglumine–
enhanced T1-weighted gradient echo sequence (T1
MPR+C). Images for analyses were selected from two
anatomical levels: the corona radiata and centrum semiovale
along with MS lesion and basal ganglia, where the nucleus
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caudatus and lentiformis were simultaneously represented in
the same image slice MS plaque also present (Fig 2). These
levels are familiar in typical MS plaques.
Texture analysis applications MaZda (3.20) and B11 (3.4)
(The Technical University of Lodz, Institute of Electronics
(22–24)) were used for ROI setting, texture parameter
calculation, and classification. Standard-size ROI boxes of
10  10 pixels were used for (a) white matter (WM) apart
from lesions, (b) white matter near lesions (normal-appearing
white matter, NAWM), (c) cerebrospinal fluid (CSF), (d)
nucleus caudatus, (e) nucleus lentiformis and (f) MS plaque
(MS plaque, 10  10 ROI). Standardized ROI boxes of 6 
6 pixels were used for (a) cortex apart from lesions (gray
matter, GM) and (b) cortex near lesion (normal-appearing
gray matter, NAGM). One nonstandard size, freehand-
drawn ROI was used for a MS plaque (MS plaque, freehand
ROI) (Fig 3, Table 1).
MS subtype was not taken as a variable because of the small
number of patients representing some of the subtypes. We
leave the testing of emerging subtle changes between disease
subtypes in plaque textural appearance to a separate study.
The ROI drawing was done manually by a practiced licentiate
of medicine, an engineer of medical technology with a special
interest in developing quantitative radiology methods in clin-
ical use. The software used did not provide any registration
tool. Visual analysis based on anatomical landmarks was used
when transferring ROIs among the imaging sequences. A
specialized and experienced senior neuroradiologist double-
checked the ROI setting by viewing the original images and
the combination images with the ROIs superimposed.
A total of 280 texture parameters calculated were based on
histogram, gradient, run-length matrix, cooccurrence matrix,
autoregressive-model (AR-model), and wavelet parameters
(24). Run-length matrix parameters were calculated in four
directions: horizontal (0), vertical (90), 45, and 135.
Cooccurrence matrix parameters were calculated in five
distances, four times on each distance. Wavelet energy param-
eters were calculated on three scales, each with four frequency
subband images. The image gray-level intensity normalization
computation was run in the texture analysis application sepa-
rately for each ROI, with method-limiting image intensities
in the range m-3s, m+3s, where m is the mean gray-level
value and s the standard deviation (24,25).
Intra-tissue texture variation for all ROIs was analyzed
between anatomical levels separately for each imaging
sequence (n = 38). Variations in texture among three sequen-
tial image slices were evaluated within a T1-weighted image
series of 23 patients chosen by random sampling from the 38
patients. The two aforementioned anatomical levels and all
ROIs were analyzed. Because of image slice thickness, T2
TIRM images were not included the sequential image slice
analysis: the anatomical image information changes signifi-
cantly between sequential T2 TIRM 5-mm-thick images.
Texture classifications for two tissue combinations were
performed for (a) WM vs. MS plaque (freehand ROI), (b)
WM vs. MS plaque (10  10 ROI), (c) NAWM vs. MS
plaque (freehand ROI), (d) NAWM vs. MS plaque (10 
10 ROI), (e) WM vs. NAWM, and (f) nucleus caudatus vs.
nucleus lentiformis (n = 38) (Table 2).
Figure 1. Texture analysis protocol.
Figure 2. Two anatomical levels analyzed from all image series.
Three sequential images from T1-weighted series from both levels
were analyzed.
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Two automated methods provided by MaZda, Fisher coef-
ficient (Fisher), and classification error probability (POE)
combined with average correlation coefficients (ACC),
were used to identify 10 texture features giving the best
discrimination between tissue pairs. Ten texture features
were chosen with both methods separately for each combina-
tion of two ROIs, sequence and image level. In addition, 25
texture features recently reported to be efficient (13) were
used (Table 3). The best 10 texture features selected with
both automated methods as well as for the manually selected
25 features used in a recent study for each sequence/
anatomical-level tissue pair combinations were analyzed by
principal component analysis (PCA) and linear discriminant
analysis, followed by nearest-neighbor classification with the
leave-one-out-method for the most expressive features result-
ing from PCA and the most discriminating features from
linear discriminant analysis. Nonlinear discriminant analysis
(NDA) was run with included artificial neural network classi-
fication. The mathematical notations of parameter calcula-
tion, image intensity normalization, feature selection
methods, and analyses are defined elsewhere (24,25).
Figure 3. T1 magnetization prepared gradient
echo sequence images representing anatomical
levels used in the analyses. Plain images on left
and images with regions of interest (ROIs) on
right. Anatomical level 1: corona radiata and
centrum semiovale with multiple sclerosis (MS)
plaques (a); level 2: basal ganglia (b). ROIs
presented in colors: red, white matter; pink,
normal-appearing white matter; aquamarine,
cerebrospinal fluid; orange, nucleus caudatus;
darker pink, nucleus lentiformis; blue, MS
plaque (10  10 ROI); green, cortex apart from
lesions (gray matter); yellow, cortex near lesion
(normal-appearing gray matter); violet, hand-
drawn MS plaque (freehand ROI).
TABLE 1. Tissues Used as ROIs and Sizes of ROIs in Pixels
ROI Size
White matter 10  10
Normal-appearing white
matter
10  10
Cerebrospinal fluid 10  10
Normal-appearing gray
matter apart lesion
6  6
Normal-appearing gray
matter near lesion
6  6
Nucleus caudatus 10  10
Nucleus lentiformis 10  10
MS plaque, freehand ROI Varying
MS plaque, standard size
ROI
10  10
MS = multiple sclerosis; ROI = region of interest.
TABLE 2. Tissue Pairs Used in the Classification of Tissues
Tissue pairs used in classification
White matter/MS plaque, freehand ROI
White matter/MS plaque, 10  10 ROI
White matter/normal-appearing white matter
Normal appearing white matter/MS plaque, freehand ROI
Normal appearing white matter/MS plaque, 10  10 ROI
Nucleus caudatus/nucleus lentiformis
MS = multiple sclerosis; ROI = region of interest.
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Because of the small sample size and skewed distributions,
nonparametric statistical tests were used. The Wilcoxon
signed rank test was used to evaluate the raw TA parameters
used to describe the textural difference between tissues. The
Wilcoxon signed rank test was used for all raw parameters
when testing intra-tissue textural differences between imaging
levels, and the Friedman test was used for intra-level analyses.
A level of P < .05 was considered statistically significant.
These analyses were performed using SPSS for Windows,
version 16.0.2.
RESULTS
Intra-tissue Difference in Sequential Image Slices and
between Anatomical Levels
The tissue textural variation between two anatomical levels of
interest (n = 38) was analyzed separately for all three imaging
series. Tests were performed forWM,NAWM, CSF, NAGM,
andMS plaque (standard-size and freehand ROIs). The differ-
ence between levels was evaluated by the number of TA
parameters with statistically significant differences. There
were 280 TA parameters in total. The T1 MPR series proved
to be uniform with a mean percentage difference of parame-
ters of 6% in the Wilcoxon signed rank test. The T1 MPR
with contrast agent and T2 TIRM series succeeded with
a mean percentage difference of parameters of 10%. Within
all series, freehand MS plaque ROI stood out with a mean
percentage of 27% statistically different parameters, as opposed
to the standard size MS ROI, with a mean percentage of 6%
(Table 4).
Texture intra-level variation for three sequential image slices
(n = 23) was analyzed for T1 MPR series with and without
contrast agent. Tests were performed for WM, NAWM, CSF,
NAGM, and MS plaque (standard size and freehand ROIs), in
addition to which, nucleus caudatus and nucleus lentiformis
were taken into the analyses on the level of basal ganglia. Slice-
to-slice texture variation was evaluated as the proportion of
parameters having a statistically significant difference in a total
of 280 parameters in the Friedman test. The variation was small
in both anatomical levels (mean percentages 5%–8%), and the
presence of contrast agent did not show any advantage. Tissue-
specific results were even, and MS freehand ROIs did not
show differences as great as between levels (mean percentage
9%). However, NAGM appeared to change more than other
tissues from slice to slice (mean percentage 10%) (Table 5).
Classification of Tissues
Classification was performed on six pairs of two-tissue
combinations (Table 2). Classification with B11 analyses for
WM-NAWM performed the best in NDA, with a correct
classification percentage of 85% within T2 TIRM images at
the anatomical-level basal ganglia and feature selection with
POE+ACC. Nucleus caudatus–nucleus lentiformis classifica-
tion was unsuccessful with a high rate of misclassification in all
analysis combinations. All combinations of white matter and
MS lesions (WM-MS plaque [10  10 ROI], WM-MS pla-
que [freehand ROI], NAWM-MS plaque [10  10 ROI],
and NAWM-MS plaque [freehand ROI]) gave highly accu-
rate classification results in all image types, anatomical levels,
and feature selection methods (NDA 96%–100%).
On the whole, feature selection with POE+ACC resulted
in the best classification; the Fisher method of selecting
parameters was somewhat worse, and the manually selected
group of parameters was inferior to both. T1 MPR with
contrast agent sequence showed slightly better overall classifi-
cation than without contrast agent and then the T2 TIRM
series. However, all sequences achieved similar classification
results, the best one varying somewhat between PCA, linear
discriminant analysis, and NDA analyses. Separation of WM
or NAWM from MS plaques proved slightly better when
the ROI of the plaque was hand-drawn and white matter
ROI was drawn apart from the MS lesion. A summary of
TABLE 3. List of 25 Texture Analysis Parameters used in
Manual Feature Selection
Parameters used in Manual Feature Selection
Parameter Group Parameter Name
Cooccurrence matrix Contrast S(0,1)
Cooccurrence matrix Contrast S(1,0)
Cooccurrence matrix Contrast S(1,1)
Cooccurrence matrix Contrast S(1,-1)
Cooccurrence matrix Difference variance
S(0,1)
Cooccurrence matrix Difference variance
S(1,0)
Cooccurrence matrix Difference variance
S(1,1)
Cooccurrence matrix Difference variance
S(1,-1)
Cooccurrence matrix Sum of squares S(0,1)
Cooccurrence matrix Sum of squares S(1,0)
Cooccurrence matrix Sum of squares S(1,1)
Cooccurrence matrix Sum of squares S(1,-1)
Cooccurrence matrix Sum variance S(0,1)
Cooccurrence matrix Sum variance S(1,0)
Cooccurrence matrix Sum variance S(1,1)
Cooccurrence matrix Sum variance S(1,-1)
Run length matrix Gray level
nonuniformity, 135o
Run length matrix Gray level
nonuniformity, 45o
Run length matrix Gray level
nonuniformity, 0o
Run length matrix Gray level
nonuniformity, 90o
Gradient Mean absolute gradient
Gradient Variance of absolute
gradient
Autoregressive model Standard deviation
Wavelet Energy, subband 1, HL
Wavelet Energy, subband 2, HL
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classifications based on PCA and NDA for tissue pairs is pre-
sented in Tables 6a-c.
In different combinations of imaging sequences, anatomical
level classification, and tissue pair classification, a total of 88
parameters was selected with automated methods POE+ACC
and Fisher for discrimination ofWM andMS lesion tissues. In
the top 10 ranked parameters, the T1MPR sequence had total
of 63 automatically selected parameters, T1 MPR+C 55, and
T2 TIRM a total of 47. The automated methods–based
parameter group had 12 parameters in common with the
manually selected group of parameters. The 10 best texture
parameters for each image sequence are listed in Tables 7a-c,
with the distribution median values and results of the Wil-
coxon signed rank test P values showing statistically significant
differences. Statistical differences between the raw parameters
of tissue pair combinations tested were, in general, uniform.
Distributions of the cooccurrence parameter sum average
S(1,1) for WM, NAWM, MS 10  10 pixel, and freehand
ROIs are shown in Figure 4 to demonstrate the separability
of raw parameters between tissues, imaging levels, and
sequences.
DISCUSSION
MRI texture analysis based on statistical, autoregressive-
model, and wavelet-derived texture parameters yielded excel-
lent classification of tissue-pair MS plaques and WM or
NAWM with high accuracy (NDA 96%–100%), and this
study strengthens the results reported in a recent study (13).
Likewise, the texture parameter sets gave accurate classifica-
tion in nearest-neighbor and artificial neural network anal-
yses, and parameters assessed individually by the Wilcoxon
signed rank test showed good discriminatory power of raw
parameters between tissues. The WM, NAWM, and MS
lesions examined with T2-weighted TIRM and T1-
weighted MPR with and without contrast agent sequences
TABLE 4. Intra-tissue Differences between Anatomical Levels Calculated for Three Imaging Sequences
Imaging Sequence T1 MPR T1 MPR+C T2 TIRM
n % of Total n % of Total n % of Total
WM 9 3% 18 6% 35 12%
NAWM 3 1% 8 3% 7 2%
CSF 20 7% 28 10% 20 7%
NAGM apart lesion 18 6% 21 7% 26 9%
NAGM near lesion 7 2% 9 3% 10 4%
MS plaque, freehand ROI 46 16% 94 34% 85 30%
MS plaque, 10  10 ROI 13 5% 22 8% 13 5%
MPR = magnetization prepared gradient echo sequence; MPR+C = T1 MPR with contrast agent; WM = white matter; NAWM = normal-
appearing white matter; CSF = cerebrospinal fluid NAGM = normal-appearing gray matter; MS = multiple sclerosis; ROI = region of interest.
The number and percentage of parameters having statistically significant difference in theWilcoxon test (P < .05) are given in columns; the total
number of parameters was 280. The total number of patients was 38.
TABLE 5. Intra-tissue Differences between Three Sequential Image Slices Calculated for T1-weighted Imaging Sequences T1MPR
and T1 MPR+C on Both Anatomical Levels with the Friedman Test
Imaging Sequence T1 MPR T1 MPR+C
Imaging Level 1 2 1 2
n % of Total n % of Total n % of Total n % of Total
WM 14 5% 20 7% 11 4% 15 5%
NAWM 18 7% 13 5% 26 9% 12 4%
CSF 3 1% 18 6% 17 6% 13 5%
NAGM apart lesion 22 8% 18 6% 18 6% 18 6%
NAGM near lesion 26 9% 26 9% 36 13% 21 8%
Nucleus caudatus 24 9% 18 6%
Nucleus lentiformis 11 4% 6 2%
MS plaque, freehand ROI 14 5% 38 14% 36 13% 15 5%
MS plaque, 10  10 ROI 17 6% 14 5% 20 7% 15 5%
MPR = magnetization prepared gradient echo sequence; MPR+C = T1 MPR with contrast agent; WM = white matter; NAWM = normal-
appearing white matter; CSF = cerebrospinal fluid; NAGM = normal-appearing gray matter; MS = multiple sclerosis; ROI = region of
interest.
Nucleus caudatus and nucleus lentiformis were visible only in level 2 and were thus left out of the analyses of level 1. The number and
percentage of parameters having statistically significant differences (P < .05) are given in columns. The total number of texture parameters
was 280. The total number of patients was 23.
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led to nearly identical classifications, the sequence with
contrast agent being slightly superior to the others. Consid-
ering this, different imaging sequences may be selected for
analysis without notable loss of accuracy, and invasive use of
contrast agent is not necessary in analyses of these tissues to
this extent. The additional value of combining parameter
values from different sequences for single-classification anal-
ysis remains to be investigated.
In the classification of WM and NAWMwe achieved up to
85% accurate classification. This corroborates the results of an
earlier study (13). It should be considered whether the classi-
fication could be enhanced with some particular analysis
protocol, and if not, whether this classification result of
WM and NAWM is sufficient for automated classification
for scientific purposes or can be used as a second opinion
tool in a clinical setting.
The method did not succeed in distinguishing the tissue
pair of nucleus lentiformis and nucleus caudatus, indicating
that the texture parameters and image acquisition as per-
formed were not sufficient for detecting the textural change
between the tissues investigated.
There were no significant intra-tissue differences in slice-
to-slice comparisons when standard size ROIs were used,
indicating that image slice selection for analyses tolerates
changes. Parameters describing tissues did not change consid-
erably in slice-to-slice comparisons if the image slice was
selected one or two slices cranially or caudally from the rec-
ommended slice, if slice thickness was 0.9 mm and if there
was no spacing between slices. The difference between
anatomical levels was also acceptably small, especially in
T1-weighted MPR sequences without contrast agent. Varia-
tion was still found in the best discriminating features selected
with automated methods, indicating changes between levels.
In all comparisons, there were some small differences between
imaging sequences. We recommend that tissue samples (ie,
ROIs) be selected from fixed anatomical levels if possible,
TABLES 6A–C. Rate of Correct Classification of Tissue Pairs Independently Calculated for the Three Imaging Sequences T1 MPR
(6a), T1 MPR+C (6b), and T2 TIRM (6c)
Table 6a
T1 MPR
Imaging Level Level 1 Level 2
Feature Selection F P M F P M
WM vs. MS freehand ROI
PCA 94% (72/76) 98% (75/76) 85% (65/76) 90% (69/76) 97% (74/76) 85% (65/76)
NDA 100% (76/76) 100% (76/76) 100% (76/76) 98% (75/76) 100% (76/76) 98% (75/76)
WM vs. MS 10  10 ROI
PCA 94% (72/76) 96% (73/76) 78% (60/76) 81% (61/75) 94% (71/75) 81% (61/75)
NDA 100% (76/76) 100% (76/76) 98% (75/76) 97% (73/75) 100% (75/75) 98% (74/75)
NAWM vs. MS freehand ROI
PCA 92% (70/76) 98% (75/76) 86% (66/76) 98% (75/76) 97% (74/76) 85% (65/76)
NDA 100% (76/76) 100% (76/76) 100% (76/76) 100% (76/76) 100% (76/76) 100% (76/76)
NAWM vs. MS 10  10 ROI
PCA 90% (69/76) 90% (69/76) 81% (62/76) 93% (70/75) 97% (73/75) 85% (64/75)
NDA 98% (75/76) 98% (75/76) 98% (75/76) 100% (75/75) 100% (75/75) 97% (73/75)
Table 6b
T1 MPR+C
Imaging Level Level 1 Level 2
Feature Selection F P M F P M
WM vs. MS freehand ROI
PCA 97% (73/75) 100% (75/75) 93% (70/75) 96% (73/76) 96% (73/76) 93% (71/76)
NDA 100% (75/75) 100% (75/75) 100% (75/75) 100% (76/76) 100% (76/76) 98% (75/76)
WM vs. MS 10  10 ROI
PCA 92% (70/76) 94% (72/76) 82% (63/76) 96% (73/76) 97% (74/76) 77% (59/76)
NDA 100% (76/76) 100% (76/76) 96% (73/76) 100% (76/76) 100% (76/76) 98% (75/76)
NAWM vs. MS freehand ROI
PCA 93% (70/75) 98% (74/75) 90% (68/75) 90% (69/76) 96% (73/76) 88% (67/76)
NDA 96% (72/75) 100% (75/75) 100% (75/75) 98% (75/76) 97% (74/76) 98% (75/76)
NAWM vs. MS 10  10 ROI
PCA 94% (72/76) 92% (70/76) 81% (62/76) 100% (76/76) 98% (75/76) 82% (63/76)
NDA 100% (76/76) 100% (76/76) 96% (73/76) 100% (76/76) 100% (76/76) 98% (75/76)
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though some acceptable slice-to-slice variation still remains
even with the use of anatomical landmarks for slice selection.
The ROI setting with standard-size vs. freehand ROIs was
tested with one tissue sample, MS plaque. There were distinct
differences between the hand-drawn and standard ROIs of
MS plaques in intra-tissue texture parameter comparison.
Standardized ROI on a lesion gave slightly weaker classifica-
tion from WM than hand-drawn ROI; naturally, a standard-
size ROI box may overlap some NAWM neighboring a MS
plaque. Compared to hand-drawn ROIs, the advantages of
standardized ROIs include increased tolerance for slice selec-
tion and reproducibility. The advantages and disadvantages of
ROI-drawing methods on lesions should be taken into
consideration when establishing the analysis protocol.
When automated feature reduction methods were
compared, the POE+ACC method was found to select
parameters giving better separation between tissue pairs. It
should be noted that feature selections that were run indepen-
dently for each tissue pair combination led to superior classi-
fication results compared to the fixed feature group used in
another study (13). The best discriminating texture parame-
ters showed a change between the imaging sequences and
tissue pairs of interest; automated methods recommended
88 parameters out of a total of 280 for analyses. Future studies
should examine whether there are sensitive sets of features
robust to changing imaging sequences and tissues in the
neuroradiological context.
In MRI, the images may suffer from artefacts of different
origin, such as image thermal noise, image background
nonuniformity from magnetic field inhomogeneities, and
nonstandardness of image gray-scale intensity. High image
quality and minimization of image artefacts are important,
especially in quantitative analyses. There are numerous
methods to correct intensity inhomogeneity artefacts, but
this problem is still not completely solved (26). Several
reports have shown effective methods for image intensity
standardization (27–29). The clinical images obtainable in
our normal clinical procedures, including elliptical and
prescan filtering to improve the image quality, also
appeared to lead to accurate classification of WM and MS
lesions. If extended artefact-correcting methods or a combi-
nation of methods was used, the texture analysis results
would probably have shown even better discrimination
between tissues.
Our texture analysis protocol is suitable for the classification
of MS plaques from WM and NAWM. Using one image
sequence in the protocol would meet the goal; all sequences
tested were suitable for TA purposes. However, this situation
may change due study design–specific issues; for example, the
study focuses on expected differences in the contrast enhance-
ment of lesions or lesions visible in different types of
sequences. According to the requirements of the case in ques-
tion, more than one sequence should be considered when
establishing a protocol and selecting imaging sequences to
analyze. As was shown here, both anatomical levels used in
the analyses resulted in equal classification. When construct-
ing the analysis protocol, it does not seem necessary to select
more than one anatomical level of interest. The ROI drawing
Table 6c
T2 TIRM
Imaging Level Level 1 Level 2
Feature Selection F P M F P M
WM vs. MS freehand ROI
PCA 100% (76/76) 100% (76/76) 89% (68/76) 98% (74/75) 100% (75/75) 96% (72/75)
NDA 100% (76/76) 100% (76/76) 100% (76/76) 100% (75/75) 100% (75/75) 100% (75/75)
WM vs. MS 10  10 ROI
PCA 85% (65/76) 86% (66/76) 80% (61/76) 88% (66/75) 97% (73/75) 86% (65/75)
NDA 97% (74/76) 98% (75/76) 96% (73/76) 97% (73/75) 100% (75/75) 98% (74/75)
NAWM vs. MS freehand ROI
PCA 98% (75/76) 100% (76/76) 93% (71/76) 100% (76/76) 100% (76/76) 89% (68/76)
NDA 100% (76/76) 100% (76/76) 100% (76/76) 100% (76/76) 100% (76/76) 100% (76/76)
NAWM vs. MS 10  10 ROI
PCA 77% (59/76) 81% (81/76) 68% (52/76) 86% (66/76) 89% (68/76) 69% (53/76)
NDA 96% (73/76) 96% (73/76) 98% (75/76) 97% (74/76) 98% (75/76) 98% (75/76)
Results are presented for two anatomical imaging levels: corona radiata and centrum semiovale and basal ganglia, for three feature reduction
methods: Fisher (F), POE+ACC (P), andmanual (M). Classifications were based on 1-NN for features of principal component analysis (PCA) and
onANN for nonlinear discriminant analysis (NDA) features. Data are percentages of correct classification. Data in parentheses are the number of
region of interest (ROI) samples correctly classified and the total number of ROI samples in the analysis in question used to calculate
percentages. The total number of patients was 38.
MPR = magnetization prepared gradient echo sequence; MPR+C = T1 MPR with contrast agent; WM = white matter; NAWM = normal-
appearing white matter; CSF = cerebrospinal fluid NAGM = normal-appearing gray matter; MS = multiple sclerosis; ROI = region of interest.
TABLES 6A–C. (continued) Rate of Correct Classification of Tissue Pairs Independently Calculated for the Three Imaging
Sequences T1 MPR (6a), T1 MPR+C (6b), and T2 TIRM (6c)
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method should be considered for each individual study. The
automated feature selection method POE+ACC, provided
by MaZda, led to better separation between tissues than the
other two methods, but all methods used were effective.
Regarding a clinical analysis protocol in MRI-based MS
texture analysis, we evaluated the effects of imaging sequence,
anatomical level of interest, slice-to-slice variation, ROI
drawing method, and feature selection method. Statistical,
autoregressive-model, and wavelet-derived texture parameters
are suitable for the classification ofwhitematter andMS lesions.
All imaging sequences used in this study performed the classifi-
cations equally well; different types of sequences can be used for
the analyses. ROIs should be selected from fixed anatomical
levels to minimize TA parameter variation. Using anatomical
landmarks for slice selection still leaves some acceptable slice-
to-slice variation. Standard size ROI boxes were shown to
tolerate changes in image slice selection. StandardROIs vs. free-
handROIs should be considered according to the requirements
of the study. Case-specific selection of the texture parameters to
analyze outperformed the discriminatory power of the fixed
parameter group by a small margin. These results are important
in protocol determination and should always be considered
regarding the case in question when striving for a robust and
reproducible protocol in the clinical setting.
Appropriate MRI texture analyses (ie, analyses of NAWM
andNAGM) inMS patients can, along with routineMRI anal-
yses (ie, analyses of plaques and atrophy), increase the extent of
pathological lesions detected (total lesion load). This kind of
combination analysis, when performed longitudinally, can
adequately quantify the lesion load after treatment, thereby
helping to monitor treatment effects. MRI texture analyses of
lesions in MS can also help in specifying the types of MS (clin-
ically isolated syndrome, primary progressive MS, progressive-
relapsing MS, relapsing-remitting MS, secondary progressive
MS) based on the differences in analyses between the groups.
In conclusion, we believe that a robust and reproducible MRI
TA protocol based on statistical, autoregressive-model and
wavelet-derived texture parameters can provide a new and
better clinical method for the early diagnosis and monitoring
of quantitative disease progression and of the effectiveness of
various treatment protocols in multiple sclerosis.
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